Effect of Tissue Viscoelasticity and Stiffness on Hemodynamics and Endothelial Cell Signaling by Elliott, Winston Howard
 i 
 
Effect of Tissue Viscoelasticity and 
Stiffness on Hemodynamics and 
Endothelial Cell Signaling 
 
By, 
Winston Elliott 
A thesis submitted to the 
 Faculty of the Graduate School of the  
University of Colorado in partial fulfillment 
of the requirement for the degree of 
Doctor of Philosophy 
Department of Mechanical Engineering 
November 15, 2017 
 
Advisors: 
Wei Tan 
Claudio Migliaresi 
Antonella Motta 
 
 ii 
 
 
This thesis entitled: 
Effect of Tissue Viscoelasticity and Stiffness on Hemodynamics and Endothelial Cell Signaling 
written by Winston Howard Elliott 
has been approved for the Department of Mechanical Engineering 
 
 
 
       
Dr. Wei Tan 
 
 
 
       
Dr. Virginia Ferguson 
 
Date    
 
 
The final copy of this thesis has been examined by the signatories, and we 
find that both the content and the form meet acceptable presentation standards 
of scholarly work in the above mentioned discipline. 
  
 iii 
 
Elliott, Winston H. (Ph.D., Mechanical Engineering) 
Effect of Tissue Viscoelasticity and Stiffness on Hemodynamics and Endothelial Cell Signaling 
Dissertation directed by Associate Professor Wei Tan 
 
Cardiovascular disease (CVD) is the most common cause of death in the United States of America, 
accounting for 24% of all deaths each year,(Anderson et al., 2003) and is projected to rise above 20% 
globally by 2030.(Mathers and Loncar, 2006) Options for CVD treatment do exist, but are limited by 
availability of healthy replant tissue from the patient or long term effectiveness and failure rates of both 
autologous tissue grafts and artificial implants. Grafting failure may often be attributed to the poor 
mimicry of the site-specific, healthy arterial tissue. While much TEVG research focuses on 
endothelialization of the graft lumen through chemical signaling, mechanotransduction plays a large role 
in forming and maintaining a healthy endothelial cell (EC) monolayer. Arteries and grafts interact with 
hemodynamics to determine flow pulsatility and create healthy, or pathological, mechanical signaling 
environments. Though arterial tissue is known to be viscoelastic,(Armentano et al., 2006; Bergel, 1961; 
Bia et al., 2006) the importance of this in developing healthy blood flow is undetermined. Therefore, a 
gap in the knowledge occurs in the importance of arterial mechanics affecting graft outcomes. To address 
this we attempt to examine specific shortcomings: 1) Determine whether pathological flow is capable of 
maintaining EC monolayer in a low arterial compliance model, 2) Establish methods of catering protein 
hydrogel frequency-dependent properties towards establishing biodegradable materials intended for 
TEVG, 3) Determine benefits of viscous wall damping in improving hemodynamics towards improved 
cell response. 
This proposal centers on improving cell response to pathological hemodynamics through catered 
viscoelastic material response at the arterial wall. To address this, we hypothesize that maintaining 
healthy EC monolayer is predicated on hemodynamic mechanotransduction, which results from both graft 
compliance and viscous damping of the material. To validate this hypothesis, we examine healthy and 
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pathological hemodynamic effects on EC monoculture, and systematically determine the role of 
viscoelastic material response in maintaining healthy hemodynamics.  
 
 
 
 
  
 v 
 
 
Table of Contents 
Table of Contents ............................................................................................................................. v 
Chapter 1 ........................................................................................................................................... 1 
Introduction & Background ........................................................................................................ 1 
1.1 Arterial Properties ...................................................................................................................... 4 
1.2 Disease State ................................................................................................................................. 6 
1.3 Cell Response to Fluid Shear ................................................................................................... 7 
1.4 Treatment Options ...................................................................................................................... 9 
1.5 Conclusion and Impact ........................................................................................................... 10 
Chapter 2 ......................................................................................................................................... 12 
Cardiovascular Mechanobiology: Exploitation for Medical Benefit ........................... 12 
2.1 Introduction ............................................................................................................................... 13 
2.2 Arterial Wall Mechanics and Mechanobiology .............................................................. 14 
2.3 Mechanical Signal and Mechanotransduction on the Arterial Wall ....................... 15 
2.4 Physiological and Pathological Responses to Mechanical Signals .......................... 18 
2.5 The Role of Vascular Mechanics in Modulating Mechanical Signals ...................... 20 
2.6 Therapeutic Strategies Exploiting Mechanobiology .................................................... 23 
2.7 The Role of Haemodynamics in Mechanobiology ......................................................... 24 
2.7.1 Computational Fluid Dynamics ...................................................................................................... 24 
2.7.2 Biomedical Applications of CFD ..................................................................................................... 27 
2.7.3 Vascular Grafting ................................................................................................................................. 27 
2.7.4 Vascular Graft Failure ........................................................................................................................ 29 
2.7.5 Novel Graft Designs ............................................................................................................................. 30 
2.7.6 Haemodynamic Metrics .................................................................................................................... 34 
2.7.7 Haemodynamics of Spiral and Helical Grafts ........................................................................... 35 
2.8 SUMMARY AND CONCLUSION ............................................................................................... 39 
 High Pulsatility Flow Promotes Vascular Fibrosis by Triggering Endothelial 
EndMT and Fibroblast Activation .................................................................................................. 41 
3.1 Introduction ............................................................................................................................... 44 
3.1 Materials and Methods ........................................................................................................... 47 
3.1.1 Cell Culture ............................................................................................................................................. 47 
3.1.2 Flow Setup and Experiments .......................................................................................................... 47 
3.1.3 Western Blot .......................................................................................................................................... 49 
3.1.4 Real-Time PCR ...................................................................................................................................... 49 
3.1.5 Fibroblast Migration and Proliferation Assay.......................................................................... 50 
3.1.6 Apoptosis Assay.................................................................................................................................... 50 
3.1.7 Data Analysis ......................................................................................................................................... 51 
3.2 Results .......................................................................................................................................... 52 
 vi 
 
3.2.1 HPF induced EndMT after 48 hr stimulation ........................................................................... 52 
3.2.2 Flow-conditioned media from ECs under HPF induced EndMT of HPAEC and 
activated migration and proliferation of AdvEC ............................................................................................ 56 
3.2.3 Taxol reduced EndMT response of HPAEC ............................................................................... 58 
3.2.4 Cell apoptosis preceded the EndMT ............................................................................................ 60 
3.3 Discussion ................................................................................................................................... 60 
 Silk Hydrogels of Tunable Structure and Viscoelastic Properties Using 
Different Chronological Orders of Genipin and Physical Crosslinking ............................ 64 
4.1 Introduction ............................................................................................................................... 67 
4.2 Materials and Methods ........................................................................................................... 70 
4.2.1 Materials .................................................................................................................................................. 70 
4.2.2 Preparation of Silk Fibroin Solution. ........................................................................................... 70 
4.2.3 Hydrogel Formation ........................................................................................................................... 71 
4.2.4 Molecular Structure ............................................................................................................................ 73 
4.2.5 Microstructure Visualization .......................................................................................................... 76 
4.2.6 Mechanical Properties ....................................................................................................................... 76 
4.3 Results and Discussions ......................................................................................................... 78 
4.3.1 Physical appearance of gels ............................................................................................................. 78 
4.3.2 Molecular Structure ............................................................................................................................ 79 
4.3.3 Microstructure from SEM and confocal imaging .................................................................... 84 
4.3.4 Mechanical Properties ....................................................................................................................... 88 
4.4 Discussion ................................................................................................................................... 90 
4.5 Conclusions ................................................................................................................................. 93 
 Effect of Arterial Viscoelasticity and Stiffness on Hemodynamics .................... 95 
5.1 Overview .................................................................................................................................... 125 
5.2 Materials and Methods ......................................................................................................... 125 
5.2.1 Material Fabrication ........................................................................................................................ 125 
5.2.2 Material Characterization.............................................................................................................. 125 
5.3 Hemodynamics ........................................................................................................................ 125 
5.3.1 Fluid/Material Coupling................................................................................................................. 125 
5.3.2 Conduit Design ................................................................................................................................... 125 
5.3.3 Fabrication of the Conduit ............................................................................................................ 125 
5.3.4 Applied Flow ....................................................................................................................................... 125 
5.3.5 Data Analysis ...................................................................................................................................... 125 
5.4 Results ........................................................................................................................................ 125 
5.4.1 Material Properties Match Literature ...................................................................................... 125 
5.4.2 Comparison of Conduit Stiffness and Wave Speed ............................................................. 125 
5.4.3 Pressure and Diameter Waveforms are Attenuated in Viscoelastic Conduits ........ 125 
5.4.4 Wall Shear Stress Waveforms are Attenuated with Viscoelastic Wall Properties . 125 
5.4.5 Mechanical Energy of Flow ........................................................................................................... 125 
5.5 Discussion ................................................................................................................................. 125 
 Future Directions ............................................................................................................. 126 
6.1 Coupling Material Properties and Hemodynamics .................................................... 126 
6.2 Application of Cells ................................................................................................................ 127 
References ............................................................................................................................................... 129 
APPENDIX 1: Mechanics of the Tube .............................................................................................. 150 
A1.1 Thick-Walled Pressure Vessel Mechanics ..................................................................... 150 
 vii 
 
A1.1.1  Material Characterization ......................................................................................................... 150 
A1.1.2  Radial Wall Strain ........................................................................................................................ 152 
A1.1.3 Longitudinal Strain ...................................................................................................................... 153 
A1.1.4 Error in Radial Strain ................................................................................................................. 153 
APPENDIX 2: Normalization of the Flow System ....................................................................... 155 
A2.1 Normalizing Flow from Tee-Junction ............................................................................................ 155 
 
  
 viii 
 
Tables 
Table 5.1- Material parameter guidelines for viscoelastic conduit design………………………..p. 109 
  
 ix 
 
Figures 
Figure 1.1- Scheme of proposed dissertation………………………………………………………p. 12 
Figure 1.2- Historical perspective of arterial mechanics contributing to disease and resulting treatment 
designs………………………………………………………………………………………………….p. 13 
Figure 1.1.1- Noticeable hysteresis curve of Ovine Artery………………………………………...p. 15 
Figure 1.1.2- Representative cross sections of the aorta and muscular arteries ……….…………..p. 15 
Figure 1.3.1- Examples of different pulsatility indices (PI). ………………………….…...………p. 18 
Figure 1.3.2- Cell mechanotransduction in response to fluid shear…………………….………….p. 19 
Figure 1.5.1- Project outline…………………………………………………………….………….p. 21 
Figure 2.2.1 – The impact of vessel mechanics and geometry on blood flow………….………….p. 25 
Figure 2.7.1.1- An example of a typical CFD process in a biomedical application…….…………p. 36 
Figure 2.7.4.1- Spatial distribution and localized sites of intimal thickening/intimal hyperplasia in a 
typical arterial bypass graft…………………………………………………………………………….p. 40 
Figure 2.7.5.1- Industrial examples of inducing helical flow……………………………..……….p. 41 
Figure 2.7.7.1- Schematics and the dimensions of the present four geometric models…….……...p. 47 
Figure 2.7.7.2- Distributions of different haemodynamic parameters……………………………..p. 48 
Figure 3.3.1.1- Gene expression results showing that ECs after 48 hr HPF stimulation undergo the 
EndMT process…………………………………………………………………………………………p. 64 
Figure 3.3.1.2- Results from western blotting assays show the EndMT-related markers expressed by 
ECs after 48 hr of flow stimulation. …………………………………………………………………...p. 66 
Figure 3.3.2.1- Flow-conditioned media (FCM) from ECs after 48 hr stimulation with HPF induced 
quiescent ECs and AdvFBs to express α-SMA protein expression…………………………………….p. 67 
Figure 3.3.2.2- Flow-conditioned culture media from ECs exposed to HPF significantly enhanced 
AdvFB migration and proliferation…………………………………………………………………….p. 69 
 x 
 
Figure 3.3.3.1- Results from western blotting assays show that taxol induced changes in the protein 
expression in ECs after 48 hr of HPF stimulation………………………………..………………...p. 70 
Figure 3.3.4.1- The EMT process of ECs is preceded with cell apoptosis………..…………....p. 71 
Figure 3.4.1- Possible mechanisms showing the effect of HPF on vascular fibrosis…..………p. 75 
Figure 4.3.1.1- Preparation protocols and physical appearances of the gel samples…………..p. 91 
Figure 4.3.2.1- Gel permeation chromatography results………………………………………p. 92 
Figure 4.3.2.2- Genipin fluorescence emission results………………………………………...p. 93 
Figure 4.3.2.3- Primary amine sites quantified by ninhydrin assay…………………………...p. 94 
Figure 4.3.2.4- Infrared Spectra (FTIR) showing similar peak patterns among gel samples treated 
with PCT……………………………………………………………………………………………p. 95 
Figure 4.3.3.1- SEM micrographs showing the gel microstructure and morphology…………p. 97 
Figure 4.3.3.2- Comparison of Control (Top) and Pre48CX (Bottom) microstructures……...p. 98 
Figure 4.3.3.3. SEM (left) and confocal microscopy (right) images, showing the gels in dry and wet 
environments, respectively………………………………………………………………….……...p. 99 
Figure 4.3.4.1- Storage (E1’) and loss (E1’’) moduli as functions of frequency……….……..p. 100 
Figure 4.3.4.2- Energy dissipation per cycle was calculated from hysteresis curves, and plotted 
against frequency……………………………………………………………….…………………..p. 101 
Figure 5.2.1– Diagram of the molecular structure of swollen poly(dimethylsiloxane………..p. 112 
Figure 5.3.1.1- Frequency spectrum of Harvard Apparatus rodent pump…………………….p. 115 
Figure 5.3.2- Mock vessel design diagrammed on the left, with modeled lumen radius response on 
the right…………………………………………………………………………………………….p. 116 
Figure 5.4.2.1- Pressure Modulus of conduits………………………………………………..p. 117 
Figure 5.4.2.1- Harmonic wave speed values of the Fourier series indicate increasing values with 
viscoelasticity and with physiological applied pressures………………………………………….p. 126 
Figure 5.4.3.1- Inlet and outlet pressure plotted against diameter……………………………p. 127 
 xi 
 
Figure 5.4.4.1- Inlet and outlet volumetric flow (Q) plotted against diameter……………….p. 128 
Figure 5.4.4.2- Comparison of PI as measured by flow rate and wall shear stress…………..p. 130 
Figure 5.4.5.1- Mechanical energy of flow as the material derivative of kinetic energy….…p. 131 
Figure 5.5.1- Phase alignment of the volumetric flow with the conduit distension for both physiologic 
(left) and pathological (right) conditions………………………………………………………….p. 132 
Figure 6.2.1- Fourier transform infra-red spectroscopy (FTIR) measurements (Left) and x-ray 
photoelectric spectroscopy (XPS) sweep (Right) of surface chemistry on treated PDMS……….p. 137 
 
  
 1 
 
Chapter 1 
Introduction & Background 
Cardiovascular disease (CVD) is the most common cause of death in the United States of America, 
accounting for 24% of all deaths each year,(Anderson et al., 2003) and is projected to rise above 20% 
globally by 2030.(Mathers and Loncar, 2006) Arterial stiffening and narrowing are important signals in 
CVD, including myocardial infarction, heart failure, and overall mortality.(Zieman et al., 2005) 
Decreased compliance and luminal narrowing are directly responsible for high pulsatile flow 
(HPF),(Mitchell, 2008; Stewart and Lyman, 1992; Tan et al., 2014) which is linked to the inflammatory 
response, vascular fibrosis, intimal hyperplasia (IH), and endothelial-to-mesenchymal transition.(Elliott et 
al., 2015; Scott et al., 2013) Conduit arteries, such as the carotid, femoral, or coronary are important in 
maintaining physiologic hemodynamics and preventing CVD. Increased resistance in conduit arteries may 
reduce transport downstream, and increase left ventricular work, which is tied to many vascular diseases. 
These phenomena result from the influence of material mechanics on blood flow, and resulting dynamic 
shear signaling on cell response. Therefore, understanding fluid-structure interaction in arterial blood flow 
is important in determining pathological mechanical and hemodynamic changes, as well as new avenues 
for treatment. 
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Figure 1.1- Scheme of proposed dissertation. Effect of arterial compliance and viscoelasticity on fluid 
body, and resulting mechanical signaling of vascular cells. 
Examining the past 25 years of arterial health and disease, focus has gradually shifted from static 
vascular geometries towards dynamic response of the wall, and their respective contributions to 
haemodynamic signaling of the cells. This has coincided with improved imaging of time-dependent 
response of tissues in situ. Early emphasis in mechanical propagation of the disease state revolved around 
geometry of the arterial tree, including branching, bifurcation, and anastomoses interaction with pulsatile 
flow.(Kim et al., 1993; Ku et al., 1985; Ojha, 1994) While the importance of compliance mismatch had 
been examined over the past 25 years,(Abbott et al., 1987; Friedman et al., 1992; Okuhn et al., 1989; 
Shadwick, 1999) arterial mechanics as a measure of health have been a focus in the past 10-15 
years.(Gessaroli et al., 2012; Liu et al., 2010; Wagenseil and Mecham, 2009) This has allowed for 
treatment design schemes to shift towards maintaining dynamic mechanical response of arterial 
walls.(Greenwald and Berry, 2000; Inoguchi et al., 2006; Madhavan et al., 2013; Nagiah et al., 2015; 
Sarkar et al., 2006) Time-dependent response of the arterial wall has garnered more attention in the past 
10 years.(Armentano et al., 2014; Bia et al., 2006; Valdez-Jasso et al., 2011) This has led to viscoelastic 
properties of arteries being used as a metric of health,(Liu et al., 2015; Wang et al., 2013c) and coincided 
with application of time-dependent materials in tissue replacement treatments,(Zhao, 2014; Zhao et al., 
2014), including vascular grafting.(Nagiah et al., 2015; Neufurth et al., 2015) Further understanding of 
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the interaction between viscoelastic properties and haemodynamics is important moving forward in both 
understanding vascular health, and defining treatment design criteria. 
 
Figure 1.2- Historical perspective of arterial mechanics contributing to disease and resulting treatment 
designs. 
 
This dissertation reports a comprehensive study, expanding on the importance of mechanical signaling 
in maintaining healthy arteries, integrating time-dependent material property design schemes into an 
experimental platform for studying vascular mechanics to improve our understanding of the relationship 
between blood flow and vascular material properties. By expanding on this complex relationship, we may 
help provide direction in further understanding arterial health and vascular graft design. Chapter 2 reports 
our comprehensive reviews of state-of-the-art understanding of vascular mechanobiology, and its 
application to improve treatments. Chapter 3 reports our own contribution towards understanding cellular 
mechanotransduction of high pulsatility flow (HPF) in the vasculature. Chapter 4 is our study on time-
dependent material design schemes of a biodegradable material, silk fibroin. Chapter 5 reports the results 
of time-dependent properties on pulse wave propagation, and therefore mechanical signals applied to 
vascular cells. Chapter 6 concludes and discusses the overall study by highlighting important findings and 
provides suggestions for future direction in the area. 
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1.1 Arterial Properties 
Vasculature may be separated into three distinct layers: the intima, media, and adventitia. Endothelial 
cells line the inner lumen of the vasculature, and are attached to the basal media, which forms the tunica 
intima. Tunica intima structure contributes little to overall vascular stiffness, as it is approximately 1-2 
microns thick with elastic modulus of 1-3 kPa.(Peloquin et al., 2011) Alternately, in muscular arteries 
such as the carotid, femoral, and coronary arteries, extra cellular matrix (ECM) of the media contributes 
to 50% of the dry weight. The media layer consists of layered elastin lamellae, which alternate with 
collagen, vascular smooth-muscle cells (vSMC), and high proteoglycan layers. This layer is largely 
responsible for material properties within the physiologic range,(Wagenseil and Mecham, 2009) and the 
viscoelastic response of muscular arteries.(Armentano et al., 1995) . Additionally, proteoglycan (PG) 
content contributes to tissue swelling and hydration, and has been shown to provide poroelastic viscous 
response within other tissues.(Korhonen et al., 2003) The adventitia, or outer layer, is primarily composed 
of Collagen Type-I (COL-I) and fibroblasts (FB), and counters vessel over-distension.(Dobrin, 1978; 
Wagenseil and Mecham, 2009) 
The highly elastic, and relatively soft elastin layering within the media acts as an energy reservoir 
within the aorta. During systole, the aorta undergoes significant strain, which decreases as during 
aging.(Redheuil et al., 2010) Contrastingly, the muscular arteries, such as the carotid, femoral, and 
coronary exhibit stiffer wall properties, and greater viscous material response (Figure 1.1.1).(Armentano 
et al., 1995, 2014; Bergel, 1961; Bia et al., 2006; Learoyd and Taylor, 1966)  
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Figure 1.1.1- Noticeable hysteresis curve from ovine femoral artery (dashed line), as compared to 
artificial polymer material (Poly(L-lactic acid), solid line). Image taken from Armentano. (Armentano et 
al., 1995) 
 
This may be seen in histological comparison of ECM and cellular content, with muscular arteries 
exhibiting much greater SMC and PG content (Figure 1.1.2). These properties may directly relate to flow 
and pressure wave attenuation in healthy physiology, decreasing pulsatility and improving cell response 
downstream. 
 
Figure 1.1.2- Representative cross sections of the aorta and muscular arteries. Material components 
were stained using the Cajal-Gallengo histological method, with smooth muscle cells (yellow), elastin 
A
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(red), and collagen (blue), being the main components imaged. Image taken from Valdez-Jasso, 
2011.(Valdez-Jasso et al., 2011) 
 
Fluid shear at the wall, both direction and amplitude, has a significant effect on cell response and 
disease development, therefore healthy blood flow is important to maintain. There is some disagreement 
in the literature of how these properties affect wave attenuation. Previously, arterial compliance was 
described as the main contributor to decreased blood velocity, by increasing the cross-sectional area and 
maintaining volumetric flow.(O’Rourke et al., 2011) Additionally, conduit artery viscoelasticity has been 
described as damping pressure and flow wave forms.(Armentano et al., 1998, 2006) This is additionally 
supported by coupling wall and fluid mechanics, both in continuous body theory, and advanced numerical 
models.(Raghu and Taylor, 2011) More recently, attenuation has been attributed to pressure wave 
reflections resulting from impedance disparities between the aorta and muscular arteries.(Mitchell, 2008) 
 
 
1.2 Disease State 
Common disease states in the vasculature are atherosclerotic plaques, vascular fibrosis, and intimal 
hyperplasia, all of which increase arterial stiffness and eventually lead to occlusion.(Zieman, 2005) 
Atherosclerosis occurs through the deposition of calcified scar tissue, which may eventually occlude the 
artery, and is associated with vascular fibrosis and IH.(Lan et al., 2013) Vascular fibrosis and IH exhibit 
cell proliferation within the vascular intima, though origins of these cells have been indicated throughout 
all layers of the artery, and are an ill-defined cell-type.(Arciniegas et al., 2000; Berard et al., 2013; Elliott 
et al., 2015; Frid, 2002; Li et al., 2007; Rekhter et al., 1993; Sakao et al., 2009) Additionally, vascular 
cells respond with increased matrix metalloproteinase (MMP) and transforming growth factor-β (TGF-β) 
release, with resulting inflammatory response and COL-I production. This all contributes to adventitial 
FB migration and endothelial-to-mesenchymal transition (EndMT), as well as increased scarring and 
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vascular stiffness.(Elliott et al., 2015; Lan et al., 2013; Li et al., 2007; Medici et al., 2011; Owens, 2010; 
Zeisberg et al., 2007a) Eventually, cell proliferation and migration end in vascular occlusion, or stenosis. 
As stated in the preceding section, vascular material properties are important in maintaining healthy 
hemodynamics. Unhealthy wave reflectance may cause pressure amplification,(O’Rourke and Hashimoto, 
2007) and systemically increase flow pulsatility within the peripheral arteries.(Mitchell, 2008) 
Additionally, locally decreased compliance in arteries, which occurs during the aging process, or other 
disease states such as vascular fibrosis and IH, increases PI values present.(Okuhn et al., 1989; Tan et al., 
2014) As mentioned previously, this is important not only as an indication of pathological flow 
conditions, but increased PI and HPF are indicated heavily in the inflammatory response, vascular 
fibrosis, and IH.(Elliott et al., 2015; Scott et al., 2013) Vascular fibrosis, IH, and atherosclerosis all 
decrease arterial compliance,(Lan et al., 2013; O’Rourke and Hashimoto, 2007; Zieman, 2005) which in 
turn begins a positive feedback loop, worsening hemodynamics and resulting disease state. 
Effects of the disease state on viscoelasticity are unclear, and change between species, anatomical 
location, and disease types. Viscoelastic arterial response has most frequently been examined in 
hypertensive patients,(Armentano et al., 1998, 2006; Wang et al., 2013c) though results vary. Previous 
work examining human common carotid artery indicate similar ratio of viscous to elastic response after 
remodeling occurs.(Armentano et al., 1998, 2006) This corresponds well with the PG rich medial 
thickening known to occur in hypertension. Alternately, changes in viscoelastic response to vascular 
fibrosis have not been thoroughly examined, but it is known that remodeling occurs within the wall 
material,(Claridge et al., 2009) most likely from increased COL-I presence. 
 
1.3 Cell Response to Fluid Shear 
Hemodynamics play a large role in plaque formation, vascular fibrosis, and IH. Normal blood flow 
involves an oscillating flow waveform which is unidirectional, ergo the mean flow is greater than the 
waveform amplitude. Blood flow is most easily quantifiable by the pulsatility index (PI), which as 
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defined as the quotient of peak-to-peak wave amplitude, and mean flow rate (𝑃𝐼 =
𝑉𝑀𝑎𝑥−𝑉𝑀𝑖𝑛
?̅?
). Healthy, 
unidirectional, low pulsatile flow (LPF) occurs when PI is less than one, and is important in maintaining 
EC homeostasis, and protecting against artherosclerotic pathology.(Chien, 2006) Cells respond to this 
flow type by maintaining a quiescent state, with elongated morphology in the direction of flow.(Malek 
and Izumo, 1996) 
 
Figure 1.3.1- Examples of different pulsatility indices (PI). Here we see examples of healthy, or low 
pulsatility flow (LPF  PI < 1.0), pathological high pulsatility flow (HPF 1.0 < PI < 2.0), and 
recursive flow (PI > 2.0). 
 
Pathological flows may be advanced by discontinuities at the wall, or diseased tissue, both of which 
will increase local PI values. High pulsatile flow (HPF) results from decreased wall compliance, and/or 
reduction of wave reflection during the pulse cycle. HPF has been shown to induce the inflammatory 
response, resulting in vascular fibrosis.(Elliott et al., 2015; Scott et al., 2013) This flow type is clinically 
measured through pathological PI values greater than 1. These PI values correlate with high risk of CVD, 
in both the elderly,(Mitchell et al., 2011) and diabetics with a history of smoking, hyperlipidemia, and 
hypertension.(Panaritis et al., 2005) Reciprocating flow defined by PI as greater than two, is indicated at 
wall discontinuities resulting from compliance mismatch and anastamosa structure.(Chien, 2006; Ku et 
al., 1985; Ojha, 1994) This additionally contributing to many atherosclerotic pathologies. Both HPF and 
reciprocating flow are marked by increased PI, inflammation, and IH. 
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Figure 1.3.2- Cell mechanotransduction in response to fluid shear. Primary cilia, and G-proteins sense 
fluid shear, causing actin cytoskeleton tension, and subsequently interacting with focal adhesions and cell 
junctions. This mechanical signal communicates to the nucleus to respond. Image taken from Egorova et 
al. (Egorova, 2012)  
 
1.4 Treatment Options 
Treatment of vascular occlusion has evolved over the years from balloon angioplasty, vascular 
stenting, and ultimately grafting. Compliance mismatch in many treatments is additionally indicated in 
producing IH,(Abbott et al., 1987; Fontaine et al., 1994; Okuhn et al., 1989; Seifalian et al., 2002; Stewart 
and Lyman, 1992) leading to restenosis. The gold standard in vascular grafting is autologous grafts, 
specifically the saphenous vein. Saphenous veins may not be available in the patient for transplant, and 
still results in 30-50% failure rate, specifically due to arterial hemodynamics.(Jiang et al., 2009; Morinaga 
et al., 1987; Owens, 2010) In alternative treatments such as stenting, resulting wall rigidity leads to 
HPF,(Greil et al., 2003; Vernhet et al., 2001) and IH without drug treatment. The only FDA approved 
prosthetic graft materials are polyethylene terephthalate (PET), and expanded polytetrafluoroethylene 
(ePTFE), which may only treat arteries above 6mm in diameter,(Deutsch et al., 2009) and can exhibit a 
Egorov
a, 2012 
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10-40 fold increase in construct stiffness from native arteries.(Bia et al., 2006) While newer artificial graft 
design has centered on improving compliance,(McKenna et al., 2012; Neufurth et al., 2015; Soletti et al., 
2010; Wise et al., 2011) this has been measured as a static, time-independent stiffness response. Most 
saphenous vein and artificial graft mechanical characterization do not examine dynamic pressure loading 
of the wall, nor resulting hemodynamics. Above works indicate the necessity and difficulty in matching 
artery mechanical response, and additionally do not address the dynamic viscoelastic response of arterial 
tissue, within graft design. 
 
1.5 Conclusion and Impact 
Native arterial tissue is viscoelastic, with measurable viscous and elastic properties.(Bergel, 1961; Bia 
et al., 2006; Gow et al., 1974; Tanaka and Fung, 1974) In artificial graft development, previous work has 
focused on improved graft compliance.(Hasan et al., 2014; McKenna et al., 2012; Neufurth et al., 2015; 
Sankaran et al., 2015; Soletti et al., 2010; Wise et al., 2011) But this has not included testing dynamic 
compliance or hemodynamics,(McKenna et al., 2012; Neufurth et al., 2015; Wise et al., 2011) thereby 
assuming frequency independence and perfectly elastic response. Mechanical signaling in arterial disease 
and treatment is important in improving outcomes, understanding the effect of viscoelastic properties in 
blood vessels on cell response may improve occlusion treatment design. While viscoelastic tissue 
properties may be important in creating healthy environments for vascular cells, they are rarely mimicked 
or examined in occlusion solutions. Understanding of the hemodynamic effects on vascular cell 
populations, in both healthy and pathological flow, may contribute to new directions in treatment design. 
Therefore, we attempt herein: to determine the effect of compliance on endothelial cell response, explore 
new avenues in viscoelastic material development for tissue engineering, and establish a bench top model 
for fluid-structure interaction. 
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Figure 1.5.1- Project outline: contributions of both compliance and viscoelasticity fluid-structure 
interaction. This may affect HPF signaling in the arterial lumen, generate new design schemes for grafting 
materials, and provide insight into arterial mechanics on mechanical signaling of vascular cells. 
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2.1 Introduction 
Cardiovascular disease (CVD) is the most common cause of death in the United States of America, 
accounting for 27% of all deaths each year (Anderson et al., 2003), and is projected to rise above 20% 
globally by 2030 (Mathers and Loncar, 2006).  Traditional CVD biomedical research studies have been 
largely focusing on biochemical signaling cascades which then lead to improved understandings of CVD 
pathogenesis and thus innovations in CVD treatment. In the last two decades, more attention has been 
brought to cardiovascular mechanobiology, and researchers have started the journey of exploiting it for 
medical benefit, including modeling vascular diseases and vascular treatments to unravel insightful 
understandings and to achieve optimal therapeutic results, respectively. This chapter reviews recent trends 
in research related to cardiovascular mechanobiology, and contains two main topics, (i) arterial wall 
mechanics and mechanobiology and its exploitation in understanding arterial disease progression and 
therapeutics, and (ii) the role of computational hemodynamics in cardiovascular mechanobiology and its 
exploitation in vascular graft application. We will discuss each particular topic only in its essentials with 
no intention of exhausting it. 
The cardiovascular system is a dynamic, cyclically-loaded, pressure-driven flow system, involving 
ongoing mechanical feedback loops directing cell response and/or extracellular matrix (ECM) 
remodeling, which sustains homeostasis of the system, guides adaptive remodeling of the vessel wall, or 
perpetuates disease progression. Mechanotransduction thus represents an important mechanism in 
determining vascular health and disease response. Mechanical signals within the vasculature have been 
shown to be atheroprotective in healthy blood vessels, while initiating or exacerbating vascular lesions in 
diseased vessels. Current knowledge about mechanical signaling in the cardiovascular system has 
extended to improve treatment options; for example, performances of many artificial grafting and stenting 
devices resulting in restenosis may be enhanced, when the local impact of their mechanics on the 
biomechanical environments in the vascular of neighboring blood vessels as well as the global impact on 
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the upstream and downstream vascular system are considered for design optimization. To address how the 
interactions of vascular flow and vessel wall have an impact on vascular health and disease, we begin 
with an overview on the importance of mechanotransduction to vascular health and the development of 
different mechanical signals leading to the disease states. We then give examples showing that the 
pulsatile artery flow interacts with artery structural mechanics to alter mechanical signals, making the 
healthy vasculature progressing to diseased one. We also review the use of computational flow dynamics 
(CFD) to explore vascular mechanobiology and guide the design of vascular implants, and finally we 
suggest the potential avenues for future work using fluid-structure interaction combining CFD and finite 
element models (FEM) together with the bench mechanobiology models for better understanding of 
clinical measures and improved design of treatment interventions. 
 
2.2 Arterial Wall Mechanics and Mechanobiology 
In general, mechanical signaling in the vasculature originates from the intermittent (or pulsatile) blood 
flow due to the rhythmic ventricular contractions. The flow travels through the vasculature, interacting 
with each vascular section and altering its waveform along the way. In particular, the structure and 
mechanical properties of arteries including conduit elastic arteries and muscular arteries, play important 
roles in modulating the blood flow, thus influence arterial cell biology as well as ventricular loading and 
downstream vascular function (). Increased resistance in conduit arteries may reduce transport 
downstream, and increase ventricular work, which is tied to many vascular diseases. Muscular arteries, 
such as femoral or coronary arteries, are also important in maintaining physiologic hemodynamics and 
preventing CVD. Such influences result from the impact of vessel material mechanics or vessel geometry 
on blood flow in the vessel, which is translated into dynamic shear signaling on cell response promoting 
vessel homeostasis or vessel adaptive remodeling towards dysfunctional conditions. Arterial stiffening 
and narrowing (or stenosis), for example, are both important indicators to predict CVD conditions, 
including myocardial infarction, heart failure, and overall mortality (Zieman et al., 2005). Therefore, 
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understanding how fluid-structure interaction influence flow stresses on vessel wall and resulting cell 
mechano-sensing and mechano-transduction mechanism of the flow stresses is crucial to modeling and 
predicting pathological progression of CVD, as well as to the determination of new avenues for treatment 
optimization. 
 
Figure 2.2.1 – The impact of vessel mechanics and geometry on blood flow dynamics through the 
interaction of flow with vessel wall, which in turn promotes mechano-sensing and mechano-transduction 
signaling cascades within vascular cells to further determine tissue homeostasis or remodeling and thus 
vascular healthy or diseased states.    
 
2.3 Mechanical Signal and Mechanotransduction on the Arterial Wall  
Historically, chemokine release and reception was the initial paradigm studied towards physiologic 
and pathologic understanding of vascular tissue response (Gimbrone et al., 1997). Further work in 
biochemical signaling also emerged, examining extracellular matrix (ECM) ligand and integrin influence 
on cellular response (Alenghat and Ingber, 2002; Clark and Brugge, 1995; Davis and Senger, 2005). 
Within the vasculature, this has then progressed to focus on mechanical signaling, another important 
initiator of cell and tissue adaptation within the artery (Birukov, 2009; Chien, 2006; Chiu and Chien, 
2011; Lan et al., 2013). Similar to biochemical signals, mechanical signals applied on the blood vessel 
wall alters cellular activities, through signaling cascades that lead to morphological, functional and 
behavioral changes in cells, and thereby remodeling of vascular tissue. Mechanical signals applied onto 
the blood vessel wall result from three different stresses: compressive stress from hydrostatic pressure, 
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cyclical circumferential stress from wall stretching, and fluid shear stress. Mechanotransduction occurs in 
response to application of stresses on the vascular cell, as well as traction forces applied by the cell on the 
ECM (Davis and Senger, 2005; Huynh et al., 2011; Mason et al., 2013). Additionally, applied stress and 
resulting strain may be shared amongst cells through cell-cell connections such as vascular endothelial 
cadherin (Birukov, 2009; Chien, 2006; Chiu and Chien, 2011; Shav et al., 2014). This results in not only 
localized disease response, but likely also systemic responses within the vasculature.  
From the viewpoint of clinical measures, the determination of the mean and/or dynamic pressure and 
cyclic stretch occurs indirectly through a pressure cuff, or cyclic stretch and fluid velocity values may be 
measured directly through Doppler ultrasound (McArthur et al., 2011; Mitchell, 2008; Mitchell et al., 
2010, 2011). Often, clinical measured hemodynamic results focus on the mean arterial pressure, peak-to-
peak pressure values, and the pulsatility index (PI; 𝑃𝐼 =
𝑉𝑀𝑎𝑥−𝑉𝑀𝑖𝑛
𝑉𝑀𝑒𝑎𝑛
 ), which may each be differentiated 
between physiological and pathological values in determining disease states (Armentano et al., 2006; 
Arribas et al., 2006; Lemarié et al., 2010; Mitchell, 2008; Mitchell et al., 2011; Panaritis et al., 2005). 
At the cell and tissue level, studies on mechanical forces applied to the blood vessel have mainly 
focused on wall stretch stress and fluid shear stress. While hydrostatic pressure exerts compressive stress 
to affect vascular ECs (Shin et al., 2002), its most important role lies in regulating fluid shear and cyclic 
stretch through radial expansion of the arterial wall (Ando and Yamamoto, 2009; Birukov, 2009; Chien, 
2006; Chiu and Chien, 2011). ECs are especially susceptible to shear forces, with numerous mechano-
signaling transduction methods, namely, ion channels, surface glycocalyx, primary cilia, tyrosine kinase 
receptors, G-proteins, caveolae, adhesive proteins, and simply the cytoskeleton (Ando and Yamamoto, 
2009; Chien, 2006; Chiu and Chien, 2011). Cyclic stretch of the vascular wall is also important in 
determining cell response, for both ECs (Birukov, 2009; Birukov et al., 1995) and smooth muscle cells 
(SMCs) (Birukov, 2009; Birukov et al., 1995; Haga et al., 2007; Kim et al., 1999; Leung et al., 1976; 
Mata-Greenwood et al., 2005). These may induce the release of molecules that facilitate paracrine 
signaling, such as nitric oxide, reactive oxygen species, and protein or steroidal paracrine molecules 
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(Birukov, 2009; Chien, 2006; Chiu and Chien, 2011; Egorova et al., 2011a; Elliott et al., 2015; Leung et 
al., 1976; Scott et al., 2013; Tan et al., 2014). These biomolecular signals may in turn cause changes in 
vascular tone, ECM production or degradation, which effectively alter matrix composition and stiffness, 
and in turn change hemodynamic environment (Birukov, 2009; Chien, 2006; Chiu and Chien, 2011; 
Davis and Senger, 2005; Noris et al., 1995). Some signal cascades may only occur when mechanical and 
chemical signals are applied together (Bergh et al., 2009; Birukov, 2009; Mata-Greenwood et al., 2005; 
Resnick and Gimbrone, 1995; Shav et al., 2014), indicating a complicated signaling network and interplay 
between chemical and mechanical signaling. 
At the subcellular level, vascular cell cytoskeletal structure, cellular protrusion (i.e. primary cilia) as 
well as cell membrane proteins or macromolecules such as PECAM, VE-cadherin, surface glycocalyx and 
ion channels, play key roles in sensing or measuring mechanical signals applied on the vessel wall. Cell 
cytoskeletal structure aids in controlling the cell cycle and regulating proliferation or apoptosis (Chien, 
2006; Chiu and Chien, 2011). In particular, cell shape is an indicator of focal adhesion location and 
density (Caterina, 2000), cytoskeletal restructuring in response to stress (Chien, 2006), and cytoskeletal 
actin tension. Flow stresses as well as substrate or ECM stiffness and fiber alignment have been shown to 
play an important role in determining cell spreading and orientation (Chaudhuri et al., 2015; Chien, 2006; 
Huynh et al., 2011; Mason et al., 2013; Uttayarat et al., 2010). Additionally, ECM chemical structure aids 
in EC migration to denuded areas (Herbst et al., 1988; Uttayarat et al., 2010), regulates EC activity 
through focal adhesion kinase (Chien, 2006; Chiu and Chien, 2011; Lu and Rounds, 2012; Wu, 2005; 
Zebda et al., 2012). Also, specific matrix ligands and their corresponding integrins may further alter cell 
mechano-sensing and mechanotransduction of flow stress conditions (Wu, 2005). Regarding intracellular 
signaling molecules involved in flow mechanotransduction, several transcriptional factors as well as 
epigenetic mechanisms have been identified in recent studies as critical players in ECs that respond to 
mechanical signals applied on the vessel wall. The regulatory hierarchy of endothelial function includes 
control at the epigenetic level; very recent reports have highlighted three epigenetic mechanisms in cell 
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mechanotransduction of flow. MicroRNAs, histone modifications and DNA methylation to endothelial 
gene expression are all recognized epigenetic regulators that respond to disturbed flow. The discovery of 
a connection between endothelial cell structures such as cilia and signaling mechanisms at the genetic and 
epigenetic levels would open a new chapter in our understanding of the molecular mechanisms regulating 
vascular responses to the changes in flow. 
 
2.4 Physiological and Pathological Responses to Mechanical Signals 
Mechanical signaling is an important mediator of healthy vascular activities, affecting both vascular 
EC and SMC in concert with paracrine signaling. Fluid shear and cyclic wall stretch signaling to cells 
within the vasculature may preserve a healthy, physiological state (Asakura and Karino, 1990; Bergh et 
al., 2009; Berk, 2008; Birukov, 2009; Birukov et al., 1995; Ku et al., 1985; Takada et al., 1994; Traub and 
Berk, 1998; Uttayarat et al., 2010; Zarins et al., 1983), or induce a pathological response (Birukov, 2009; 
Egorova et al., 2011b; Elliott et al., 2015; Sakao, 2006; Scott et al., 2013; Tan et al., 2014). Importantly, 
these mechanical signals can exhibit a dose-dependent response (Ando and Yamamoto, 2009; Bergh et 
al., 2009; Birukov, 2009; Noris et al., 1995; Shav et al., 2014; Takada et al., 1994; Uttayarat et al., 2010), 
or may be optimized towards physiological ranges (Birukov, 2009; Birukova et al., 2008; Scott et al., 
2013; Shi et al., 2009; Shin et al., 2002). Additionally, vascular cells have been found to be 
phenotypically specific between different vascular branches (Chiu and Chien, 2011; Liu et al., 2008), in 
that beneficial shear and cyclic stretch values in arteries could initiate inflammation and remodeling 
response in the venous system (Liu et al., 2008; Owens, 2010). Both wall shear and stretch stresses may 
work in concert with each other, or with matrix signals, paracrine signals or other biochemical signals 
(Bergh et al., 2009; Egorova et al., 2011a). 
For normal vascular physiology, mechanical signaling plays a critical role in maintaining homeostasis 
of arteries, with both cyclic stretch and fluid shear sustaining healthy state of the blood vessel. Vascular 
lumen is lined with a confluent, interconnected, EC monolayer, protecting the lumen from occlusion. 
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Laminar flow occurs throughout the vasculature, and induces a quiescent state in arteries (Asakura and 
Karino, 1990; Berk, 2008; Chien, 2006; Chiu and Chien, 2011; Ku et al., 1985; Traub and Berk, 1998; 
Zarins et al., 1983). Expression of anti-thrombogenic factors (Ando and Yamamoto, 2009; Chien et al., 
1998; Takada et al., 1994; Traub and Berk, 1998), cell alignment (Chien, 2006; Chiu and Chien, 2011; 
García-Cardeña et al., 2001; Resnick and Gimbrone, 1995), cell migration (Chien, 2006; Hsu et al., 2001; 
Urbich, 2002), EC cell-cell connections (Chien, 2006; Kladakis and Nerem, 2004; Levesque et al., 1986; 
Traub and Berk, 1998), and nitric oxide (Chiu and Chien, 2011; Noris et al., 1995; Uematsu et al., 1995), 
are all upregulated by exposure to laminar shear stresses, while monocyte chemotactic protein, and lipid 
metabolism are downregulated (Chien, 2006; Chiu and Chien, 2011). Luminal laminar flow is 
additionally effective in preventing SMC and adventitial fibroblast migration (Garanich, 2005; Garanich 
et al., 2007), and counters inflammatory paracrine signals (Bergh et al., 2009). Additionally, cyclic stretch 
within the physiological range results in aligned actin and tubulin fibers within the EC (Birukov, 2009; 
Chien, 2006; Chiu and Chien, 2011), as well as SMC contractility (Birukov, 2009; Birukov et al., 1995; 
Kim et al., 1999; Leung et al., 1976). Alignment of the EC cytoskeleton, by shear and cyclic stretch, was 
shown to prevent proliferation or apoptosis (Chien, 2006). Cell-cell connections and cross-talk between 
EC and SMC are important factors to consider in maintaining homeostasis (Elliott et al., 2015; Liu and 
Goldman, 2001; Scott et al., 2013; Shav et al., 2014; Sho et al., 2002b; Wang et al., 2006). 
Pathological conditions may also be progressed by mechanical signaling, either through reduction in 
atheroprotective expression (Asakura and Karino, 1990; Chiu et al., 2003; Hsu et al., 2001; Ku et al., 
1985), paracrine signaling by ECs (Chien, 2006; Chien et al., 1998; Resnick and Gimbrone, 1995; Scott et 
al., 2013; Shav et al., 2014), or apoptosis of ECs (Elliott et al., 2015; Sakao, 2006; Shin et al., 2002). 
While high laminar shear stress (e.g. a mean value of 10-20 dynes/cm2), in comparison to low shear stress 
(e.g. 1-2 dynes/cm2), has been shown to be atheroprotective, shear above threshold values (e.g. 60-100 
dynes/cm2) for the cell type may induce apoptosis, endothelial-to-mesenchymal transition, and 
remodeling (Chien, 2006; Egorova et al., 2011b, 2012a; Sho et al., 2002a). Alternatively, interstitial flow 
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or low shear stress, induce SMC and adventitial fibroblast migration (Liu and Goldman, 2001; Sakamoto 
et al., 2006; Shi et al., 2009; Sho et al., 2002b), which may lead to IH when considered in conjunction 
with increased monolayer permeability. In addition to the mean flow shear conditions, dynamic flow 
profiles have great effects on disease progression, with increased PI associated with systemic fibrosis 
(Mitchell, 2008; Mitchell et al., 2011; Panaritis et al., 2005; Scott et al., 2013), endothelial-to-
mesenchymal transition,(Elliott et al., 2015) increased lipid metabolism,(Chiu and Chien, 2011) plaque 
deposition (Asakura and Karino, 1990; Hsu et al., 2001; Ku et al., 1985), and inflammation (Chiu and 
Chien, 2011; Chiu et al., 2003; Elliott et al., 2015; Scott et al., 2013; Tan et al., 2014). Most notably, 
clinically measured high PI has indicated systemic fibrosis (Mitchell, 2008; Mitchell et al., 2011; 
Panaritis et al., 2005), in particular at branching points within the vascular tree, where reciprocal or 
disturbed flow occurs (Asakura and Karino, 1990; Chien, 2006; Chiu and Chien, 2011; Ku et al., 1985). 
This could account for shear-induced apoptosis and EC permeability (Chien, 2006; Chiu and Chien, 2011; 
Elliott et al., 2015), resulting in pathogenic cell migration or material deposition on the sub-endothelial 
ECM. Cyclic stretch outside physiologic ranges may also increase EC monolayer permeability, 
exacerbated by reactive oxygen species and VEGF release (Birukov, 2009; Mata-Greenwood et al., 
2005), further perpetuating pathological conditions.  
 
2.5 The Role of Vascular Mechanics in Modulating Mechanical Signals 
Mechanical signaling within the vasculature is initiated and driven by the volumetric contraction of the 
heart which produces a complex flow wave that transmits throughout the hierarchical vascular system. 
The heart contraction causes a pulsatile pressure wave which precedes the volumetric flow wave in the 
vascular system. Localized pressure-induced stretch stress and flow-induced shear stress on the blood 
vessel are both reliant on local mechanical properties of the vessel. Radial expansion from resulting 
pressures increases cross-sectional area, decreasing centerline velocity of blood flow, and resulting fluid 
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shear at the wall. Therefore, localized remodeling of vessel ECM has an impact on local hemodynamics 
due to changes in vessel mechanics, and the matrix remodeling may thus exacerbate the disease process. 
Arterial compliance has been often related to the maintenance of healthy hemodynamics (O’Rourke et 
al., 2011). Arterial compliance likely results from changes in elastin and/or collagen content or in vascular 
tone, and its importance is evident in maintained steady shear values throughout the arterial tree 
(Humphrey, 2007). The ECM content changes along the arterial tree, with higher elastin content 
occurring within the aorta, and greater SMC and proteoglycan content in branching, muscular arteries and 
arterioles (Kawasaki et al., 2005; Valdez-Jasso et al., 2011). This results in different mechanical 
properties of arteries and varied arterial response to flow, namely an elastic response coming from elastin 
content, creating a “windkessel” damping effect (O’Rourke et al., 2011; Wagenseil and Mecham, 2009), 
and a viscoelastic response resulting from proteoglycan content (Armentano et al., 1995). Compliance, 
and the “windkessel” effect associated with aortic damping of pressure and fluid shear, have been the 
most commonly examined effect of arterial mechanics on hemodynamics, and have been shown in vivo 
and in vitro to decrease PI levels (Elliott et al., 2015; Humphrey, 2007; Scott et al., 2013; Tan et al., 
2014). While cell mechanotransduction with steady shear has been studied thoroughly (Chien, 2006; Chiu 
and Chien, 2011), dynamic flow shear conditions have mostly been examined in clinical settings or 
computational studies (Mitchell et al., 2010, 2011), and only recently been studied with benchtop models 
(Elliott et al., 2015; Scott et al., 2013; Tan et al., 2014). Pathological dynamic flow profiles may be 
related by PI values, with normal physiologic pulsatile flow marked by PI less than one, high pulsatility 
flow marked by an increased PI value, and oscillating or reciprocating flows with even higher PI. 
Occurrence of high pulsatility flow was related to systemic fibrosis within the arterial tree (McArthur et 
al., 2011; Mitchell, 2008; Mitchell et al., 2011), while recursive flow is often indicated in atherosclerotic 
lesions (Asakura and Karino, 1990; Ku et al., 1985). To further understand the dynamic interaction and 
relationship of hemodynamics and arterial wall mechanics, studies should be performed to relate wall 
mechanics to hemodynamics at different vascular disease states. This information will also advise 
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treatment options. To keep this amount of information manageable, we will limit ourselves to localized 
responses within the aorta and arteries, leaving systemic effects to other reviews. 
Within the aorta, the highly elastic, and relatively soft elastin layering within the media acts as an 
energy reservoir. During systole, the aorta undergoes significant strain, which decreases during aging 
(Redheuil et al., 2010). Contrastingly, the muscular arteries, such as femoral and coronary arteries exhibit 
stiffer wall properties, and greater viscous material response (Armentano et al., 1995; Bergel, 1961). Such 
difference in arterial wall mechanics may be explained by the histological comparison of ECM and 
cellular content, in that muscular arteries exhibiting much greater SMC and proteoglycan content. These 
mechanical properties may directly be related to flow and pressure wave attenuation in healthy vascular 
physiology, decreasing pulsatility and improving cell response downstream. The effect of wall mechanics 
becomes more apparent in diseased conditions. In chronic hypertension, for example, increased systemic 
pressures result in arterial remodeling with initial ECM breakdown and weakening, allowing for luminal 
expansion and thereby decreasing mean fluid shear, which is followed by wall thickening and ECM 
stiffening to counter increased pressure (Arribas et al., 2006; Lemarié et al., 2010). Eventually, ECM 
reconstruction results in decreased elastin content, and increased collagen type-I content with greater 
crosslinking of the ECM protein, or even calcification of the tissue (Lemarié et al., 2010). Arterial wall 
stiffening in hypertension has been associated with downstream vascular dysfunction, enhancing risks of 
stroke and kidney failure. Increased collagen I deposition and calcification on the lumen may additionally 
be seen in the lumen under recursive flow (Asakura and Karino, 1990; Chien, 2006; Chiu and Chien, 
2011; Ku et al., 1985; Peloquin et al., 2011). Atherosclerotic plaque may also build at, and distal to 
branching points (Asakura and Karino, 1990; Ku et al., 1985), identified by altered flow pulsatility. 
Stiffness of plaque depositions are much greater (100-300 fold) than healthy ECM (Ebenstein et al., 2009; 
Peloquin et al., 2011), affecting EC health (Huynh et al., 2011; Mason et al., 2013), and creating surface 
discontinuities exacerbating local PI values (Ojha, 1994). 
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Generally speaking, arterial tissue is moderately viscoelastic (Bergel, 1961; Bia et al., 2006; Fung, 
1967; Tanaka and Fung, 1974), with significant hysteresis curves present during in situ dynamic 
measurement (Armentano et al., 1995, 2006; Giannattasio et al., 2008). Hysteresis marks energy loss, and 
wave attenuation in flow, and is predominantly located within the muscular arteries which further reduce 
pulsatility before flow enters the arterial tree. While the impact of viscous material response within the 
vasculature is not fully understood, some previous modeling efforts using in vivo pressure/diameter 
relationships have exhibited significant pressure and flow wave attenuation, especially with increased 
frequencies associated with exercise (Holenstein et al., 1980; Vignon-Clementel et al.). Remodeling in 
mild-to-moderate hypertensive patients also suggests the importance of viscous property, when the ratio 
of viscous-to-elastic damping ratio is still maintained though wall stiffening through media thickening 
occurs (Armentano et al., 1998, 2006). This provides an interesting new avenue in understanding the 
fluid-structure relationship and future treatment design. 
 
2.6 Therapeutic Strategies Exploiting Mechanobiology 
With the fast increasing research efforts devoted to vascular mechanobiology recently, the next decade 
may see a big surge in exploiting the new findings to identify novel therapeutic targets, to develop new 
therapeutic drugs targeting mechanosensing or mechanotransduction pathways, or to enhance disease 
prognosis and management of CVD. Thereby, the future application perspective of vascular 
mechanobiology is likely expanded beyond the realm of its current uses, often towards the design of 
vascular implant devices. Current solutions in small vessel occlusion often results in compliance 
mismatch, a common cause of restenosis (Abbott et al., 1987; Okuhn et al., 1989; Stewart and Lyman, 
1992). The gold standard in vascular grafting, for example, is autologous grafts, specifically the 
saphenous vein. Saphenous veins may not be available in the patient for transplant, and still results in 30-
50% failure rate, specifically due to arterial hemodynamics (Morinaga et al., 1987; Owens, 2010). The 
anastomosis has long been a source of disturbed flow or high pulsatility flow (Chiu and Chien, 2011; Kim 
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et al., 1993), and new directions aim to cuff the graft anastomosis to reduce disturbed flow and 
compliance mismatch (Chiu and Chien, 2011). The only FDA approved prosthetic graft materials are 
polyethylene terephthalate, and expanded polytetrafluoroethylene (ePTFE), which may only show 
satisfactory outcomes for treating arteries above 6mm in diameter (Deutsch et al., 2009), and can exhibit a 
10-40 fold increase in construct stiffness from native arteries (Bia et al., 2006). Alternatively, the design 
of tissue engineered vascular substitutes have often centered on improving compliance through 
incorporation of active biomolecules (McKenna et al., 2012; Neufurth et al., 2015; Soletti et al., 2010; 
Wise et al., 2011). While some may achieve similar values to native arteries (Wise et al., 2011), these 
studies often do not examine the hemodynamic response of the proposed graft. Also, testing of 
compliance focuses on steady-state material responses, assuming little or no frequency dependence. 
Similar compliance issues also exist in vascular stents which result in enhanced wall stiffness and thus 
flow pulsatility and tissue remodeling (Greil et al., 2003; Vernhet et al., 2001). These all indicate the 
necessity and difficulty in matching artery mechanical properties for proper hemodynamics and its 
beneficial effects on vascular cells. Additionally, current device designs do not address the dynamic 
viscoelastic response of arterial tissue. The next section provides review and examples of the current work 
that examines arterial flow environments computationally to aid in parametric design optimizations of 
vascular implant devices. 
 
2.7 The Role of Haemodynamics in Mechanobiology 
2.7.1 Computational Fluid Dynamics 
 
The equations governing fluid flows are a set of coupled, non-linear partial differential equations such 
as: 
 
Continuity      
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Momentum  
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𝝏𝒙𝒋
) (2.7.1.2) 
 
These equations are known as Navier-Stokes equations. Many real problems include additional terms 
and/or equations, governing heat transfer, chemical species, etc. Analytical solutions are known only for a 
few very simple flow cases. An alternative is to solve the governing equations numerically, on a 
computer. Computational Fluid Dynamics (CFD) is this process of obtaining numerical approximations to 
the solution of the governing fluid flow equations.  
One could view CFD as a numerical experiment. In a typical fluids experiment, an experimental 
model must be built and the flow interacting with that model needs to be measured using various 
measurement devices, and the results are then analysed. In CFD, the building of the model is replaced 
with the formulation of the governing equations and the development of the numerical algorithm. The 
process of obtaining measurements is replaced with running an algorithm on the computer to simulate the 
flow interaction. The analysis of the results is, however, the same for both techniques.  
Despite its many advantages, CFD does not remove the need for experiments; numerical models need 
to be validated to ensure they produce reliable and accurate results. Particularly in clinical applications, 
there is a pressing need for rigorous model validation against detailed laboratory data. With the growth of 
available computing power and the advent of powerful user-friendly graphical user interfaces and 
automated options/features in commercial CFD codes, it has become possible for a wide range of users to 
apply CFD to even very complex flowfields, giving detailed information about the velocity field, 
pressure, temperature, etc. This sometimes results in producing solutions that are haemodynamically 
irrelevant and fail to capture even the most basic flow features. 
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Figure 2.7.1.1- An example of a typical CFD process in a biomedical application: (a) a typical 
peripheral bypass grafting, (b) the solid Computer Aided Model (CAD) for the computational domain, (c) 
a hybrid mesh created consisting of quadrilateral cells near the wall boundaries and tetrahedral cells 
further away from the wall, (d) post-processing of the CFD simulation results using streamlines and 
contours of the haemodynamic parameters.  
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2.7.2 Biomedical Applications of CFD 
In recent years, advances in vascular biology, biomechanics, medical imaging and computational 
techniques including CFD have provided the research community with a unique opportunity to analyse 
the progression of vascular diseases from a new angle and to improve the design of medical devices and 
develop new strategies for intervention. The increasing power-to-cost ratio of computers and the advent 
of methods for subject-specific modelling of cardiovascular mechanics have made the CFD-based 
modelling sometimes even more reliable than methods based solely on in vivo measurement. In fact, 
numerical simulations have played an important role in understanding the haemodynamics in several 
different clinical cases involving bypass grafting, cardiovascular treatment planning, cerebrovascular 
flow, the effects of exercise on aortic flow conditions, congenital heart disease and coronary stents.  
In addition, the recent developments in patient-specific computer simulations have provided a means 
to assess new surgeries and interventions at no risk to the patient. Also similar to other engineering fields 
such as aerospace and automotive, design optimisation is now possible and can be applied to predictive 
tools and methods to optimise surgeries for individual patients. Therefore, in the new paradigm of 
predictive medicine, the surgeons for example may use advanced imaging tools along with computational 
techniques such as CFD to create a patient-specific model and predict the outcome of a particular 
treatment for an individual patient. However, to be effective and attractive to the medical community, 
these simulation-based medical planning systems must be quick and efficient and should require 
minimum user intervention. 
 
2.7.3 Vascular Grafting 
In general, there are two broad applications of vascular grafting: 
1) Arterial Bypass Grafts (ABGs): Examples of ABGs include peripheral vascular disease 
(PVD) and coronary artery disease (CAD). Each year over a million vascular grafts (excluding valves) 
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are used in current medical practice. Problems requiring the use of a graft include occluded vessels due 
to stenosis, damaged vessels resulting from trauma or aneurysm, and the formation of a new tissue 
structure through regenerative therapies. In ABGs, currently, the “gold standard” option is to use 
naturally occurring vessels (‘autologous’ vessels); however, this brings inherent problems including 
additional surgery for the patient, and the frequent unsuitability or limited availability of their veins due 
to systemic disease. There is also a lack of viable treatment options when the blood vessel is less than 
6mm in diameter (Sarkar et al., 2007). Hence, prosthetic grafts, following either biomaterial or tissue 
engineered approaches, are utilised. Current prosthetic surgical options commonly include Dacron 
(polyethylene terephthalate, PET) and Teflon (expanded polytetrafluoroethylene, ePTFE). 
Unfortunately, prosthetic grafts are known to exhibit unsatisfactory long-term performances (Haruguchi 
and Teraoka, 2003), therefore, much research is being performed to reduce failure rates and improve 
patency rates, particularly for vessels under 6mm in diameter. 
 
2) Arterio-Venous Access Grafts (AVGs): The world is currently facing a huge increase in 
the number of people with diabetes. For example, in the United Kingdom, since 1996 the number of 
people diagnosed with diabetes has nearly doubled and diabetes remains the single most common cause 
of end stage renal disease (Health, 2007). AVGs are mainly used for creating an ‘access point’ for 
haemodialysis treatments for patients with renal diseases. The ideal vascular access for patients 
undergoing haemodialysis is an arterio-venous fistula in the forearm. However, the recent increase in 
the incidence of diabetes mellitus and the need for haemodialysis in patients with this disorder has 
expanded the number of patients who require implantation ePTFE graft for vascular access. 
 
Generally, for prosthetic grafts, research is currently being undertaken under two separate strands; the 
first tends to focus on tissue-engineering and biomaterial science, while the second is concerned with 
biomechanics, flow field augmentations and haemodynamic forces. The attention of the present chapter is 
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restricted to the latter and introduces the role of CFD in investigating and designing novel grafts with 
improved patency rates. 
 
2.7.4 Vascular Graft Failure 
Graft failure is currently a major concern for medical practitioners in treating PVD and CAD. For 
instance, almost 35,000 coronary artery bypass graft (CABG) procedures are performed each year in the 
UK according to the British Heart Foundation, however, over 50% of CABG fail within 10 years. In 
1999, an estimated 688,000 bypass surgeries were performed in the United States but up to 10% of these 
procedures failed within 30 days of surgery (Ku et al., 2005). Similarly, stenosis at the graft-vein junction 
caused by IH is the major cause of failure of arterio-venous access grafts used for haemodialysis. For 
example, in the United States alone there are 175,000 ePTFE grafts used for permanent vascular access, 
with the 1 and 2-year primary patency rates currently at 50 and 25%, respectively. These low patency 
rates have limited the use of AVGs and have resulted in arterio-venous fistula in the forearm to remain as 
an ideal vascular access for patients undergoing haemodialysis.  
Early graft failure (within 30 days) is attributable to surgical technical errors (such as choosing a poor 
location for the distal anastomosis) and resulting thrombosis, while late graft failures are mainly caused 
by progression of atherosclerosis and intimal hyperplasia (IH) (Bryan and Angelini, 1994; Whittemore et 
al., 1981).  
It is now widely accepted that haemodynamic factors play an important role in the formation and 
development of IH (Archie et al., 2001; Ghista and Kabinejadian, 2013). The intimal thickening (IT) and 
restenosis due to IH is normally characterised by unsteady shear stress, recirculation regions, pulsatile 
stress and graft deformations (Sottiurai et al., 1983). These haemodynamic factors include low and 
oscillating wall shear stress (WSS) (Ross Ethier et al., 1998), large spatial wall shear stress gradient 
(WSSG) (DePaola et al., 1992) and long residence time of blood cells (Perktold et al., 1997). Several 
studies have shown a correlation between the haemodynamic factors and localised sites of intimal 
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thickening, which in a conventional end-to-side (ETS) configuration occur predominantly at the heel and 
toe of the anastomosis, on the artery floor opposite the anastomosis, and on the suture line (Figure 
2.7.4.1). Consequently, much research has been conducted in the past few decades to design grafts that 
will remain patent for far longer, ideally longer than the life-span of the patient. For example for CABGs, 
in order to achieve higher patency rates, numerous studies have been conducted in an attempt to improve 
the haemodynamics at the anastomosis by studying the effects of anastomotic angle, shape of distal 
anastomosis, out-of-plane graft, graft-to-host artery diameter ratio, competitive flow and distance of 
grafting (Ghista and Kabinejadian, 2013).  
 
 
Figure 2.7.4.1- Spatial distribution and localized sites of intimal thickening/intimal hyperplasia in a 
typical arterial bypass graft. 
 
2.7.5 Novel Graft Designs 
As was alluded to above, it is now widely accepted that both IH and the acute thrombosis, which are 
the main causes of arterial bypass graft and arterio-venous graft failures, have close correlations with 
haemodynamics forces, including low and oscillating wall shear stress. Therefore, designs of new 
prosthetic grafts have started to take a new direction toward improving the patency of grafts through 
novel flow field augmentations.  
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One of the most significant contributions to this field was based on a research which showed that the 
‘spiral flow’ is a natural phenomenon in the whole arterial system (Stonebridge and Brophy, 1991; 
Stonebridge et al., 1996). The spiral flow in arteries is caused by the rotational compressive pumping of 
the heart (Jung et al., 2006) and is supported by the tapered, curved and non-planar geometry of the 
arterial system (Caro et al., 1996; Stonebridge, 2011). In other words, the rotational motion of the blood 
flow is induced by the twisting of the left ventricle during contraction and then accentuated upon entering 
the aortic arch (Murphy and Boyle, 2012). 
The spiral flow has also been used in many industrial applications, mainly to enhance mixing and 
turbulence for heat transfer augmentation. For example, as shown in Error! Reference source not 
found., the fuel pins in the UK’ fleet of Advanced Gas-cooled Reactors (AGRs) have been designed to 
induce helical flow through creating a series of protrusions in the form of spiral ridges on the outer 
surface of the fuel pins. These configurations have significantly enhanced heat transfer compared to 
conventional pins. Consequently, biomedical prosthetics could potentially use this concept to modify the 
haemodynamics forces in the cardiovascular system to mimic the physiological spiral blood flow in 
arteries and grafts. In fact, two of 
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Figure 2.7.5.1- Industrial examples of inducing helical flow; (a) schematics of ‘transverse-ribbed’, 
‘multi-start ribbed’ and ‘longitudinally-finned’ fuel pins used in the nuclear fuel pins of the UK’s 
Advanced Gas-Cooled Reactors (AGRs); (b) schematic of the helical ridges on the outer surface of the 
‘multi-start’ fuel pins; (c) the profile of the rib/ridge in the ‘multi-start’ design. 
 
the most innovative and successful graft designs have used this principal in order to induce spiral flow 
in arteries. These designs are briefly discussed below:  
(i) ‘SwirlGraft’ which was developed by Caro and colleagues (Caro et al., 2005) at Veryan 
Medical Ltd was a new AV shunt graft with a helical out-of-plane geometric feature incorporating 
‘Small Amplitude Helical Technology’ (SMAHT). Compared to a conventional ePTFE graft, the 
animal experiments reported in (Caro et al., 2005) demonstrated that there was less thrombosis in the 
SwirlGraft than in the conventional ones. The difference became even more remarkable after 8 weeks 
of implementation when occlusion occurred in the conventional grafts, while less thrombosis and IH 
occurred in the SwirlGraft. Recently a few attempts have been made to numerically simulate the 
blood flow in out-of-plane graft geometries that induce 3D swirling flows (Cookson et al., 2009; Lee 
et al., 2011; Sun et al., 2010; Zheng et al., 2009) with an aim of understanding the flow physics and 
improving the current graft designs. In addition, Veryan Medical Ltd has recently designed a 
peripheral stent known as ‘BioMimics 3D Helical Stent’ which appears to have evolved from 
SwirlGraft and SMAHT and is currently under clinical trials. However, there are some concerns 
associated with both SwirlGraft and 3D helical stent such as an increase in the pressure drop across 
the helical segment. The helical stent can also impose a severe geometric change on an artery causing 
damage to the arterial wall. The details of this design and its results are beyond the scope of this 
chapter and therefore will not be discussed any further.  
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(ii) ‘Spiral Flow Peripheral Vascular Graft’ which was introduced by Vascular Flow 
Technologies (VFT) Ltd consists of a prosthetic ePTFE graft design that is engineered to induce 
spiral flow through an internal ridge within its distal end. This design is primarily based on research 
carried out by Stonebridge and colleagues at Ninewells Hospital in Dundee, Scotland into the 
naturally occurring helical flow found in studies of the cardiovascular system using Doppler 
ultrasound. The results of an early clinical non-randomised study for VFT peripheral bypass graft are 
promising and show primary patency rates of 81% for above-the-knee bypasses and 57.3% for below-
the-knee bypasses at 30 months of follow-up. The respective secondary patency rates were 81% and 
64% (Stonebridge et al., 2012). In an unpublished research, similar improvements were also found 
when using the spiral flow graft for AV access for haemodialysis (‘Spiral Flow AV Access Graft’). 
While these initial results highlight the potential for the idea of spiral-induced grafts in bypass 
surgeries, it has a number of limitations. For instance this design cannot currently be used for CABG 
since satisfactory prosthetic grafts have shown to be unsuccessful for small calibre applications due 
to their poor long-term patency rates (Yellin et al., 1991) (i.e. autologous internal thoracic arteries, 
radial arteries and saphenous veins still remain the most widely used conduits for CABG (Angelini 
and Newby, 1989; Cameron et al., 1996; Desai et al., 2011)). Another disadvantage of this type of 
prosthetic graft is associated with its limitation to ePTFE, which has shown to have poor patency 
rates due to poor mechanical characteristics (i.e. low compliance) and the lack of endothelial cells 
(ECs) lining the lumen (Salacinski et al., 2001). 
While the physiological importance of secondary motion in circulation has clearly been highlighted in 
the literature (Stonebridge and Brophy, 1991; Stonebridge et al., 1996), the benefits of helical/spiral 
prostheses in vascular conduits have yet to be firmly established. Moreover, the range of possible design 
configurations is large and the effects of different design/geometrical parameters on haemodynamics 
forces are still not clear. Therefore, there is a scope to investigate existing and innovative flow field 
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augmentations using computational techniques to inform potential designs of novel prostheses and 
surgical vascular reconstructions.  
 
2.7.6 Haemodynamic Metrics  
One of the main attractions of using CFD in biomedical problems is its ability to calculate several 
different haemodynamic parameters/metrics, which could potentially have important clinical implications. 
For example, previous studies have shown that:  
(i) localised distribution of low Wall Shear Stress (WSS) and high-Oscillatory Shear Index 
(OSI) strongly correlates with the focal locations of atheroma (He and Ku, 1996), 
(ii) large spatial WSS Gradient (WSSG) contributes to the elevated wall permeability and 
atherosclerotic lesions (DePaola et al., 1992),  
(iii) combination of high-shear stress and large exposure times may induce platelet activation 
(Hellums, 1993; Ramstack et al., 1979; Wurzinger et al., 1985, 1986), and  
(iv) stagnant and recirculation flow regions can cause platelet aggregation and thrombogenesis. 
The above haemodynamic parameters can be directly derived from the flow fields obtained by CFD-
based simulation tools. It is worth noting that the reason for having to define different metrics for the 
variation in blood flow characteristics is mainly due to anatomic and physiologic variations and system 
complexity of the fluid flow as well as its interaction with the vessel wall and tissue. In addition, single-
feature-haemodynamic metrics are generally unable to capture the multi-directionality of the flow field 
(Peiffer et al., 2013), hence, having to define different parameters. 
In this chapter, the distributions of haemodynamic parameters, including Time-Averaged WSS 
(TAWSS), TAWSSG (Buchanan et al., 2003), OSI (He and Ku, 1996) and Relative Residence Time 
(RRT) (Lee et al., 2009) are calculated for one study below, according to the following equations: 

T
W dt
T
TAWSS
0
1
τ

 (2.7.6.1) 
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(2.7.6.4) 
In the above equations, Wτ

 is the WSS vector and T is the time period of the flow cycle. 
 
2.7.7 Haemodynamics of Spiral and Helical Grafts 
The main configuration studied in this section represents a typical ETS distal graft anastomosis, which 
can be found in the following three graft configurations: 1) Peripheral Artery Bypass Graft, 2) Coronary 
Artery Bypass Graft and 3) Arterio-Venous Access Graft. The former has been selected for the present 
work since both of the novel flow field augmentation designs discussed earlier, have only been tested for 
the peripheral artery bypass configuration.  
It is important to note that while some resemblances can be found amongst the above three ETS graft 
configurations, the haemodynamic pattern and consequent location of IH formation are different. For 
instance, the blood flow rate in arterio-venous grafts is about 5-10 times higher than that in peripheral or 
coronary artery bypass grafts; consequently the spatial distribution of IH is different in each configuration 
(Haruguchi and Teraoka, 2003).  
The dimensions and the schematics of the models tested here are given in Error! Reference source 
not found.. A brief description of each model is as follows:  
• Model 1 (Control Graft): This model represents a baseline and a conventional ETS distal 
graft anastomosis for a peripheral artery bypass configuration.  
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• Model 2 (Spiral Graft): This model has an internal spiral inducer within the distal end of 
the graft in the form of an internal ridge. The ridge, which is one pitch long, provides ridged cross-
sectional geometry to engender and deliver a single-spiral flow pattern.  
• Model 3 (Helical Graft): The distal end of the bypass graft in this model consists of a 
small amplitude out-of-plane (non-planar) helical configuration. The helical section of this model 
involves a one-turn helix with pitch and amplitude approximately 14D and 0.5D, respectively (where 
D is the internal diameter of the graft). 
• Model 4 (Helical+Spiral Graft): The distal end of the bypass graft in this model combines 
the geometrical features present in both models 2 and 3. Note that in this model the out-of-plane 
helical and the internal ridge have the same pitch and turn in the same direction.  
 
Figure 2.7.7.1- Schematics and the dimensions of the present four geometric models. 
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Figure 2.7.7.2- Distributions of different haemodynamic parameters viewed from the host arterial 
wall, opened ventrally and shown en face: (a) Time-Averaged Wall Shear Stress (TAWSS); (b) Time-
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Averaged Wall Shear Stress Gradient (TAWSSG); (c) Oscillatory Shear Index (OSI); and (d) Relative 
Residence Time (RRT). Note that the colour scale of the TAWSS map is inverted for ease of comparison. 
Error! Reference source not found.2.7.7.2 shows the distribution of the above metrics for all the 
four geometrical models displayed on an unfolded model of the host artery, which has been opened 
ventrally. The maps shown in Error! Reference source not found. should be interpreted so that the 
vertical axis represents distance along the host artery (with blood flow from bottom to top) and the 
horizontal axis represents the circumferential distance along the wall of the host vessel (the bed region 
appears at the centre). 
Investigation of the haemodynamic parameters distribution in 2.7.7.2 shows that the TAWSS increases 
on the arterial bed and around the anastomosis by adding the non-planar helicity (while the effect of 
including the spiral ridge was minimal). There are indications that the blood monocytes are more likely to 
adhere to the endothelial layer at regions with low-TAWSS (Pritchard et al., 1995); hence, introducing the 
non-planar curvature to the graft may reduce the spatial extent of early wall lesion. Also, significant 
correlations have been reported between the preferred sites of IT and the regions of low-WSS (Sunamura 
et al., 2007; White et al., 1993); as such the observed altered flow patterns may be perceived as a 
beneficial feature of the helical grafts which may positively impact the graft patency rate. 
It was also found that the elevated OSI region on the host arterial wall (distal to the toe) reduces in size 
considerably in helical graft models (i.e., Models 3 and 4) and moderately in the spiral graft model (i.e., 
Model 2). Hence, a low-TAWSS/high-OSI region in the control model is replaced by a high-
TAWSS/low-OSI area in the helical graft models. This is another positive feature of introducing the non-
planar helicity (and to a lesser extent the inclusion of the spiral ridge) to the bypass grafts, since the 
combination of high-TAWSS and low-OSI is believed to be contributing to IT and atherosclerosis 
development as well as increasing the risk of the aggregation of red blood cells (He and Ku, 1996; Ku et 
al., 1985; Malek et al., 1999). 
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In addition, the swirling flow induced by the helical graft in Models 3 and 4 reduces the RRT distal to 
the toe of the anastomosis, by eliminating the flow separation in this region (which was present in Model 
1 and to a lesser extent in Model 2). This could reduce the chance of platelet aggregation and thrombus 
formation (Hellums, 1993), and consequently enhances the patency of the bypass graft. 
 
2.8 SUMMARY AND CONCLUSION 
As observed in this chapter, cardiovascular biomechanics and mechanobiology is a pivotal research 
area for the improvement of existing therapeutic strategies for CVD or new therapeutics development. For 
example, inducing swirling flow into the bypass grafts can bring about positive flow features and more 
favourable distribution of haemodynamic parameters in the graft, anastomotic region, and the host artery, 
which may enhance the patency and longevity of the bypass graft. For this purpose, graft helicity was 
found to be significantly more effective than a spiral ridge. Also, it was found that a combination of graft 
helicity and spiral ridge can further enhance this swirling effect on the flow. However, in order to 
optimize these features for their utility in different types of bypass grafts, further studies are warranted. 
Equally important to future parametric improvement is more realistic models of the vessel wall. Instead of 
treating the wall as a non-linear orthotropic elastic cylindrical membrane for CFD analysis, the 
experimentally observed material damping (elastic) properties or the viscoelastic properties of the wall 
tissues should be incorporated in the analysis to reflect more realistic flow environments in vivo and thus 
more accurate prediction of cell and tissue responses based on the existing knowledge about cell 
mechanobiology of flow. Using models considering the fluid-structure interaction, analytical expressions 
for the displacement and shear stresses developed in the wall as well as the velocity distribution, fluid 
acceleration and volume flow rate of blood can be derived computationally.  
In summary, future vascular mechanobiology studies will greatly benefit from highly integrated 
approaches using computational analysis together with in vitro and in vivo measures as well as benchtop 
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flow models containing vascular cells for the explorations of mechano-sensing and mechano-transduction 
mechanisms. 
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Abbreviations, symbols, and terminology:  
   EndMT –  Endothelial-to-mesenchymal transdifferentiation 
 HPF – High pulsatility flow  
 EC – Endothelial cell 
 SMC – Smooth muscle cell 
 AdvFB – Adventitial fibroblast 
 HPAEC – Human pulmonary arterial ECs  
 PI  – Pulsatility index 
 TGF-β – Transforming growth factor β  
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ABSTRACT 
Vascular fibrosis, the formation of excess fibrous tissue on the blood vessel wall, is characterized by 
unmitigated proliferation of fibroblasts or myofibroblast-like cells exhibiting α-smooth-muscle-actin in 
vessel lumen and other vascular layers. It likely contributes to vascular unresponsiveness to conventional 
therapies. This paper demonstrates a new flow-induced vascular fibrosis mechanism. Using our developed 
flow system which simulates the effect of vessel stiffening and generates unidirectional high pulsatility 
flow (HPF) with the mean shear flow at a physiological level, we have shown that HPF caused vascular 
endothelial dysfunction. Herein, we further explored the role of HPF in vascular fibrosis through 
endothelial-to-mesenchymal transdifferentiation (EndMT). Pulmonary arterial endothelial cells were 
exposed to steady flow and HPF, which have the same physiological mean fluid shear but different in 
flow pulsatility. Cells were analyzed after being conditioned with flows for 24 hr or 48 hr. HPF was 
found to induce EndMT of cells after 48 hr stimulation; cells demonstrated drastically decreased 
expression in endothelial cell marker CD31, as well as increased transforming growth factor β, α-SMA, 
and collagen type-I, in both gene and protein expression profiles. Using the flow media from HPF-
conditioned endothelial culture to cultivate arterial adventitial fibroblasts and endothelial cells 
respectively, we found that the conditioned media respectively enhanced migration, proliferation and α-
SMA expression of adventitial fibroblasts, and induced EndMT of endothelial cells. It was further 
revealed that cells exposed to HPF exhibited much higher percentage of caspase-positive cells compared 
to those exposed to steady flow. Apoptotic cells together with remaining, caspase-negative cells 
suggested the presence of apoptosis-resistant dysfunctional endothelial cells which likely underwent 
EndMT process and perpetuated fibrosis throughout vascular tissues. Therefore, our results indicate that 
prolonged HPF stimuli induce vascular fibrosis through triggering EndMT and EC-mediated AdvFB 
activation and migration, which follows initial endothelial inflammation, dysfunction and apoptosis.  
Key Terms: vascular fibrosis, endothelial cell, mechano-transduction, high pulsatility 
flow, endothelial-to-mesenchymal transition. 
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3.1 Introduction 
Tissue fibrosis is the formation of excess fibrous connective tissue, due to increased activities of 
fibroblast-like cells in a reparative or reactive process. It is often preceded by tissue inflammation and 
resulting in increased content of collagen type I to improve structural integrity of injured or weak tissues. 
As a consequence of fibrosis, collagen-rich scar tissues accumulated with fibroblast- or myofibroblast- 
like cells replace normal functional tissues. Therefore, fibrosis is common in a number of diseases 
showing gradual tissue deterioration, as in the case of vascular tissue fibrosis, which is an important 
aspect of extracellular matrix remodeling in hypertension and other cardiovascular diseases. The exact 
cell type contributing to vascular fibrosis during blood vessel remodeling after injury is unclear. Evidence 
shows fibrosis may occur in all vascular tissue layers, namely intima, media and adventitial layers, as 
occurring in atherosclerosis, pulmonary artery hypertension, vascular grafting anastomose or stenting. 
Vascular fibrosis likely involves all resident vascular cell types, endothelial cell (EC), smooth muscle cell 
(SMC) and adventitial fibroblast (AdvFB). (Arciniegas et al., 1992, 1992; Berard et al., 2013; Frid, 2002; 
Li et al., 2007; Owens, 2010; Rekhter et al., 1993; Sakao et al., 2005) Understanding of vascular fibrosis 
pathologies are further complicated by all cells within vessel walls presenting α-smooth muscle actin (α-
SMA), (Frid, 2002; Varcoe et al., 2006) most commonly associated with SMC previously. Studies also 
suggested that these α-SMA+ cells might be associated with the presence of transforming growth factor β 
(TGF-β). (Suwanabol et al., 2012; Tsai et al., 2009) Though the majority of previous studies have focused 
on illustrating the role of SMCs in vascular neointimal hyperplasia and fibrosis, evidence from recent 
studies supports the potential trans-differentiation of other vascular cells (ECs and AdvFBs) into the 
myofibroblast phenotype during pathological vascular remodeling (Sakao et al., 2007), but the underlying 
mechanism, particularly in relation to hemodynamics present in vascular diseases, has been seldom 
explored. 
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Increasing attention is now given to endothelial-to-mesenchymal transition (EndMT) and to its 
occurrence and roles in artery maturation during embryonic development as well as in intimal fibrosis 
during vascular remodeling. (Arciniegas et al., 2000; Egorova et al., 2011a, 2012b; Nakajima et al., 2000) 
EndMT is believed to contribute, at least partially, to pulmonary, renal, and cardiac fibrosis in adult 
mammals. (Hashimoto et al., 2010; Zeisberg et al., 2007b, 2007a, 2008) Activation of EndMT can result 
from biomechanical and/or biochemical signaling. It was shown increasing the mean magnitude of shear 
stresses from 0.5 to 5.0 Pa promoted murine and chicken embryonic ECs to the EndMT process, showing 
reduced endothelial marker and increased α-SMA expression. (Egorova et al., 2011b, 2011a) While flow-
induced EndMT was thought to be a necessary step during vascular development, it may be harmful to 
healthy blood vessels. Recent findings have highlighted the contribution of EndMT to vascular 
pathogenesis in a number of fibrotic diseases. (Hashimoto et al., 2010; Maddaluno et al., 2013; Zeisberg 
et al., 2007a, 2008) The EndMT process is particularly correlated to the presence of TGF-β. (Arciniegas 
et al., 1992; Hashimoto et al., 2010; Imamura et al., 2010; Kokudo et al., 2008; Medici et al., 2011; 
Zeisberg et al., 2007b, 2008)  In addition to EndMT, activation of AdvFB migration, proliferation or 
matrix production may also contribute to vascular fibrosis, hardening and reduced response to 
vasodilation therapy. Activation of AdvFB can be triggered by flow and/or cytokine stimuli. High 
interstitial flow was shown to activate AdvFB migration. (Acharya et al., 2008; Battegay et al., 1990; 
Garanich et al., 2007) TGF-β was also found to be involved in activating AdvFB proliferation and matrix 
production. (Khalil et al., 2005) Though the respective contributions of EC and AdvFB to vascular 
fibrosis during remodeling are increasingly recognized, few studies have examined their collaborative 
efforts in driving the fibrotic process. Understanding the cellular mechanisms during vascular fibrosis and 
hardening could greatly assist the development of new therapeutic approaches towards cardiovascular 
disease and hypertension.  
Our previous studies have established unidirectional high pulsatility flow (HPF), a proximal 
stiffening-induced flow condition indicated in disease and aging,(Mitchell et al., 2011; Panaritis et al., 
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2005) as a determinant to distal pulmonary artery endothelial health.(Li et al., 2009) We have shown that 
HPF altered pulmonary artery SMC physiology via vasoactive substances and cytokines produced by the 
endothelium. (Scott et al., 2013) In response to HPF with physiologic, mean shear stresses (1.2 Pa), distal 
ECs also demonstrated acute inflammatory response, simulating that occurring in pulmonary 
hypertension. Growing evidence supports that vascular intimal thickening of distal pulmonary arteries in 
diseased condition, due to inflammation or fibrosis, might contribute to the unresponsiveness of arteries 
to vasodilation therapies. (Gan et al., 2007; Pries et al., 2005) Palevsky et al. showed that an intimal area 
of more than 18% of the vascular cross-section had an 85% predictive value for identifying poor outcome 
from vasodilation treatment. (Palevsky et al., 1989) It is well known that during wound healing, fibrosis 
follows inflammatory events. This might occur during flow-induced vascular inflammation and 
remodeling. To further establish the role of HPF (with the mean flow shear at a physiological level) in 
fibrosis of vascular intima and other vascular layers, we therefore sought to test the hypothesis that 
prolonged HPF stimuli induce vascular fibrosis through triggering EndMT and EC-mediated AdvFB 
activation and migration, following initial endothelial inflammation. To address this hypothesis, we 
applied our developed flow system, simulating the effects of vessel stiffening, and HPF generation on the 
downstream cells.  
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3.2 Materials and Methods 
3.2.1 Cell Culture 
Human pulmonary arterial ECs (HPAEC) were obtained from Lonza Inc, and kept in a CO2 incubator 
at 37oC and 5% CO2. Cells were thawed as needed and grown to approximately 70-80% confluency using 
EGM-2 with additional growth factor and fetal bovine serum bullet kit (Lonza, Basel, Switzerland). Once 
confluent, cells at passages of 3-8 were seeded on two glass slides for the flow experiment. Human 
pulmonary artery adventitial fibroblasts were maintained in DMEM media containing 10% FBS and 
cultured in similar conditions.  
 
3.2.2 Flow Setup and Experiments 
To examine the response of HPAECs to various flow conditions, plain microscope glass slides were 
chemically functionalized with 20% of aqueous sulfuric acid and then coated with 6% of 3-
aminopropyltriethoxysilane in acetone. After silanization, the glass slides were treated with 1.5% of 
glutaraldehyde solution. This formed an aldehyde which could initiate amine linkage to protein coating. 
The slides were then coated with 25 µg/ml fibronectin aqueous solution for 30-60min to provide a 
functional attachment layer for the HPAECs. HPAECs at a concentration of 6.0×105 per ml were seeded 
on the fibronectin-coated slides and given one hour to attach to the slides, and then the cells were covered 
in growth media and allowed to reach confluency, before they were transferred to the flow chamber 
apparatus.  
To ensure the sterility and cleanness of the flow experiments, the exterior of a pulsatile blood pump 
(Harvard Apparatus Inc; Holliston, MA) or a peristaltic pump (Cole Parmer), which was used to circulate 
the medium, was sterilized by wiping it with 70% ethanol. Sterilization of the flow circuit was completed 
through perfusing all the tubings, pump chamber and connectors with 10% hydrogen peroxide (H2O2) 
under ultraviolet light within a biosafety cabinet Type II for a minimum of 30 minutes. To clean the 
circuit of any cytotoxicity, sterile Dulbecco’s phosphate buffered solution (DPBS) was circulated through 
and removed. Perfusion with DPBS was repeated twice before flow experiments started. For generating 
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HPF condition, the blood pump simulated the heart function generating cardiac output, while the 
compliance-adjustment chamber simulated the flow buffering or cushion function of proximal arteries. 
The fluid levels of the compliance-adjustment chamber allowed for pulsatility control of dynamic flows, 
with lower fluid levels allowing greater dampening of dynamic pressures. Downstream to the compliance-
adjustment chamber was the cell-plate flow chamber which holds the endothelium representing the distal 
pulmonary artery endothelium. Each component was connected by stiff polystyrene tubing. The 
circulating media used in the experiments consisted of a basal media (EBM-2, Lonza, Basel, 
Switzerland), medical grade dextran (MP-products Inc, Solon, OH) (7% w/w), and 
penicillin/streptomycin (2% v/v), as its viscosity was close to blood viscosity so that it reduces volumetric 
flow rate while maintaining a high shear stress. For flow measurements, a digital flow meter (Alicat 
Scientific Inc, Tucson, AZ) was placed before the flow chamber. A manifold section was used to run 
parallel studies. 
Two flow conditions were applied within a closed fluid circuit: high pulsatility flow (HPF) using the 
blood pump and steady flow using peristaltic pump. Both pulsatile flows had the same mean flow rate 
with a mean surface flow shear stress of 1.2 Pa, at the frequency of 1 Hz. The steady flow showed no 
great variation in flow velocity with the flow pulsatility index (PI) less than 0.2, while the PI value of 
HPF was determined to be 1.7,(Mitchell et al., 2011; Panaritis et al., 2005) using the following equation: 
 
The pulsatility index (PI) =
∆𝐹𝑙𝑜𝑤 𝑉𝑒𝑙𝑜𝑐𝑖𝑡𝑦
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐹𝑙𝑜𝑤
 
 
For all the experiments, cells were preconditioned at low or no pulsatility (PI < 0.5) with low shear 
stress for between 4-6 hr before experimental flow conditions began. Experiments consisted of 24 hr and 
48 hr of flow conditions. For the pharmacological treatment of cells using taxol (Paclitaxel, Sigma-
Aldrich Inc), the experiments were performed with the addition of 10 ng/ml of taxol in the flow culture 
media. HPAECs grown in the absence of flow (the static condition) were used as a control. After 
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HPAECs were exposed to different flows, they were collected and analyzed for gene expression using 
real-time PCR and for protein expression using western blotting. The circulating media during flow 
culture period were collected as flow conditioned media (FCM) for studies that evaluate EC and AdvFB 
activation, in which confluent HPAECs and AdvFBs were cultured for 24 hr in FCM. Western blot 
analysis was performed on resulting cells, comparing α-SMA protein expression with β-actin. FCM was 
also used to evaluate its potential to induce AdvFB migration and proliferation. 
 
3.2.3 Western Blot 
Western blot analyses were performed as per the manufacturer’s suggestions (Invitrogen, Carlsbad, 
CA). Briefly, to retrieve proteins, ECs were gently scraped off glass slides, lysed with RIPA lysis buffer, 
and then centrifuged at 14,000 rpm for 20 min at 4°C. Supernatant was then transferred to a clean tube. 
Protein concentrations were determined using a standard curve of BSA. Twenty micrograms of protein 
from each sample were separately loaded and subjected to gel electrophoresis. Following electrophoresis, 
resulting protein was transferred to a nitrocellulose membrane. The membrane was blot with COL1A1 
rabbit polyclonal antibody, PECAM-1 mouse monoclonal, TGFβ1 mouse monoclonal, and 1A4 (α-SMA) 
antibodies (all antibodies from Santa Cruz Biotech, Santa Cruz, CA).  
 
3.2.4 Real-Time PCR 
      To study the effects of HPF on the pulmonary artery endothelium, HPAECs were conditioned with 
HPF and steady flow for 24 hr and 48 hr, respectively. Real-time PCR was used to analyze the gene 
expression of the biomarkers important for EndMT. 
Cell samples were gently scraped from slides after applying RLT buffer tissue lyser using the RNeasy 
mini-kit from Qiagen (QIAGEN, Hilden, Germany), according to the manufacturer’s instructions. 
Samples were then prepared as per manufacturer’s instructions for real time- PCR using RT2 SYBR 
Green FAST Mastermix and corresponding gene primers, also from QIAGEN. Gene expression in 24 and 
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48-hr flow cycles were examined for PECAM-1 (CD31), α-SMA (ACTA2), TGF-β (TGF-beta1), and 
Collagen-I (COL1A1) with β-actin expression (ACTB) as the housekeeping gene. Primers (PPH01362E, 
PPH00508A, PPH01299F and PPH01300B) were directly obtained from Qiagen Inc. Data was analyzed 
using the ΔΔCT method, and plotted. Statistical significance between groups was found using Welch’s t-
test using degrees of freedom derived from the Welch-Satterthwaite equation for unequal sample sizes 
and unequal variances. 
 
3.2.5 Fibroblast Migration and Proliferation Assay 
The flow conditioned media (FCM) from HPAECs were taken from those exposed to steady or HPF 
culture conditions for 24 hr or 48 hr, and were used to determine migration and proliferation of AdvFB.  
For cell migration study, the FCM was placed in the bottom well covered with a 3-mm transwell insert 
(BD Biosciences, San Jose, CA), while AdvFBs were placed on top of the insert and cultured for 24 hr. 
Subsequently, the cells on the top of the insert were gently scraped off with a cotton tip, and the cells on 
the other side of the insert were stained with 2% crystal violet or DAPI, and then imaged under a light 
microscope. The number of migrated cells was determined using ImageJ (National Institute of Health, 
Bethesda, MD). 
For measurement of fibroblast proliferation, FCM was used to culture adventitial fibroblasts for 24 hr. 
Then, CyQuant proliferation assay kit (Invitrogen, Grand Island, NY) was used according to the 
manufacturer's instruction. Proliferation of AFB was measured using a CyQuant proliferation assay kit 
(Invitrogen, Grand Island, NY). Cells were cultured in FCM for 24 hr, and the assay was completed as per 
manufacturer’s instructions. 
 
3.2.6  Apoptosis Assay 
Previous studies have shown that EC released TGF-β1 during EC apoptosis. (Cucina et al., 1998; Ten 
Dijke et al., 2012) These in conjunction with our findings that show ECs exposed to HPF continuously 
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produce TGF-β1 which further induce EC transition to mesenchymal fibroblastic phenotype and enhance 
AdvFB activities, suggest that ECs might show enhanced apoptotic activity prior to the EndMT process, 
releasing TGF-β1 for autocrine and paracrine signaling towards fibrosis. Apoptosis assay was applied to 
cells after exposure to flow for 24 hr.  FLICA poly caspase reagent (Immunochemistry Technology LLC, 
Bloomington, MN) including fluorescent-labeled inhibitor of caspases, is a simple yet accurate method to 
measure apoptosis via caspase activity in whole cells.  The assay was performed by following the 
manufacturer’s instruction.  
 
3.2.7 Data Analysis 
All data are expressed as mean ± SEM, and the number of sample studied (n) is ≥3. One-Way 
ANOVA was used to determine effects of flow pulsatility on gene expression. If significantly difference 
exists, Student’s t-test for one-to-one comparison and Tukey for post-hoc analysis were used to compare 
means of each individual group. A P value < 0.05 was considered significantly different. 
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3.3 Results 
3.3.1 HPF induced EndMT after 48 hr stimulation 
Our previous studies have shown that HPF changes vasoactive and proinflammatory activities of 
bovine PAECs. (Scott et al., 2013) Similar to the responses of bovine cells to HPF, HPAECs produced 
pro-vasoconstriction and pro-inflammation factors after exposure to HPF. We further asked whether 
HPAECs would resolve acute inflammation and vasoconstrictive response by making the phenotypic 
transition to a mesenchymal phenotype. As shown in Figure 3.3.1.1A, results demonstrated that HPF 
significantly increased HPAEC mRNA expression of α-SMA, TGF-β1, and COL1A1 molecules by 4-20 
folds, when compared to steady flow after 48 hr of flow condition, while no significant difference in all 
these mRNAs were found between cells under HPF and steady flow after 24 hr of flow condition. Also, 
HPF enhanced cell mRNA expression of these EndMT markers after cells were exposed to the flow for a 
longer period of time (48 hr vs 24 hr), whereas steady flow reduced cell expression of these mRNAs over 
the time, which, except COL1A1, showed no significant difference from the static condition after 48 hr. 
On the other side, HPAEC exposure to HPF for 48 hr significantly reduced mRNA expression of EC 
marker, PECAM-1, exhibiting up to 148-fold decrease when compared to the steady flow or static 
conditions (Figure 3.3.1.1B). Comparison to static control provided baseline EC response to fluid shear 
within the study, and reinforced steady flow as relevant model for comparison to HPF. These results 
indicate that EndMT occurs in the endothelial cells exposed to the HPF condition after 48 hr, a relatively 
longer period of time than that needed to induce pro-inflammatory responses (6-24 hr).  
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Figure 3.3.1.1- Gene expression results showing that ECs after 48 hr HPF stimulation undergo the 
EndMT process. (A) The EC expression of αSMA, COL1A1 (for collagen type I) and TGF-β1 mRNAs 
after 24 hr or 48 hr under steady flow or HPF, using the static condition for comparison. Compared to those 
exposed to the steady flow, cells after 48 hr of HPF stimulation showed significantly higher levels in all of 
*
*
*
*
0
5
10
15
20
25
30
35
40
45
50
Steady HPF Steady HPF
m
R
N
A
 F
o
ld
 C
h
an
ge
 R
el
at
iv
e 
to
 S
ta
ti
c 
C
o
n
to
l
TGF-β1
COL1A1
αSMA
24 hr 48 hr
*
-180
-160
-140
-120
-100
-80
-60
-40
-20
0
Steady HPF Steady HPF
Fo
ld
 C
h
an
ge
 R
el
at
iv
e 
to
 S
ta
ti
c
24 hr 48 hr
 54 
 
these mesenchymal phenotypic genes while cells after 24 hr of HPF stimulation only showed significantly 
higher expression in α-SMA mRNA. The ΔΔCT method was used to determine the gene expression.  (B) 
The mRNA expression of endothelial marker, platelet endothelial cell adhesion molecule (PECAM-1), in 
ECs after flow stimulation. Compared to those under steady flow, the cells under HPF for 48 hr showed 
significantly reduced PECAM-1 mRNA expression, indicating a reduction in EC phenotype; the cells under 
HPF for 24 hr did not show different PECAM-1 expression when compared to those under steady flow. 
These results suggest that HPF promoted the mesenchymal transition of ECs after stimulation for a longer 
time period (48 hr). Statistical analysis using ANOVA and Welch’s two-tailed t-test:  “*”indicates p < 0.05 
versus the steady flow after flow stimulation for the same period of time.  
To confirm the findings from gene expression, protein analyses were performed on selected molecular 
markers. Results from western blots support the PCR results. As shown in Figure 3.3.1.2, when compared 
to the cells under steady flow for 48 hr, ECs under the HPF condition for the same duration increased the 
protein expression of α-SMA, TGF-β1, and COL1A1, by 191%, 33%, and 25%, respectively, while these 
HPF-stimulated ECs exhibited 42.8% reduction in PECAM-1 protein expression.  
 
 
 
 
 55 
 
 
 
Figure 3.3.1.2- Results from western blotting assays show the EndMT-related markers expressed by 
ECs after 48 hr of flow stimulation.  Compared to the steady flow condition, HPF significantly 
downregulated EC marker PECAM while it upregulated all the mesenchymal phenotype markers, which 
demonstrates the change of ECs under HPF from the endothelial phenotype to the mesenchymal, 
myofibroblast-like phenotype. Quantitative measures of protein expression increase and representative 
western blotting bands are shown. Statistical significance (p<0.05) was found in all the protein expression 
comparisons between the steady flow and the HPF. 
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3.3.2 Flow-conditioned media from ECs under HPF induced EndMT of HPAEC and activated 
migration and proliferation of AdvEC  
As we found that HPF promoted EC production of TGF- β1, we further asked whether TGF- β1 and 
other cytokines produced by the cells remain active in the flow conditioned media (FCM) and sufficient 
to affect neighboring ECs or AdvFBs. To address this question, FCM were collected after 24 hr or 48 hr 
flow experiments and were used to culture normal HPAEC and AdvFB, respectively. As shown in Figure 
3.3.2.1, results demonstrated that FCM taken from the EC culture stimulated by the HPF condition for 48 
hr significantly increased α-SMA protein expression in both AdvFB and EC, when compared to all the 
other FCM conditions. This suggests the cytokines secreted by HPAECs under HPF could sustain 
continuous trans-differentiation of ECs and activation of AdvFBs. 
 
 
Figure 3.3.2.1- Flow-conditioned media (FCM) from ECs after 48 hr stimulation with HPF induced 
quiescent ECs and AdvFBs to express α-SMA protein expression. AdvFBs and ECs both cultured in FCM 
pre-conditioned with steady flow and HPF for both 24 hr and 48 hr time points. Quantitative measures of 
protein expression increase and representative western blotting bands are shown. (Left) Fold change of α-
SMA/β-actin in AdvFBs cultured in different FCM conditions relative to that from the steady FCM. (Right) 
Fold change of α-SMA/β-actin in ECs cultured in different FCM conditions relative to that from the steady 
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FCM. Results showed that fractional differences in SMA dramatically increase for the 48 hr time points, 
with 127% and 52% for AdvFBs and ECs respectively. “*” shows p < 0.05 versus FCM from the steady 
flow condition after the same stimulation period.  
In addition, migration and proliferation assays were performed on the AdvFB cultured with various 
FCM. As shown in Figure 3.3.2.2, migration assay results showed that significantly more AdvFB cells 
migrated towards FCM taken from ECs under HPF, when compared to the cells migrated towards steady 
flow, for both 24 hr and 48 hr time points. Proliferation assay results showed that AdvFB cell 
proliferation in FCM from HPF conditions was also significantly higher, when compared to that in FCM 
from steady flow, for both 24 hr and 48 hr time points.  
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Figure 3.3.2.2- Flow-conditioned culture media from ECs exposed to HPF significantly enhanced 
AdvFB migration and proliferation. (Top) Representative images showing AdvFB migration towards flow 
conditioned media (FCM) from ECs under different flow conditions. AdvFBs are stained on the opposite 
side of the filter with crystal violet. (Middle) Quantitative results from AdvFB migration assays, showing 
fold changes of migrated cells in comparison with the control using unconditioned culture media. (C) Cell 
proliferation results of AdvFB cultured with FCM. Statistically significant results (p < 0.05) in AdvFB 
migration or proliferation are shown between FCM from high pulsatility flow and FCM from steady flow 
by (*) for similar time points. “†” shows statistically significant results (p < 0.01) between experimental 
conditions and the unconditioned media (control).  
 
3.3.3 Taxol reduced EndMT response of HPAEC 
Herein, we asked whether inhibiting microtubule dynamics using Paclitaxel (taxol) could inhibit 
microtubulin dynamics, and reverse the EndMT process of HPAECs under HPF stimuli. As shown in 
Figure 3.3.3.1, the addition of taxol reduced EndMT markers in HPAECs under HPF, including α-SMA, 
TGF-β1 and COLIA1, and retained the expression level of endothelial marker (PECAM-1). These results 
may be compared to steady-flow rate, which shows approximaMicrotubulin thus played an essential role 
in HPF-induced EndMT and stabilized the EC structure to protect cells from transitioning to a 
mesenchymal myofibroblast-like phenotype. 
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Figure 3.3.3.1- Results from western blotting assays show that taxol induced changes in the protein 
expression in ECs after 48 hr of HPF stimulation. Fractional increase in EC expression of EMT-related 
proteins after taxol treatment (HPF+Taxol) is shown in comparison with the untreated group, HPF(-). 
Quantitative measures of protein expression increase and representative western blotting bands are shown. 
Statistical significance (p<0.05) was found in all the protein expression comparisons between the treated 
and untreated groups. Increased PECAM expression as well as decreased TGF-β1, collagen I, and α- SMA 
all indicate a reduction in phenotype changes in ECs caused by HPF. Additionally, these results are 
additionally shown when taxol treatment (HPF+Taxol) compared to steady flow results, with the exception 
of α-SMA, which shows a significant increase. 
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3.3.4 Cell apoptosis preceded the EndMT  
We therefore studied whether the occurrence of endothelial transition into a pathological fibroblastic 
phenotype were preceded by endothelial apoptosis. To address this question, caspase assay was used to 
assess cell apoptosis after 24 hr flow conditioning. Results showed that HPF induced much higher 
percentage of apoptotic cells when compared to steady flow (Figure 3.3.4.1). The co-existence of 
apoptotic cells and non-apoptotic cells are interesting facts of the HPF-induced changes. 
 
 
Figure 3.3.4.1- The EMT process of ECs is preceded with cell apoptosis.   
 
3.4 Discussion 
Results from the present study demonstrate that HPF induces EndMT in HPAECs, likely stemming 
from HPF-induced endothelial dysfunction characterized by inflammation, adverse production of 
vasoactive substances and apoptotic responses. Evidence is presented in gene and protein assays of cells 
after 48 hr exposure to HPF, showing dramatic downregulation of PECAM-1 (EC marker), and 
significant upregulation of mesenchymal cell markers including α-SMA, COL1A1, and TGF-β1. This 
demonstrates EC changes into a myofibroblast-like mesenchymal phenotype. In addition, flow-
conditioned media further sustained the stimulating effects of HPF on EndMT and on activation, 
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migration and proliferation of AdvFBs, all of which are related to progressive fibrosis of vascular tissues 
in diseased conditions. We also found that paclitaxel application in the flow media effectively reduced 
EndMT response.  
TGF-β1 could play a critical role in perpetuating flow-induced vascular fibrosis. TGF- β1 is such a 
highly potent cytokine that it alone may not only induce the inflammatory response, but also induce 
EndMT of ECs. 11, 42, 43 The presence of TGF-β1 produced by HPAECs under HPF is likely instrumental in 
sustaining EndMT and increasing fibroblast proliferation, migration and activation to α-SMA+ 
myofibroblasts through myogenic process. Our finding is consistent with previous studies showing that 
TGF-β1 release was found after EC apoptosis, (Sakao, 2006; Sakao et al., 2005; Solovyan and Keski-Oja, 
2005) or during EC exposure to high shear. (Cucina et al., 1998; Ten Dijke et al., 2012) TGF-β1 has also 
been repeatedly shown to increase fibrosis and the encapsulation phase of the inflammatory response. 
More relevant to the current study is that TGF-β1 was shown to directly initiate EndMT in a number of 
previous studies. (Hashimoto et al., 2010; Imamura et al., 2010; Kokudo et al., 2008; Medici et al., 2011; 
Zeisberg et al., 2008)  
Though little is known about cellular mechanisms underlying the EndMT and few successful chemical 
signals have been shown to prevent EndMT, evidence emerges that lack of primary cilia, acetylated 
microtubule, primes the EndMT process in the endothelium, while EndMT diminished with increasing 
primary cilia expression in ECs. (Egorova et al., 2011b) Our previous study showed that the microtubulin 
played an important role in transducing HPF to proinflammatory signals. (Li et al., 2009) Paclitaxel 
(taxol), inhibits microtubule dynamics and thus cell proliferation in cancer chemotherapy, has also been 
previously used to reinforce primary cilia. (Hamel et al., 1981; Hierck et al., 2008) Paclitaxel is 
commonly used in cancer chemotherapy to prevent tumor growth, and as prevention in restenosis through 
preventing SMC migration and proliferation. (Lao and Venkatraman, 2008) This study suggests that 
paclitaxel may attenuate vascular dysfunction by additionally helping to stabilize EC cytoskeleton and 
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reduce EndMT via altered endothelial mechano-transduction of HPF. (Egorova et al., 2011b; Hierck et 
al., 2008) 
Different from previous studies on flow-induced endothelial dysfunction using disturbed flow, (Nagel 
et al., 1999) or oscillatory flow shear conditions (Ziegler et al., 1998) with the mean flow shear stress 
below a physiological value, as occurring in the case of arterial stenosis, HPF is characterized by 
unidirectional flow condition with the mean flow shear within the physiological range, and is correlated to 
increased upstream vascular stiffness. (London et al., 2011) The results shown here as well as our 
previous studies have provided evidence that HPF would create a positive feedback loop through applying 
high flow pulsatility to ECs on a stiff structure, exacerbating endothelial dysfunction and vascular 
fibrosis. Besides enhanced inflammatory response and EndMT in EC, HPF also led to increased apoptosis 
prior to EndMT. Previous studies have shown that a direct result of apoptosis-resistant EC, due to 
unfavorable flow conditions, chemically-induced EC apoptosis, or growth factor inhibition, is post-
apoptosis proliferation of these cells; apoptosis-resistant ECs, likely showing a mesenchymal phenotype, 
may be hyperproliferative and more capable of withstanding harsh biochemical and biophysical stimuli. 
(Cucina et al., 1998; Sakao, 2006; Sakao et al., 2005, 2007, 2009; Scott et al., 2013; Ten Dijke et al., 
2012) HPF fosters the emergence of mesenchymal fibroblasts, which likely are apoptosis-resistant cells 
either proliferating to thicken vascular intima by fibrosis or producing cytokines to activate fibroblast 
migration and proliferation. This may further explain in vivo findings of vascular fibrosis, which often is 
characterized by α-SMA+ cells in all vascular layers and/or increased intimal area. (Dilley RJ et al., 1988) 
The possible mechanism of HPF on vascular fibrotic remodeling is illustrated in Figure 7.  
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Figure 3.4.1- Possible mechanisms showing the effect of HPF on vascular fibrosis. 
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ABSTRACT 
Catering hydrogel manufacturing process towards defined viscoelastic properties for intended 
biomedical use is important to hydrogel scaffolding function and cell differentiation. Silk fibroin 
hydrogels may undergo “physical” crosslinking through β-sheet crystallization during high-pressure 
carbon dioxide treatment, or covalent “chemical” cross-linking by genipin. We demonstrate here that 
time-dependent mechanical properties are tunable in silk fibroin hydrogels by altering the chronological 
order of genipin crosslinking with β-sheet formation. Genipin crosslinking before β-sheet formation 
affects gelation mechanics through increased molecular weight, affecting gel morphology, and decreasing 
stiffness response. Alternately, genipin crosslinking after gelation anchored amorphous regions of the 
protein chain, restricting reptation, and increasing stiffness. These differences are highlighted and 
validated through large amplitude oscillatory strain near physiologic levels, after incorporation of material 
characterization at molecular and micron length scales. 
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4.1 Introduction 
 During the past 30 years, engineered tissues have been researched as permanent treatments for 
many disorders.(Bartels and Lei, 1988; Lei et al., 1985) Tissue engineering implants require mimicry of 
tissue: chemically,(Aumailley and Timpl, 1986; Dahl et al., 2011) mechanically,(Dahl et al., 2011; Engler 
et al., 2006; Stewart and Lyman, 1992; Wingate et al., 2012) and morphologically, to best aid tissue 
growth. Both decellularized matrix,(Badylak and Nerem, 2010; Chen et al., 2001; Dahl et al., 2011) and 
novel biomaterials have been successful in developing new tissues. While decellularized matrices are 
advantageous in mimicking intended tissue, lab synthesized materials may still be a best option due to 
availability, storage, and cost. Hydrogels excel at mimicking tissue due to highly visco-elastic mechanical 
properties and nutrient transport capabilities.(Drury and Mooney, 2003; Peppas et al., 2000; Vepari and 
Kaplan, 2007) High porosity and hydrophilicity both aid in nutrient transport, especially peptide and 
protein-based drugs, through swelling and reduced adsorption,(Wahlgren and Arnebrant, 1991) leading to 
higher efficiencies. Due to the wide range of tissues requiring replacement, tunable hydrogels are ideal 
candidates for tissue engineering scaffolding. 
 While mechanical replacement of tissue has long been an emphasis in implantation medicine and 
tissue engineering, research in the last decade has shown that the cell interaction with scaffold mechanics 
is equally important. Tissue and implant mechanics have been shown as characteristic features in many 
disease pathologies(Ingber, 2003) and as critical factors to regulate cell activity,(Guo et al., 2006; Wang 
et al., 2000) such as stem cell fate.(Engler et al., 2006; Guilak et al., 2009; Wingate et al., 2012) Material 
stiffness may affect cells through cell deformation caused by matrix strain via cell adhesion sites,(Engler 
et al., 2006; Guo et al., 2006; Howard et al., 1997; Kim et al., 1999; Lee and Bader, 1997; Sen et al., 
2008; Simmons et al., 2003; Wang et al., 2000; Wingate et al., 2012) where the time scale of strain 
loading is dependent on tissue use and location. Physiologic loading varies in frequency from static, to 
~0.05 Hz in the small intestine, to ~1 Hz in the circulatory system, and to varied levels in orthopedics. 
The static environment, however, is most frequently used in examining cell activity,(Engler et al., 2006; 
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Guo et al., 2006; Wang et al., 2000; Wingate et al., 2012) which shows cell response over extended time 
scales.(Bao and Suresh, 2003; Wottawah et al., 2005) Stiffness of viscoelastic materials across a range of 
time scales offers frequency-dependent response for cells. Viscoelasticity of hydrogels measured by large 
amplitude oscillatory strain (LAOS) determines material response in application, and provides insight into 
contribution of microstructure to material stiffness response.(Guan et al., 2013; Hyun et al., 2011) 
Mechanical properties of hydrogels and tissues are dependent on hierarchical material organization, 
ranging from molecular structures to microstructures.(Discher, 2005; Saha et al., 2008) By characterizing 
material hierarchies of different length scales, we may gain more comprehensive understanding of 
hydrogel viscoelasticity, and thus develop new methods of tuning time-dependent properties. 
Silk fibroin hydrogels are a versatile material, capable of excellent cell attachment and control of 
material properties. Silk fibroin derived from domesticated silk worms (Bombyx mori) is a long chain 
protein (~375 kDa) with repeat GAGAGS and GAGAGT amino acid sequences consisting of 90% of 
their primary structure. These repeat units form β-sheet secondary structures with hydrophobic side 
groups on their surface, leading to intra- and intermolecular, close-packed crystallization structures,(Bini 
et al., 2004; Hu et al., 2006, 2011) acting as “physical” crosslinks, resulting in stable gel structures. These 
gels can be highly porous and exhibit excellent cell attachment and viability.(Vepari and Kaplan, 2007) 
Fibroin gelation may occur through reduction of solution pH until the molecule isoelectric point is 
reached, and resulting nucleation and crystallization of the protein.(Ayub Haider et al., 1993) Fibroin 
stiffness is heavily reliant on secondary and quaternary protein structures and the overall content of β-
sheet crystals within the gel.(Hu et al., 2006, 2011; Keten et al., 2010) Morphology of gel 
microstructure,(Discher, 2005; Hollister, 2005; Saha et al., 2008) and resulting pore 
connectivity,(Hollister, 2005; Mak, 1986) also contribute material stiffness response. 
In addition to crystallization or physical crosslink through β-sheet formation, silk fibroin can be 
chemically crosslinked. Genipin, due to its low cytotoxicity and ease of use, is a common chemical 
crosslinker.(Bi et al., 2011; Madhavan et al., 2010; Silva et al., 2008a; Xiao et al., 2012; Yao, 2003) It 
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contains a bicyclic, fused ring structure of pentane and dihydropyran rings, and covalently bonds to 
primary amine structures,(Butler et al., 2003) often forming dimer bridges during crosslinking.(Mi et al., 
2005; Sundararaghavan et al., 2008) Primary amines are available at the protein N-terminus and 2% of 
fibroin amino acid side groups,(Marsh et al., 1955; Wang et al., 2013a) allowing additional, but limited, 
tailoring of material by chemical crosslink formation.(Butler et al., 2003) Additionally, genipin 
crosslinking (GCX) was shown to increase fibroin “physical” crosslinking by β-sheet crystallization in 
both electro-spinning,(Silva et al., 2008a) ultrasonication gelation,(Sun et al., 2014) and film 
castings.(Motta et al., 2011) Genipin reactivity is proportional to its concentration, crosslinking 
temperature and time,(Bi et al., 2011; Madhavan et al., 2010; Nickerson et al., 2006) but is reduced at low 
pH,(Mi et al., 2005) allowing for control over crosslink density. Increased stiffness from changes in 
chemical cross link density by genipin content could be quantifiable by coloration changes,(Butler et al., 
2003) primary amine content,(Foss et al., 2013; Sun et al., 2014) and fluorescence.(Sundararaghavan et 
al., 2008)  
 Though crystallization and genipin crosslinking are both employed in previous studies to 
manufacture fibroin hydrogels, no studies have been attempted to examine the impact of the sequence of 
using both processes for manufacturing.(Motta et al., 2011; Silva et al., 2008a, 2008b; Sun et al., 2014; 
Wang et al., 2013a; Xiao et al., 2012) Combining crystallization with chemical crosslinking may provide 
more control over hydrogel properties such as mechanical stiffness, viscoelastic ratio, and gel 
microstructure. However, the chemical crosslinking process is reliant on contact between two primary 
amine groups and the genipin molecule, which is limited by low primary amine amounts in fibroin and 
restricted diffusion and reptation within the hydrogel with β-sheet crystals. Additionally, the reaction 
would be limited by low pH of the solution during the gelation process of crystal formation. Therefore, 
optimizing crosslinking potential would be reliant on material phase transition and its relation to the order 
of crosslinking treatments; the chronology of these two processes can greatly influence the stiffness and 
morphology of fibroin gel.  
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 This paper examines the interaction between chemical crosslinking and crystallization in the 
formation of fibroin hydrogels. We have previously developed high pressure carbon-dioxide treatment 
(PCT) to decrease solution pH for β-sheet crystal formation in silk fibroin, which improved gel structure 
when compared to common citric acid titration methods.(Floren et al., 2012) We also characterized silk 
fibroin materials chemically crosslinked with genipin.(Silva et al., 2008a, 2008b; Sun et al., 2014) Bulk 
gel strength, stiffness, degradation rate, and swelling properties are highly reliant on crosslink density.(Bi 
et al., 2011; Eichenbaum, 1992; Madhavan et al., 2010)  Incorporation of these separate effects would 
allow for control over gel structures and properties. Cell response and activity may be improved and/or 
dependent on control of hydrogel scaffolding material properties over various time and length scales. By 
characterizing gel material properties at the molecular and micron length scales, and comparing to 
modeled viscoelastic modulus, we may better interpret tunability of genipin/fibroin gels. Herein, we 
characterize how tunability of genipin/fibroin hydrogel frequency response and viscoelastic moduli are 
dependent on the order of crosslinking treatments.    
 
4.1  Materials and Methods 
4.1.1  Materials 
Bombyx mori polyhybrid silkworms were bred and selected by Centro Sperimentale di 
Gelsibachicoltura (Como, Italy). Silk cocoons were kindly supplied by Cooperativa Sociolario (Como, 
Italy). Lithium Bromide salt (LiBr) was purchased from Fluka Chemicals (Buchs, Switzerland) and 
Genipin was obtained from Waco Chemicals (Neuss, Germany). Other reagents, buffers and salts were 
purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.) and used without further purifications. 
 
4.1.2 Preparation of Silk Fibroin Solution.  
Silk fibroin solutions in water were prepared according to Kim et al.,(Kim et al., 2005) with limited 
modifications. First, Bombyx mori cocoons were degummed to remove sericin proteins; silk cocoons were 
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treated twice in alkaline water baths at 98°C for 1.5 hr with concentrations of 1.1 g/L and 0.4 g/L 
Na2CO3, respectively. Degummed silk was then washed several times in de-ionized (DI) water and dried 
at room temperature (RT) to obtain pure silk fibroin fibers. Fibroin fibers were then dissolved in 9.3M 
LiBr (2 g of fibroin in 10 mL of LiBr solution) at 65°C for 2.5 h. The solution was then dialyzed against 
DI water for 3 days at RT in a Slide-A-Lyzer dialysis cassette (3.5K MWCO, Pierce, Rockford, IL, USA) 
to remove the LiBr salt and then filtered through a ceramic filter foam (porosity <5 μm) to eliminate 
impurities. Protein concentration was determined using a NanoDrop ND-1000 spectrophotometer 
(Nanodrop Tech Wilmington, DE, USA), and concentration was adjusted to 4 %w/v. Fibroin solution was 
then frozen in liquid nitrogen and stored at -80 °C until use. Frozen solution was later thawed at RT, re-
filtered to remove any aggregate formation, and concentration was adjusted to 3% to obtain working 
fibroin solutions. For all solutions except control, genipin was added to obtain a 1mM concentration 
within the 3% fibroin solution. 
 
4.1.3 Hydrogel Formation 
4.1.3.1 High  Pressure CO2 reactor 
Fixed volumes (240 µL) of initial fibroin solution were pipetted into custom-made 
polytetrafluoroethylene (Teflon) cylindrical molds (8mm Diameter x 5 mm Depth) and placed within a 
stainless steel high pressure reaction vessel (BR-300, Berghof Products + Instruments, Eningen, 
Germany). The temperature of the reactor was controlled through an electrical heating jacket run by a 
BDL-3000 temperature controller (Berghof). CO2 gas was introduced in the reactor and pressurized at a 
working pressure of 60 bar through a high-performance liquid chromatography (HPLC) pump (Model 
426, Alltech, Deerfield, IL, USA).  
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4.1.3.2 Fibroin gelation 
Genipin was activated to chemically crosslink neighboring fibroin molecules by heat-treating samples 
at 37OC for a minimum of 24 hours. To prevent GCX reactions during PCT, temperature during the 
treatment was held at room temperature, unless otherwise noted. Control samples were fabricated at 37oC 
during PCT, consistent with previous work.(Floren et al., 2012) Co-crosslinked (CCX) samples were 
treated at 37OC during PCT, allowing for maximum genipin activation during the physical crosslinking 
process. All other gels underwent heat treatment for 24 or 48 hours, before (Pre24CX, Pre48CX) or after 
(Post24CX) PCT. After gel formation, samples were immediately submerged in 5 mL DI water, and 
stored at 4OC. DI was changed after 24 hours to remove any free genipin residual diffused out of gels. 
Any samples visibly fractured or damaged during the gel removal process from the mold were removed 
from mechanical testing. 
 
4.1.3.3  Modeling CO2 Diffusion 
Diffusion of CO2 into the fibroin solution and the resulting pH was modeled using coefficient values 
determined by Duan et al.(Duan and Sun, 2003; Duan et al., 1992, 2006), and the pH model of CO2 in 
fibroin solution derived by Floren, et. al.(Floren et al., 2012) Resulting concentrations were discerned for 
60 bar and temperatures of 20°C, 22°C, 25°C, and 37°C. Modeling shows higher concentration 
equilibrium at lower temperatures, and therefore faster diffusion of CO2 into the fibroin solution. These 
values concur with tables listed in Duan et al.(Duan and Sun, 2003; Duan et al., 2006) Resulting pH was 
between 1.5 and 4, where gelation occurs through fibroin approaching the isoelectric point, and a plateau 
region in gelation times.(Ayub Haider et al., 1993) 
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4.1.4 Molecular Structure  
4.1.4.1 Determination of amino acid composition by RP-HPLC 
The amino acid content of frozen fibroin samples was determined with Waters AccQ-FluorTM Reagent 
Kit using the AccQ-TagTM amino acid analysis method (WatersCorp., Milford, MA, USA). Briefly, 
fibroin-based hydrogels and solutions, without genipin, were frozen in liquid nitrogen and freeze-dried 
using a Lio-5P lyophilizer (5Pascal, Milan, Italy). About 5 mg of lyophilized fibroin were hydrolyzed 
with 6 N HCl at 114 ± 2 °C in a silicone oil bath for 24 h. Air-dried hydrolysates were later reconstituted 
with 20 mM HCl to obtain a solution at a concentration in the range 4-200 pmol and then derivatized with 
Water AccQ Flour Reagent to obtain stable amino acid. The amino acid content was determined by 
reverse phases high performance liquid chromatography (RP-HPLC) using a AccQ-TagTM column 
(Waters Corp) with a gradient of Waters AccQ-TagTM Eluent A, Milli-Q water and Acetonitrile (HPLC 
grade) at a flow rate of 1 ml/min. The amino acids were detected with Jasco UV-1570 detector set (Jasco, 
Bouguenais, France) at 254 nm. The chromatograms obtained were compared with waters amino acid 
hydrolysate standards to identify single amino acid residues. 
 
4.1.4.2 Molecular weight measurement by GPC 
Gel permeation chromatography (GPC) analysis of the fibroin samples was conducted with a Shodex 
SB-805HQ column (Shodex OH pak®, Showa Denko, Munich, Germany). Freeze-dried fibroin-based 
hydrogels and solutions were re-dissolved in 9.3 M LiBr at 65°C for 0.5 h. The obtained fibroin solutions 
were dialyzed against DI water at RT and diluted with eluent solution (3 M Urea, 0.02 M Tris HCl, 0.15 
M NaCl, pH 7.5) to obtain a protein concentration in the range of 0.5-0.8 mg/ml. The chromatography 
system was operated with a flow rate of 1 ml/min at 27 ± 1 °C and elution was detected with a Jasco UV-
1570 detector set (Jasco, Bouguenais, France) at 224 nm. Calibration curve was obtained with Low/High 
Molecular Weight Gel Filtration Calibration Kit (GE Healthcare Europe, Freiburg, Germany).  
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4.1.4.3  Determination of genipin crosslinking activity by confocal microscopy 
Previous literature shows GCX content is fluorescent with the excitation peak at 590 nm and emission 
peak at 630 nm.(Sundararaghavan et al., 2008) Increased fluorescence from GCX formation occurs due to 
increased π-bonding within the genipin bicyclic fused ring structure after opening of the dihydropyran 
ring.(Butler et al., 2003; Mi et al., 2005; Sundararaghavan et al., 2008; Wang et al., 2013a) Further 
increase in π-bonding and genipin concentration may occur in genipin dimerization during cross-linking, 
and is a commonly proposed mechanism of genipin crosslinking,(Mi et al., 2005; Sundararaghavan et al., 
2008) including to fibroin.(Wang et al., 2013a)  
Lyophilized gels were rehydrated using DI for 24 hours. Maximum GCX efficiency was measured by 
Control gels immersed in 15 mM glycine solution and 1 mM genipin for 24 hours at 37°C. Samples were 
removed from DI and separated on a single chamber slide, partitions removed, and a second glass slide 
placed over the samples to ensure homogeneous surface depth. Samples were then imaged using confocal 
microscopy (Nikon Corporation, Chiyoda, Tokyo, Japan). Genipin was excited by means of a diode 
pumped solid state laser (561±0.5 nm, Melles Griot). Emission band collected ranged from 616-658 nm, 
with the gain set to maximize emission intensity without saturation for the gel with the highest emission 
intensity, and kept constant for all the others. Images where collected using  a 20x Plan Flu objective with 
2x scanning zoom (40x total, 4.97 μm/pixel resolution). Microscope pinhole was opened maximally to 
permit high PMT sensitivity, even with low emitting samples, and from the thickest optical section 
possible (7.83 μm), with a dwell time of the laser equal to 12.6 μs/voxel.  After maximum emission 
intensity was determined within the sample set, program settings were maintained as a method of 
comparing between samples. Max GCX allows the determination of the overall GCX efficiency. 
Summation of emission intensity over the given area was recorded and converted to numerical byte 
values for each pixel in a 64 x 64 matrix. Images were analyzed using NIS-Elements Viewer (Nikon 
Corporation), and emission intensities were determined with ImageJ (NIH, Bethesda, MD, USA). 
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4.1.4.4  Determination of chemical crosslinking density by ninhydrin assay 
Ninhydrin assay was used determine active genipin content(Foss et al., 2013). Ninhydrin reacts with 
active NH2 groups, producing a visible purple color, detectable at 570 nm wavelength by 
spectrophotometer. By comparing ninhydrin content between control and variable gel samples, genipin 
bonding conditions may be determined. To ensure protein primary structures in samples were preserved, 
samples were first flash frozen by submerged in liquid Nitrogen and subsequently lyophilized at 
temperature of -50OC and pressure of 5 mmHg for no less than 24 hrs. Ninhydrin (Sigma-Aldrich) 
solution of 0.35% w/v in ethanol (>96%) was added to lyophilized samples to a concentration of 
approximately 5 mg/mL, and heated at 90°C for 30 minutes under mild shaking. Each solution was made 
in triplicate; blank and glycine control solutions underwent the same treatment. After cooling down, 
optical absorbance of each solution was measured at 570 nm using a microplate reader (Tecan Group AG, 
Mӓnnendorf, Switzerland). Change in primary amine available was calculated as: 
∆𝑃𝑟𝑖𝑚𝑎𝑟𝑦 𝐴𝑚𝑖𝑛𝑒 =
𝑁𝐻𝑁𝑆𝑎𝑚𝑝𝑙𝑒
𝑁𝐻𝑁𝐶𝑛𝑡𝑟𝑙
 (1) 
Where NHNSample is the color intensity presented by ninhydrin assay performed on the variable sample, 
and NHNCntrl is the color intensity presented by the control gel. 
 
4.1.4.5  Determination of physical crosslinking density by Fourier Transform Infrared Spectroscopy 
Protein secondary structures were determined through Fourier transform infrared spectroscopy (FTIR) 
Spectrum One (Perking Elmer, Waltham, MA, U.S.A.) with Zinc Selenide crystal. Two additional 
samples were compared with Control samples: Amorphous is fibroin solution which has not undergone 
PCT, and Genipin is 3% fibroin which has undergone 1mM genipin crosslinking for 48 hours without 
undergoing PCT. To preserve protein secondary structure, samples were lyophilized, then placed in FTIR 
sampling surface and compressed until a minimum force of 100N was reached. Sample spectra were 
averaged over 4 scans, ranging from 650 cm-1 to 4000 cm-1 at a resolution of 4 cm-1. 
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4.1.5 Microstructure Visualization 
4.1.5.1  Scanning electron microscopy imaging 
Imaging of samples was obtained using a scanning electron microscope (Quanta 200 FESEM). Prior to 
imaging, lyophilized cross sections were sputter coated (Biorad SC500, Hemel Hempstead, U.K.) with a 
thin layer of gold or platinum/palladium mixture. 
 
4.1.5.2  Confocal microscopy imaging 
It is difficult to image hydrogel microstructure without altering gel structure using lyophilization or 
environmental SEM. Therefore, wet gel samples were stained with Rho 123, a fluorescent small molecule 
capable of penetrating bulk gel material, and then imaged with confocal microscopy. Samples were 
placed in Rho 123 solution at 4OC for 24 hours for staining, and then put in DI at 4OC for 72 hours to 
remove the dye from pores. Gels were then placed on glass slides for confocal imaging. 
 
4.1.5.3 Image Analysis 
 Images were analyzed both quantitatively and qualitatively. Pore dimension was determined 
using ImageJ. Results were compared across gel sample sets, and between same sample sets across 
different imaging modes (Confocal vs SEM). Qualitative analysis was done by comparing morphology 
and gel structure across gel sample types. 
 
4.1.6 Mechanical Properties 
4.1.6.1 Swelling Ratio 
 Gels were submerged in DI for a minimum of 24 hours and stored at 4OC. Before mass 
measurement, samples were brought to room temperature and weighed. Subsequently, samples were 
submerged in liquid nitrogen and lyophilized. Dried samples were then weighed, and the swelling ratio 
was determined with the equation below: 
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𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑅𝑎𝑡𝑖𝑜 =
(𝑚𝑤𝑒𝑡−𝑚𝑑𝑟𝑦)
𝑚𝑑𝑟𝑦
 (2) 
Where mwet is the mas of the fully hydrated sample, and mdry is the mass of the lyophilized sample. 
 
4.1.6.2 Mechanical Response 
Large amplitude oscillatory strain (LAOS) in compression was performed to establish the viscous and 
elastic properties of the material. Frequency sweep of cyclic, uniaxial compression testing was used to 
determine approximate location of the transition frequency (ω), first harmonic storage modulus (E1’), and 
first harmonic loss modulus (E1’’) of samples. Samples were placed between horizontal, quartz slides 
attached to both the base fixture and driving piston of a mechanical testing machine. (Bose, Eden Prairie, 
MN, U.S.A.) The driving plate was brought into contact with the gel, and DI was placed around the gel, 
with surface tension allowing DI to maintain its integrity for the duration of the test. Subsequently, an 
average strain of 25% was applied in compression and the system allowed to reach equilibrium. Dynamic 
strain was then oscillated at peak-to-peak amplitude of 20% strain, chosen from previous studies,(Howard 
et al., 1997; Kim et al., 1999; Lee and Bader, 1997; Park et al., 2004) and in vivo examples.(Fung and 
Liu, 1992; Kalath et al., 1986) Oscillation frequencies ranged from 2.202E-3 to 1 Hz, where plateau in 
response was reached. Data was recorded after 4 seconds of pre-conditioning of the sample for each 
frequency. 
Data was analyzed using Wolfram Mathematica (Wolfram Research, Champaign, Illinois, USA). 
Discrete Fourier-Transform was taken of both strain and stress data. Complex modulus (E1*) of the first 
harmonic was discerned from stress and strain response at the dominant frequency. Stress data curves 
were additionally smoothed through convolution with the normalized Gaussian kernel. Bandwidth varied 
with data frequency. Resulting smoothed curves were plotted against strain data to measure and visualize 
hysteresis curves, as well as overall stiffness response (E). 
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4.2 Results and Discussions 
Results from the study have shown significant changes in the material structure and gel property 
among all the silk fibroin gels, with the presence of genipin as well as the order of crosslinking treatment.  
 
4.2.1 Physical appearance of gels 
Because genipin is known to produce a distinct blue coloration after GCX occurs while fibroin 
aggregation produces a white and/or cloudy liquid, the physical appearance of the gels suggests the status 
of protein aggregation and crosslinking. Thus, we first studied the physical appearances of both the 
solution and the gels of the genipin/fibroin solution. All the fibroin and genipin/fibroin solutions were 
initially transparent with no coloration. The minimal primary amine content in fibroin, and genipin 
concentration in solution would necessitate increased reaction kinetics to have significant GCX formation 
between fibroin molecules. To test this, fibroin and genipin/fibroin solutions were compared after 24, 36, 
and 48 hours at both 20OC (room temperature or RT) and 37OC. Genipin/fibroin solutions held at RT after 
a period of 24 hours indicated no color changes or noticeable increases in solution turbidity. After a 
period of 36 and 48 hours at RT, they showed a faint blue coloration, with minimal aggregation or no 
visible increases in turbidity. Minimal aggregation and coloration ensured chemical crosslinking is 
confined to the heat treatment (at 37OC) step. Fibroin and genipin/fibroin solutions held at 37OC still did 
not exhibit visible turbidity and remained a liquid after 24 or 48 hours. But the genipin/fibroin solutions 
showed a medium blue color after 24 hours, and turned into a darker blue coloration after 48 hours. The 
color changes in the solutions correlated well with the corresponding gel samples: Pre48CX and Pre24CX 
gels both showed blue coloration, with darker color in Pre48CX, while the Control, CCX, and Post24CX 
gels did not exhibit color changes, all showing white and translucent. Figure 4.3.1.1 summarizes the 
results with preparation protocols and representative pictures of the gels.  
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Figure 4.3.1.1- Preparation protocols and physical appearances of the gel samples. All samples were 
prepared from 3% w/v concentration of silk fibroin. The protocols show the order and degree of genipin 
crosslinking (GCX) with shaded blocks. Processing temperature during each 24 hour block is listed, along 
with the cumulative time of processing. Herein, the control gels were from pure fibroin solution with 24hr 
PCT-induced crystallization, while all the other samples contained 1mM concentration of genipin. 
Representative pictures of gels illustrating sample coloration and shape are shown on the right. 
 
 
4.2.2 Molecular Structure 
Results from RP-HPLC did not show significant alterations in the protein amino acid composition and 
therefore minimal difference in protein primary structure, among different gels.(Marsh et al., 1955) The 
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protein secondary and quaternary structures showed no difference when compared to the control. All the 
gels showed high concentration of intermolecular β-sheet crosslinking, with no variation in the peak 
locations or intensities. 
Results from GPC showed significant increases in both number-average and weight-average molecular 
weights (MN and MW, respectively) for Pre48CX, when compared to control gels. As illustrated with the 
Pre48CX curve, the GCX formation presented a distribution more skewed towards higher molecular 
weights, with both MW and MN higher than control gels. (Figure 4.3.2.1) 
 
Figure 4.3.2.1- Gel permeation chromatography results, showing an increase in both MN and MW for 
gels with genipin crosslinking before gelation. 
 
To further understand GCX mechanism in changing the molecular structure, confocal microscopy was 
used to image GCX fluorescent signals. Results demonstrate significant increases of fluorescence 
emission in all GCX gels, when compared to control gels. (Figure 4.3.2.2) The GCX concentration in 
Pre48CX and Pre24CX correlates with the crosslinking time.  
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Figure 4.3.2.2- Genipin fluorescence emission results. Lyophilized and rehydrated samples were 
examined for genipin crosslinking (GCX) efficiencies, illustrated with the average intensities from 
confocal images. Results show the fluorescent signals from all the crosslinked gels are statistically 
(p<0.10) different from control. Also, Pre48CX and CCX show statistically significant (p<0.10) 
differences from all other crosslinked gels (labeled with “*”). 
 
 
To examine the genipin activity along single fibroin chains, ninhydrin assay was used. Results 
demonstrate significant decreases in primary amine groups for all GCX samples compared to the control. 
(Figure 4.3.2.3) Results do not correlate with confocal fluorescence data.   
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Figure 4.3.2.3- Primary amine sites quantified by ninhydrin assay. Results show the fraction of 
primary amine quantity in GCX gels (y-axis), when compared to control gels. All gels show decreased 
fraction in primary amine groups. Higher reduction in primary amine groups suggests increased genipin 
reactivity at bonding sites along single fibroin chains, rather than reaction between two fibroin molecules. 
 
To characterize changes in major functional groups among gels, FTIR was used. Infrared spectroscopy 
results show that the presence of genipin or the order of crosslinking treatment did not induce any 
changes in peak locations or intensities. (Figure 4.3.2.4A) Resulting peaks were typical for fibroin 
hydrogels, as previously shown by our lab.(Floren et al., 2012; Sun et al., 2014) Specifically, all results 
showed the peaks representing strong, intermolecular β-sheet structures (1622 cm-1, amide I(Hu et al., 
2006)), weak β-sheet structures (1700 cm-1, amide I(Hu et al., 2006)) and peak shift for tyrosine side 
chains (1516 cm-1, amide II(Hu et al., 2011)), while peaks representing α-helix structures (1656-1662 cm-
1, amide I(Hu et al., 2006)), random coils (1640-1655 cm-1, amide I;(Hu et al., 2006) 1540 cm-1, amide 
II(Hu et al., 2011)), turns (1663-1696 cm-1, amide I(Hu et al., 2006)), or side chain residues (1605-1615 
cm-1, amide I(Hu et al., 2006)) were not present. In comparison, FTIR results of amorphous fibroin which 
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did not undergo PCT with or without GCX (Figure 4.3.2.4B) showed peaks at 1645 cm-1 (random coil) 
and 1516 cm-1 (Tyr side chains). Amorphous fibroin after GCX showed an additional peak at 1532 cm-1, 
which may result from in-plane deformation of genipin bicyclic, fused ring structure.(Suryani and Liu, 
2009) In summary, lyophilized silk solution without PCT-induced crystallization indicated no β-sheet 
formation, even after 48 hours of GCX. 
 
 
Figure 4.3.2.4- Infrared Spectra (FTIR) showing similar peak patterns among gel samples treated with 
PCT. (A) All gels presented high similarity in all major peaks of FTIR spectra, which showed the tight, 
intermolecular β-sheet crystals (1622 cm-1) and weaker β-sheet structures (1700 cm-1) of fibroin. (B) 
Lyophilized fibroin solutions without or with genipin crosslinking, undergoing no PCT gelation, are 
compared to the Control with PCT gelation. Both fibroin solutions present random coil (1645 cm-1) and 
Tyrosine side chain peak shift (1516 cm-1), common in amorphous fibroin. Additionally, there is a peak at 
1532 cm-1 in fibroin with genipin crosslinking, possibly resulting from in-plane deformation of the 
genipin bicyclic, fused ring structure.” 
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4.2.3 Microstructure from SEM and confocal imaging 
SEM images show that the gel microstructure changes with the crosslinking order. Two types of 
morphology were found in SEM images (Figure 4.3.3.1). Control gels and gels with GCX during or after 
PCT (CCX and Post24CX) exhibit porous microstructure with limited connectivity between pores. Low 
connectivity between pores is determined by decreased concentration of connected perforations, as 
illustrated with blue circles in Figure 4.3.3.2. Contrarily, gels with GCX before PCT show more fibrous 
morphology and higher pore connectivity. Morphology changes were more drastic in Pre48CX.  
Confocal imaging results supported SEM findings by showing evenly distributed pores of uniform size 
within the saturated, wet gel. (Figure 4.3.3.3) No changes were found along the depth of the gel, 
indicating homogeneous gel formation. 
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Figure 4.3.3.1- SEM micrographs showing the gel microstructure and morphology. (A) Control gel 
showed uniform pores with limited connectivity. (B) Pre48CX gels presented greater average pore size 
and more fibrous structure with high connectivity. (C) Pre24CX gels presented even larger pores with 
connectivity lower than Pre48CX. (D) CCX gels slightly increased pore size and connectivity when 
compared to the Control. (E) Post24CX gels presented little change in morphology from the Control. 
Scale bar equals 10μm. 
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Figure 4.3.3.2- Comparison of Control (Top) and Pre48CX (Bottom) microstructures. The images on 
the right panel illustrate analysis of pore changes in the pore structure (red) and connecting perforation 
(blue). Scale bar equals 3 μm 
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Figure 4.3.3.3. SEM (left) and confocal microscopy (right) images, showing the gels in dry and wet 
environments, respectively. These correlated images demonstrate that the gel microstructure retained after 
hydration. Confocal imaging was performed by illuminating pores with Rhodamine 123. A: Control; B: 
Pre48CX; C: Pre24CX; D: CCX; E: Post24CX. Scale bar equals 100μm 
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4.2.4 Mechanical Properties 
Mechanical testing results showed significant differences among all the gels (Figure 4.3.4.1). Gel 
stiffness was inversely correlated with pore connectivity visualized from SEM images. It was found that 
gels with GCX occurring during or after PCT (CCX and Post24CX) augmented stiffness while Pre48CX 
and Pre24CX gels showed decreased stiffness.  
Gel mechanical behaviors show significant changes in storage and loss modulus. Low frequency 
response indicated decreased stiffness with pre-PCT gelation GCX formation (Pre48CX, Pre24CX), and 
greater stiffness with GCX after PCT- induced gelation (Post24CX), when compared to control. (Figure 
4.3.4.1)  
 
 
Figure 4.3.4.1- Storage (E1’) and loss (E1’’) moduli as functions of frequency. Results in control gels 
indicate decreased overall stiffness at lower frequencies. Additionally, E1’’ appears lower than E1’ for all 
frequency values, and appears decreasing at similar or faster rate than E1’. (A) Comparison of Control 
(n=3), Pre48CX (n=3) and Pre24CX (n=3) show decreased stiffness for both E1’ and E1’’ at all 
frequencies. (B) Post24CX (n=2) shows increased stiffness compared to Control, while CCX (n=4) shows 
lower transition frequency. 
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Key: ●○- Control E1’ E1’’; ■□- Pre48CX E1’ E1’’; ◆◇- Pre24CX E1’ E1’’; ▲△- CCX E1’ E1’’; + +- 
Post24CX E1’ E1’’;” 
 
E1’ and E1’’ reveal typical viscoelastic response of gels, with lower and upper plateau regions at lower 
and higher frequencies, respectively, separated by a transition region. Values for E1’’ show similar results 
to E1’ across all samples when compared to control. Interestingly, E1’’ decreases with lower frequencies 
at a rate equal to or greater than that of E1’, which indicate that the material always acts as an elastic solid 
within the environmental constraints placed on the material. 
 
 
Figure 4.3.4.2- Energy dissipation per cycle was calculated from hysteresis curves, and plotted against 
frequency. (A) Comparisons of Control (n=3), Pre48CX (n=3), Pre24CX (n=3) show decreased energy 
dissipation in GCX crosslinked gels. (B) Comparisons of Control, CCX (n=4), and Post24CX (n=2) show 
increased energy dissipation from Post24CX gels, and peak shift to lower transition frequency. 
Key: ●- Control; ■- Pre48CX; ◆- Pre24CX; ▲- CCX; + - Post24CX;” 
 
Energy dissipation curves indicate significant energy loss at all frequencies for all gels. Gels with 
GCX pre-PCT gelation show decreased energy dissipation, while GCX after PCT shows much greater 
energy dissipation values. All energy dissipation values correspond well with E1’’ values (Figure 10). 
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Both Post24CX and CCX gels showed a distinct peak shift to lower transition frequency, also 
corresponding to shifts seen in E1’. 
 
4.3 Discussion 
Herein, we show order of GCX formation with PCT-induced gelation through β-sheet crystallization 
affects SF hydrogel morphology, and resulting material properties with physiologic, high amplitude 
dynamic loading. Significant differences between sample loss and storage moduli are shown, which 
become greater at higher frequencies. GCX occurrence pre-PCT presents more fibrous morphology and 
decreased stiffness at higher frequencies. Occurrence of GCX during the PCT phase showed minimal 
effect. Alternately, GCX after PCT shows similar morphology, with increased stiffness at all frequencies. 
Furthermore, this stiffness response approximates gel response in different applications. 
Silk fibroin which undergoes PCT-induced gelation forms highly hydrated, porous hydrogels,(Floren 
et al., 2012) through induction of β-sheet crystallization. All samples within this study correspond with 
this previous data, with stable, homogeneous, porous gels forming as seen in SEM and confocal 
microscopy data (Figures 4.3.3.2 & 4.3.4.1). Reported stiffness data ranges from 15-60 kPa for low 
applied strain rates (~0.3%/s), which corresponds with similar strain rates in our study (f=0.015 Hz). 
Additionally, FTIR spectra shows no significant changes between gels (Figure 4.3.2.4), indicating high 
levels of gel crystallinity between samples.(Floren et al., 2012; Hu et al., 2006, 2011) Covalent 
crosslinking before PCT leads to more fibrous morphology, and decreased stiffness response. The 
microstructure changes, taken in conjunction with changes in MW distributions by GCX formation, 
suggest differences in nucleation rates among the gels. Previous studies in polymer formation indicate 
decreased nucleation times,(Krumme et al., 2004; Song et al., 2008) and changed morphology,(Emri and 
von Bernstorff, 2006; Krumme et al., 2004; Song et al., 2008) in bimodal polymer distributions. While 
previous studies most frequently indicate chemical crosslinking increases material stiffness,(Bi et al., 
2011; Madhavan et al., 2010; Sundararaghavan et al., 2008) and morphology change,(Bi et al., 2011) 
 91 
 
testing is performed in the linear range. The fibrous morphology and greater pore connectivity may be 
responsible for decreased E1’ values.(Hollister, 2005; Mak, 1986) This decreased stiffness would also 
account for decreased energy dissipation, due to minimal elastic storage, and corresponds with decreased 
E1’’ values. 
Covalent crosslinking after PCT (PostCX) leads to much greater stiffness response, while maintaining 
similar morphology to Control. While GCX occurring post-gelation has been shown previously, 
molecular structure during GCX treatment was not fully crystallized,(Xiao et al., 2012) possibly allowing 
more amorphous chain movement. Furthermore, β-sheet content was increased after GCX 
formation,(Xiao et al., 2012) confusing mechanical response between GCX and higher crystallinity.  
Taken together, results from ninhydrin assay, fluorescence emission, and physical appearance of gels 
suggest that genipin bonding to fibroin molecules occurs at low efficiency. After PCT-induced 
crystallization, amorphous chain groups are immobile, making primary amines less available for bonding, 
thereby diminishing GCX formation. Genipin bonding to a single fibroin molecule would decrease 
primary amine content as measured by ninhydrin (Figure 4.3.2.3),(Butler et al., 2003; Foss et al., 2013; 
Silva et al., 2008b) while fluorescence (Figure 4.3.2.2) would most greatly increase with genipin dimer 
bridge formation due to additional π-bonds within the bicyclic fused ring structure.(Mi et al., 2005; 
Sundararaghavan et al., 2008; Wang et al., 2013a) Therefore, mismatch between these two data sets 
indicates partial, but not complete, GCX formation in Post24CX gels. The first reaction to occur in 
genipin bonding to a primary amine group is the opening of the dihydropyran ring within the fused ring 
structure, thereby causing one additional π-bond to form.(Butler et al., 2003) Therefore, fluorescence 
would increase without creating blue pigmentation of full GCX formation. Of the two-part genipin 
reaction, this was shown to occur first,(Butler et al., 2003) and would increase fluorescence, thereby 
creating a disparity between fluorescence and pigmentation. This may explain the similarity in 
fluorescence, but disparity in coloration between Pre24CX and Post24CX gels.  
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Stiffness response in Post24CX samples showed significant differences. GCX formation after gelation 
would cause partial formation of a polymer network within the amorphous region, reducing molecular 
motion, and increasing stiffness response. This increased stiffness response may also be seen in increased 
E1’’ values, and corresponding increased energy dissipation as seen in Figure 10. Peak shifts towards 
longer relaxation times (1/f), present in both CCX and Post24CX energy dissipation and first harmonic 
moduli plots, may result from amorphous network crosslinking.(Glatz-Reichenbach et al., 1994) 
Previously, genipin crosslinking has been studied with fibroin, though order between GCX and 
gelation was not examined.(Motta et al., 2011; Silva et al., 2008b; Sun et al., 2014; Wang et al., 2013a; 
Xiao et al., 2012) Dynamic mechanical response with physiologic, nonlinear strain was also not examined 
within these previous studies. Large compressive strain deformation  amplifies stiffness response from 
morphological structure(Hyun et al., 2011; Lockett, 1972) and permeability within poroviscoelastic 
solids.(Mak, 1986) This may be derived from Poisson’s ratio causing volumetric changes between the 
solid and fluid phases of the material, resulting in fluid flux, and corresponding pressure from fluid drag 
(Supporting Material S1).  Application of nonlinear strain would therefore highlight morphological 
changes resulting in higher permeability, and material response under physiologic strains. 
Material tunability allows broader application, and may improve scaffold design. Morphology plays an 
important role in cell activity through cell attachment(Arnold et al., 2004) and nutrient transport.(Drury 
and Mooney, 2003; Peppas et al., 2000; Vepari and Kaplan, 2007) Additionally, both micro-
structure(Discher, 2005; Hollister, 2005; Saha et al., 2008) and connectivity(Hollister, 2005; Mak, 1986) 
affect matrix stiffness, an important contributor to cell interaction and activity.(Guo et al., 2006; Ingber, 
2003; Wang et al., 2000) Material stiffness and its response to applied strain additionally play a role in 
cell differentiation.(Engler et al., 2006; Guilak et al., 2009; Sen et al., 2008; Simmons et al., 2003; 
Wingate et al., 2012) Herein, we show that stiffness response within the frequency spectrum may be 
controlled by changing order of GCX formation and PCT-induced gelation in SF hydrogels.  
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4.4 Conclusions  
Order of GCX and PCT during formation of SF hydrogels have significant effects, and are capable of 
‘tuning’ gel microstructure. Through alteration of both chemical (GCX) and physical (PCT) crosslinking, 
we may affect either the viscoelastic range, or overall stiffness of the material.  
GCX formation before PCT results in decreased stiffness response at higher frequencies due to greater 
pore connectivity.(Hollister, 2005; Mak, 1986) (figure 4.3.3.3) Underlying cause is probably greater 
skewing and spread of SF molecular weight distribution (figure 4.3.2.1) before PCT, leading to 
morphological changes.(Emri and von Bernstorff, 2006; Krumme et al., 2004; Song et al., 2008) In 
comparison to Control, microstructure is most responsible for hydrogel stiffness response, with both 
Pre48CX and Pre24CX gels showing decreased E1’ and E1’’ values. Here we illustrate GCX pre-PCT 
gelation alters microstructure, with minimal molecular structure changes. 
GCX formation after PCT causes anchoring of amorphous SF entanglements, causing much greater 
stiffness response at all loading frequencies. Increased stiffness occurred in Post24CX gels compared to 
control, (Figure 4.3.4.2) across all frequency values, for both E1’ and E1’’. Visually, SEM images of 
Post24CX indicated the greatest similarity with control gels, indicating that GCX augments stiffness of 
the control molecular and morphology structures. Though gels with GCX formation pre-PCT show much 
higher crosslinking concentration, GCX after entanglement would create polymer networks within the 
amorphous region of the fibroin. Here we see that microstructure is similarly formed compared to 
Control, but with major changes to molecular mechanics within the material.   
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 Effect of Arterial Viscoelasticity and 
Stiffness on Hemodynamics 
 
Time-dependent arterial wall property is an important but difficult topic in vascular mechanics and 
health. Arterial hysteresis curves formed through the cardiac cycle have been associated with arterial 
health. However, the cause-effect relationship between time-dependent mechanical properties of the 
arterial wall and hemodynamics, in particular the viscous contribution alone to arterial hemodynamics, 
remain elusive and challenging. Herein, we have shown comparisons between elastic (E’’/E’ <0.06) and 
highly viscoelastic (E’’/E’ = 0.45) tube conduits, in terms of their capability of altering pulsatile flow 
profile, wall shear and energy level. The tube conduits were made from varying ratio of vinyl-terminated 
and methyl-terminated poly(dimethylsiloxane), and were fit in a mimetic circulatory system with high 
accuracy measurements of waveform changes in flow, pressure and strain. Results indicated that 
attenuated distension waveforms in viscoelastic conduits, when compared to elastic conduits, resulted in 
11% greater cross-sectional area throughout a mimetic cardiac cycle. In response to changing wall 
mechanics in viscoelastic conduits, pressure and volumetric flow waves respectively decreased by 3.9% 
and 6% in the peak-to-peak amplitude. The change in conduit strain might result from frequency-
dependence of the viscoelastic materials. More importantly, diameter strain and volumetric flow showed 
greater waveform temporal alignment in viscoelastic conduits due to attenuation of both waveforms, 
resulting in 25% decrease in detrimental oscillation of wall shear stress. These changes in flow dynamics, 
due to the viscous component of viscoelastic conduit, might have beneficial influence to cell 
mechanotransduction to promote healthy arterial response.                
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The importance of viscoelasticity in blood vessels may be best illustrated by comparison of healthy to 
diseased states and to treated states. Viscoelastic properties of arteries started to become a metric of 
health,(Liu et al., 2015; Wang et al., 2013c), coincided with application of time-dependent materials in 
arterial replacements,(Zhao, 2014; Zhao et al., 2014) such as vascular graft.(Nagiah et al., 2015; Neufurth 
et al., 2015) During the progression of arterial disease, a well-known phenomenon is increased pressure 
modulus (EP) of the artery.(Beaussier et al., 2011; Huynh et al., 2011) What remains unclear is the 
importance of viscoelastic changes in arterial properties to the disease progression, though recent studies 
showed significant decrease in hysteresis loops during arterial diseases.(Wang et al., 2013c) A similar 
question also applies to arterial disease treatments such as arterial grafting. In studies comparing the 
human femoral artery to graft materials including cryogenically preserved artery, saphenous vein, and 
ePTFE graft that lacks arterial-like viscoelasticity, the viscoelastic response of arterial grafts correlated 
with the success rate. (Bia et al., 2006; Deutsch et al., 2009; Owens, 2010) While viscoelastic, tough 
biomaterials are now being explored in vascular grafting, the question on whether increasing viscous 
response of the material could improve mechanical and biological responses remain largely 
unexplored.(Neufurth et al., 2015). Therefore, the interaction between viscoelastic properties of blood 
vessels and flow dynamics is important to understanding of vascular physiology and design of vascular 
implant, but remains largely unexplored. 
  Effects of arterial wall time-dependent properties on hemodynamics have been a difficult question for 
the past 60 years. Branching of the arterial tree, arterial integration into surrounding tissues, and 
hierarchical tissue structure of the arterial wall contribute to the complexity of measuring such effects in 
situ or ex vivo. Arterial tissue consists of multiple, anisotropic layers, with varying time-dependent 
stiffness responses, and differing roles in arterial loading.(Holzapfel, 2004, 2005; Wagenseil and 
Mecham, 2009) Stress and strain of the layers additionally changes with arterial geometry,(Hunter et al., 
2010) as well as boundary conditions created by tethering of the arterial adventitia to the surrounding 
tissue.(O’Rourke et al., 2011) Additionally, healthy, native arteries express a frequency-dependent 
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viscoelastic response, with measurable hysteresis, and a viscoelastic ratio (E’’/E’) of approximately 0.1-
0.15. (Bergel, 1961; Bia et al., 2006). Muscular arteries such as femoral and carotid were shown to 
provide protective damping for the circulatory system, through significant strain and 
hysteresis.(Armentano et al., 2014; Bia et al., 2006; Giannattasio et al., 2008; Wang et al., 2013b) Though 
important, measurements taken in situ or ex vivo do not provide the cause-effect relationship between 
time-dependent mechanical properties of the arterial wall and hemodynamics. 
In computational and experimental models, viscoelasticity has been shown to attenuate pulsatile flow 
waves over long distances and during exercise.(Alastruey et al., 2011, 2012; Bessems et al., 2008; Raghu 
et al., 2011; Taylor, 1959; Wang et al., 2013b, 2016) Of the previous works that experimentally validated 
flow models, most did not independently characterize the tube material properties, (Bessems et al., 2008; 
Taylor, 1959) and all used materials with viscous responses that were only a slight fraction (tanδ ~ 0.02) 
of the overall stiffness response. (Bessems et al., 2008; Taylor, 1959; Wang et al., 2016) These studies 
also failed to experimentally separate the contributions of viscous and elastic components to 
hemodynamics. Additionally, though pressure wave attenuation was studied previously, the time-lag of 
the wall strain due to viscoelastic material properties, as well as its coupling with the flow waveforms has 
not been well studied.(Bessems et al., 2008; Taylor, 1959; Wang et al., 2016) As the wall shear stress, a 
primary signal to vascular endothelial cells and vascular health, (Chien, 2006; Chiu and Chien, 2011; 
Elliott et al., 2015; Scott et al., 2013),  is determined by volumetric flow and cross-sectional area, the 
phasic alignment of material strain and volumetric flow is important to determine impact of viscoelastic 
materials on maintaining healthy hemodynamics. However, previous studies have seldom examined that 
aspect. 
The present study has examined the effects of lumen viscoelasticity on flow dynamics, including flow 
and pressure waveforms as well as wall shear stress at both upstream and downstream. Different from 
previous studies that illustrated wave attenuation within elastic tubes relying on the use of computational 
methods for the solid-fluid interaction, we have constructed tube materials with arterial-like compliance 
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and varying viscoelasticity, which allow for greater insight into the fluid/structure interface and materials-
induced flow alterations in our experimental model that incorporates high-performance flow and pressure 
sensors. The viscous and elastic material properties may be separated and compared, with the advent of 
materials in which overall stiffness and ratio of viscous to elastic response (E’’/E’) may be 
controlled,(Kalcioglu et al., 2013; Mrozek et al., 2011). Understanding the interplay between flow 
dynamics and viscoelastic tubing may aid in establishing viscous wall response of arterial tissue as an 
important signal in arterial health, and as an important parameter in graft design and development.  
 
5.1 Material design overview 
Understanding the importance of viscoelasticity in vascular grafting may be best illustrated by 
comparison of healthy to disease states.  In comparison to disease states, clinical measures such as 
pressure modulus (EP), distensibility, and compliance, indicate increased arterial stiffness associated with 
arterial disease.(Beaussier et al., 2011; Huynh et al., 2011; Wang et al., 2013c)   
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Table 5.1- Material parameters guidelines for proposed conduit design. Carotid artery stiffness ranges 
are listed above with sources cited. Proposed viscoelasticity of the fabricated conduits are listed as tan(δ) 
relating directly to viscoelastic to elastic ratios.  
 
Viscoelasticity, as measured by the ratio of viscous to elastic response (tan(δ)=E’’/E’), was measured 
in healthy femoral, carotid, and coronary arteries, ranging between 0.1-0.15, within the frequency range 
of 1-10 Hz.(Bergel, 1961; Bia et al., 2006; Gow and Taylor, 1968; Gow et al., 1974) In the aged and 
diseased, hysteresis area has shown a marked decline,(Giannattasio et al., 2008; Wang et al., 2013c) 
supported by decreased tan(δ). Additionally, comparison of graft viscoelasticity in the few examples 
available indicates materials such as ePTFE, PCL, and PLA have negligible wall damping capabilities. 
Therefore, vascular health dependence on viscoelasticity may be compared to importance of compliance 
by varying tan(δ) with graft stiffness. Proposed graft models may be seen in table 5.1. Additionally, flow 
parameters will be measured to compare more clinical values, such as EP dynamic compliance, inlet and 
outlet pressures, mean volumetric flow, and pulsatility index (PI). This will aid in providing a mechanism 
for cell response to the disease state, (IH and vascular fibrosis) and a mechanism for reduced disease 
response. Reduction in PI or pressure wave attenuation may then be attributed to wall damping through 
the mechanical energy of flow equation. 
 
  Elastic  Viscoelastic Citations 
Non-
Compliant 
EP*=800-1200 mmHg; 
tan(δ)=0  
 (Perfectly Elastic) 
EP*=800-1200 mmHg; 
tan(δ)> 0.5  
 (Highly Viscoelastic) 
(Farrar et al. 1982; 
Buntin and Silver 1990; 
Nagai et al. 1999; 
Beaussier et al. 2011; Tan 
et al. 2014) 
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5.1 Materials and Methods 
 Material used to cater both stiffness (E*) and viscoelasticity (tan(δ)) is poly(dimethyl siloxane) 
(PDMS) swollen gels, previously described in the literature.(Kalcioglu et al., 2013; Mrozek et al., 2011) 
Different termination groups within PDMS are separated into the elastic network (vinyl-terminated) and 
swelling solvent (methyl-terminated). Vinyl-terminated PDMS (v-PDMS) is crosslinked through a 
tetrafunctional vinyl crosslinker, which additionally prevents methyl-terminated PDMS (m-PDMS) from 
bonding to the network. The elastic network stiffness may be catered both through crosslink density, and 
chain entanglements (see fig. 5.2.1). Solvent (m-PDMS) increases viscous dissipation within the material, 
which may be controlled by m-PDMS molecular weight, and additionally contributes to stiffness through 
entanglements. A diagram of the material molecular structure may be seen in figure below. 
 
 
Figure 5.2.1– Diagram of the molecular structure of swollen poly(dimethylsiloxane). Molecular 
structures are color-coded: tetrafunctional crosslinker (blue), elastic v-PDMS (black), solvent m-PDMS 
(red). Viscous flow due to molecular movement is indicated by the green arrows.  
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5.1.1 Material Fabrication 
 Swollen gels were fabricated through methods outlined previously in the literature. (Kalcioglu et 
al., 2013; Mrozek et al., 2011) Briefly, vinyl-terminated PDMS (MW : 108 kDa) were donated  by Siltech 
Corporation (Toronto, ON, Canada). Methyl-terminated PDMS (Viscosity: 500 CSt and 1M CSt) was 
purchased from Clearco (Clearco Products Company Incorporated, Willow Grove, PA). 
Tetrakis(dimethylsiloxy)silane and platinum catalyst (Pt(0)-2,4,6,8-tetramethyl-2,4,6,8-
tetravinylcyclotetrasiloxane) were both also purchased from Sigma-Aldrich. First, v-PDMS and m-PDMS 
were mixed by differing weight percentage at room temperature. Crosslinker was then added at a 
stoichiometric ratio of 4:1 crosslinker functional group to vinyl chain termination, and mechanically 
mixed for 15 minutes. Lastly, platinum catalyst was added at a concentration of 800 ppm, and 
mechanically mixed for ten minutes. PDMS was placed in vacuum and degassed until all visible gas 
bubbles were removed. Material was then crosslinked in vacuum at 80°C for 72 hours. 
 Two groups of samples were created, elastic (58.8% 500 CSt m-PDMS: 108 kDa v-PDMS) and 
viscoelastic (70% 1M CSt m-PDMS: 108 kDa v-PDMS). Because low molecular weight solvent is below 
the entanglement weight of PDMS, it has little contribution to the stiffness or viscous response. It may 
also be treated as a simple theta solvent within the swollen gel, (Kalcioglu et al., 2013; Mrozek et al., 
2011) which will have a low viscous effect. This additionally allows v-PDMS/m-PDMS fraction (ϕ) to be 
used in determining the material stiffness (|𝐺∗| ∝ 𝜑2.3). Elastic material stiffness may be easily catered to 
match viscoelastic PDMS material stiffness response. 
 
5.1.2 Material Characterization 
Material mechanical properties were evaluated using the ARES TA rheometer (TA Instruments, New 
Castle, DE). Contact force was brought to 0.5 N, and material tested at room temperature, in ambient 
conditions. Three tests were completed: strain sweep, stress relaxation, and frequency sweep. Strain 
sweep was performed at a frequency of 1 Hz, with increasing strain over the range of 0.1%-50% strain, 
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indicating strain softening occurrence at approximately 10%. Based on strain sweep results, stress 
relaxation was measured at 1%, 5%, and 10% strain, and final modulus values recorded as steady-state 
moduli. Frequency sweep tests were also performed over the range 0.1 Hz-40 Hz, and complex modulus 
recorded. 
Elastic PDMS was further evaluated using the TA Q800 rheometer (TA Instruments, New Castle, DE) 
dynamic mechanical analysis (DMA). Briefly, samples were placed in 0.01 newtons of tension within the 
DMA, and cycled at 1% strain at 1 Hz for six minutes. Final modulus was recorded as the average over 
this time period. 
 
5.2 Flow dynamics 
5.2.1 Fluid/Material Coupling 
 Coupling of the fluid pressure and the material frequency response may be accomplished through 
the assumption of a mathematically linear relationship within the frequency domain. Complex waves may 
be separated through Fourier Transform of the given waveform, and application to known material 
frequency dependence. This separates the complex waveform into a summation of sine waves, with 
discrete amplitude and phase shift, represented by a complex number. This may then be coupled to 
material data consisting of a complex modulus, and reverted to the time domain: 
 
𝜺(𝒕) = 𝓕−𝟏 {
𝓕{𝑷}
𝟑 𝑮∗
}  = 𝓕−𝟏 {
𝓕{𝑷}
𝟑|𝑮∗|𝒆𝒙𝒑(−𝒊𝜽)
}  (5.2.1)  
 
This allows us to examine the dominant frequency range in considering material testing. Below is the 
frequency spectrum of the waveform created by the pulsatile pump. As can be seen, the dominant 
frequency is 1 Hz, and the harmonics created by the wave extend out to 9 Hz, which is typical of cardiac 
waveforms.(O’Rourke et al., 2011) This is again within the range measured by the frequency sweep of the 
material (0.1-40 Hz). 
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Figure 5.3.1.1- Frequency spectrum of Harvard Apparatus pump. The largest peak is the dominant 
frequency of 1 Hz, with harmonics up to 9 Hz. This is well within the range of measurements seen in 
figure 5.2.2.3. 
 
5.2.2 Conduit Design 
To test flow dynamics, the fluid body must be recreated, and therefore only the vessel lumen 
mechanics must be mimicked. Due to the constraints in section 4.1, a simple design is necessary to 
maintain material viscosity, while also controlling stiffness. This becomes simpler in designing a rigid 
sheath which prevents radial strain. Therefore, conduit design incorporates rigid exterior wall of 
polypropylene (PP). Strain response to this can be modeled through the equation for wall motion in thick-
walled cylinders: 
 
𝐮𝐫(𝒓) =
𝟏−𝝂
𝟑 𝑮∗
(𝒓𝒊
𝟐𝒑𝒊−𝒓𝒐
𝟐𝒑𝒐)𝒓
𝒓𝒐
𝟐−𝒓𝒊
𝟐 +
𝟏+𝝂
𝟑 𝑮∗
(𝒑𝒊−𝒑𝒐)𝒓𝒊
𝟐𝒓𝒐
𝟐
(𝒓𝒐
𝟐−𝒓𝒊
𝟐)𝒓
  (5.2.2) 
 
Where ri and ro are the inner and outer radii, respectively, r is the radial coordinate, and pi and po are 
the inner and outer pressures, respectively. Material properties are both the shear modulus G* and the 
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Poisson’s ratio ν. By setting ur(𝑟𝑜) = 0 and ν to 0.5 (for PDMS), we may then solve for po in terms of pi, 
ri, and ro, and subsequently solve for ur(𝑟𝑖): 
𝒖𝒓(𝑷) = 𝓕
−𝟏 {
𝓕{𝑷}
𝟑 𝑮∗
}
𝒓𝒊(𝒓𝒊
𝟐−𝒓𝒐
𝟐)
𝟐
𝟐(𝒓𝒐
𝟐−𝒓𝒊
𝟐)(𝒓𝒐
𝟐+𝟑𝒓𝒊
𝟐)
  ( 5.2.2.1 ) 
 
We then have a geometric factor as a relationship between the inner (ri) and outer (ro) radii on the right 
side of the equation, as well as our pressure/modulus relationship (𝓕−𝟏 {
𝓕{𝑷}
𝟑 𝑮∗
}). We may then use target 
material properties (as described in Table 5.1) to project diameter strain from a pressure wave cycle. In 
the projected diameter strain from our relationship, we can see a more gradual return to the strain 
minimum, while maintaining similar peak-to-peak amplitude. Increasing the total cross-sectional area 
throughout the cycle would decrease peak pressure and flow velocity, due to decreased impedance. 
 
 
Figure 5.3.2- Mock vessel design diagrammed on the left, with modeled lumen radius response on the 
right. The lumen radius was modeled by coupling pressure and material properties for both viscoelastic 
materials (PDMS-70%(108k-1M CSt): green, dashed) and elastic materials (PDMS-58.8%(108k-500 
CSt): blue, solid). 
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5.2.3 Fabrication of the Tube Conduit 
To fabricate the tube conduit, an inner lumen was necessary to create within the material structure to 
allow the passage of flow. Therefore, a polymethylmethacrylate (PMMA) rod was inserted into the 
material before curing to allow the PDMS material to form around a lumen structure. To prevent collapse 
of the material upon removing the PMMA rod, an inner elastic layer was created to reduce viscous shear 
on the rod during removal. To create this elastic layer, pure v-PDMS material was mixed, as described in 
section 5.2.1, with the change of a stoichiometric ratio of vinyl cross-linker to v-PDMS end group of 3:1. 
This v-PDMS material was mixed in a 1:1 ratio by volume of n-Heptane to decrease solution viscosity. 
Rods were then drip-coated and hung to dry in vacuum for one hour to allow n-Heptane evaporation. 
After adequate evaporation time, v-PDMS was then cured for one hour at 50 °C, creating a fully cured 
elastic layer approximately 70-100 microns in thickness. 
Viscoelastic (PDMS-70%(108k-1M CSt)) and elastic (PDMS-58.8%(108k-500 CSt)) conduit material 
was fabricated as described previously in section 5.2.1. Material was placed into PP 50 mL tubes, with 
material added equaling 45 grams. Remaining air was removed from the material by centrifugation of the 
tubes for 20 minutes. Coated PMMA rods were then inserted into the material, and centered using a 
PDMS washer. Conduits were then cured at 70 °C for 72 hours, and removed to allow cooling at room-
temperature. Bottom PP material was removed, and PDMS was capped using v-PDMS material. Rods 
were then removed using ethanol as a lubricant, and lumens were left intact. 
To finalize conduit construction, 3/8” PP luer connections were inserted in lumen ends, and again 
sealed using v-PDMS material. Rigid outer diameter material of the PP centrifuge tube was then sectioned 
along the outer circumference, and remaining rigid material at the conduit terminals were removed to 
allow longitudinal travel of the PDMS material while undergoing radial strain. 
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5.2.4 Applied Flow 
 Fluid Parameters 
Flow was tested using deionized water within a benchtop flow circuit, with fluid viscosity assumed to 
be equivalent to water (8.9 x 10-4 Pa•s). Pulsatile flow was applied through a pulsatile flow pump 
(Harvard Apparatus, Holliston, MA), which controls volumetric flow rate through applying a driving 
piston. Complex, pulsatile pressure and flow are then applied and controlled through connecting silicone 
tubing of 3/8” inner diameter. Pulsatile pressure range and flow pulsatility are controlled through the 
introduction of a compliance chamber before the mock vessel, introducing a Windkessel pressure 
damping, as described previously.(Scott-Drechsel et al., 2012) Flow response under two pressure ranges 
were recorded: 30 mmHg (LPF) and 70 mmHg (HPF). Pressure ranges were changed through altering 
compliance chamber levels. Compliance chamber levels were normalized for each pressure range using 
Tygon B-44-4X tubing (Saint Gobain S.A., Courbevoie, France) as an effectively rigid conduit, applying 
4.67 cc/s flow rate at a frequency of 1 Hz. Compliance chamber levels were maintained as a control 
variable during testing to examine conduit effect on pressure. 
Volumetric flow rate was calculated through the intended applied wall shear stress (WSS) of 1.0 Pa, 
using the equation for laminar shear at the wall of a pipe: 
 
𝑾𝑺𝑺 = −𝝁
𝝏?⃑? 
𝝏𝒓
= 𝝁
𝟑 ?⃑⃑? 
𝝅 𝑹𝟑
→ ?⃑⃑? =
𝑾𝑺𝑺 𝝅 𝑹𝟑
𝟑 𝝁
  (5.2.4.1 ) 
 
Here, µ is the dynamic viscosity, u is the velocity, r is the location along the radial axis, Q is the 
volumetric flow, and R is the lumen radius. Therefore, assuming laminar, fully developed flow, a radius 
of 2.65 mm, and viscosity of 4 x 10-3 Pa•s (viscosity of blood), resulting volumetric flow (Q) is 4.67 cc/s 
at a frequency of 1 Hz. Flow rate, frequency, and WSS all match physiological levels as measured in large 
animal models of common carotid arteries (CCA) described in the literature.(Byrom et al., 2010) This is 
lower than previously reported WSS in EC mechanotransduction studies,(Elliott et al., 2015; Tan et al., 
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2014) but reduces strain on the flow system while more closely matching large animal studies.(Byrom et 
al., 2010) 
 
 Fluid Measurement 
The test bench fluid circuit was designed to reduce wave reflection and allow for pressure and 
volumetric flow measures through multiple cycles. Pressure sensors were purchased from Omega 
Engineering (PX209-015G15V, Omega Engineering Inc., Norwalk, CT) and fitted with nylon 
(polyamine) tee-joints. Pressure (P) sensors were placed nearest to conduit terminals to reduce head loss 
from connector tubing. Volumetric flow rate was measured concurrently with pressure (Sonoflow CO 
55/060, Sonotec USA, Islandia, NY). 
Due to constraints of the flow meter, smaller connective tubing diameter was required at the point of 
measurement, with inner diameter of 1/16”. To avoid wave reflection and increased impedance 
volumetric flow was measured in parallel to the conduit, connected through nylon tee-junctions of 3/8” 
diameter. The measured flow waveform perpendicular to the flow is not directly proportional to the flow 
in line with the conduit, due to the tee-junction head loss, and impedance change resulting from different 
diameter of the connection tubing and Q-sensor.(O’Rourke et al., 2011; Paritosh and others, 2007) 
Measured variation in flow change due to the tee is discussed further in appendix A2. Volumetric flow 
rate is minimally affected by head pressures, but is most greatly reduced and attenuated by viscous energy 
loss, therefore inlet Q-sensor was placed before the inlet P-sensor and the outlet Q-sensor was placed after 
the outlet P-sensor.  
Pressure and volumetric flow data was sampled at 225 Hz and recorded on a real-time target (RT-
Target) board (sb-RIO 9392, National Instruments, Austin, TX), which then packaged and sent data to a 
personal computer central processing unit (CPU) (Dell Inc., Round Rock, TX). Volumetric flow signal 
passed through a resistor/capacitor low-pass signal filter, with a cutoff frequency of 22 Hz. Upon startup, 
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the RT-Target internal clock was synchronized with the CPU clock. Resulting data was time-stamped 
during recording on the RT-Target before being transferred to the CPU and recorded in a text file. 
 
 Conduit Strain Measurement 
Due to the optical transparency of the conduit material, PDMS, conduit distension was measured by 
color, high speed CCD camera (Basler Ace, Ahrensburg, Germany). Video imaging occurred 
concurrently with pressure and flow recording. Images were captured at length resolution of 17.6 
microns/pixel and time resolution of 80 Hz, recorded by PXI board (National Instruments, Austin, TX). 
Frames were then time-stamped by the CPU, and packaged into audio video interleave (AVI) files.  
Fluid used was DI with red food coloring, and backlit using a white LED array. This combination of 
red fluid coloration backlit to prevent light reflections within the conduit allowed for defined conduit 
edges within the images. 
 
5.2.5 Data Analysis 
 Image Analysis 
Recorded AVI files were converted into graphics interchange format (GIF), imported into image 
analysis software written in-house in Mathematica (Wolfram Research, Champaign, IL). Analysis 
software filtered images by red coloration, binarized these images to clearly define lumen edge, and then 
measured diameter perpendicular to the lumen axis. Average lumen diameter within a single frame was 
then paired with the corresponding time-stamp and recorded. 
 
 Data Smoothing and Combination 
All recorded waveforms underwent discrete Fourier transforms (DFT), and magnitude and phases 
were recorded. To remove time disparities from different sampling frequencies within a single data set of 
PIn, POut, QIn, QOut, and diameter (D), and further error from irregularities in recording intervals, linear 
interpolation between points was performed to create regular time intervals before DFT. Resulting Fourier 
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harmonic phase values were normalized to their corresponding PIn phase, to allow for comparison 
between waveforms. Resulting harmonic moduli and phases were averaged and combined into 1-
dimensional functions for comparison of the form: 
 
𝒈(𝒙, 𝒕) = 𝑪𝟎 + ∑ |𝑪𝒇|𝑬𝒙𝒑 [−𝒊 (𝟐𝝅𝒇(𝒕 −
𝒙
𝒄𝒇
) − 𝝋𝒇)]
𝑵
𝒇=𝟏          (5.2.5.1) 
 
Where Cf is the modulus of the complex Fourier harmonic constant, cf is the wave speed of the harmonic, 
and φf is the phase shift of the corresponding harmonic. 
 Before DFT, area under Q curves were determined to estimate total volume during the recorded 
data cycle. Both QIn and QOut values were normalized to the area to reduce variance from the sensor 
between data recordings. This maintained the conservation of mass within the system between inlet and 
outlet. 
 
 System Metrics 
Previous metrics have been discussed in earlier sections. To clarify we will repeat the method of these 
clinical metrics in this section. Conduit stiffness is initially characterized by the pressure modulus (EP), a 
clinical measure in the body to determine arterial stiffness.  Here we refer EP as the quotient of peak-to-
peak pressure range (ΔP) and strain range (ΔɛR) over the loading cycle, using the mean value between 
pressure inlet (ΔPIn) and pressure outlet (ΔPOut) to account for head loss: 
 
𝑬𝑷 =
∆𝑷
∆𝜺𝑹
=
𝑴𝒆𝒂𝒏(∆𝑷𝑰𝒏,∆𝑷𝑶𝒖𝒕)
∆𝜺𝑹
    ( 5.2.5.2 ) 
 
Additionally, wave speeds were calculated from locating the wave foot by locating the maximum of 
the double derivative of the waveform with respect to time. This locates the acceleration of the waveform, 
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and initial base of the recorded waveform. Wave speed (c) was then calculated as the length (x) between 
sensors divided by the time (t) between inlet and outlet waveforms for each harmonic: 
 
𝒄 =
∆𝒙
∆𝒕
=
𝒙𝑶𝒖𝒕−𝒙𝑰𝒏
𝒕𝑶𝒖𝒕−𝒕𝑰𝒏
= 𝝎
𝒙𝑶𝒖𝒕−𝒙𝑰𝒏
𝝋𝑶𝒖𝒕−𝝋𝑰𝒏
     ( 5.2.5.3 ) 
 
Wave speed values become necessary for the governing equations listed in the subsequent section. 
 Governing Equations 
To examine relationships between the conduit material properties and hemodynamics, previously 
established mathematical relationships must be defined. These relationships range from clinically 
measured values such as the pulsatility index (PI) and wave speed (c), to values such as the mechanical 
energy of flow and impedance (Z) of the conduit. 
Coupling material strain to pressure and flow in the system begins with determining the relationship 
between conduit strain and conduit impedance. A simple theoretical relationship of impedance without 
wave reflections will be quantified to better highlight coupling of diameter to upstream waveforms. 
Impedance is defined as the summation of resistance (R) and inductance (L): 
 
𝒁 = 𝑹 + 𝒊𝝎𝑳 =
𝒊𝝎𝝆
𝝅𝑹𝟐
(𝟏 −
𝟐𝑱𝟏(𝜶 𝒊
𝟑
𝟐)
𝜶 𝒊
𝟑
𝟐𝑱𝟎(𝜶 𝒊
𝟑
𝟐)
)
−𝟏
  ( 5.2.5.4 ) 
 
Where ω is the frequency, ρ is the density, R is the lumen radius, α is the Womersley number, and J0 are 
zero order Bessel functions of the first kind. The Bessel functions are simply mathematical relationships 
derived by Womersley (Womersley, 1955) for pulsatile flow in a conduit, and will not change between 
conduit types or applied waveforms. Additionally, fluid density and frequency will not change between 
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conduit material types, therefore Womersley number and iωρ term may be dropped. This may therefore 
be simplified to relate impedence only to radius: 
 
𝒁 ∝
𝟏
𝑹𝟎
𝟐𝝀(𝒕)𝟐
∝
𝟏
𝜺𝑹(𝒕)𝟐
     ( 5.2.5.5) 
 
Where R0 is the initial radius, λ is the stretch ratio, and ɛR is the radial strain. From this we may further 
compare conduit strain with upstream pressure and flow through the relation of conduit radius and 
frequency. 
Average cross-sectional area (ɛr2) value was estimated through integrating radial strain over the cycle 
using a Riemann sum, using time intervals below the image sampling frequency. This allows a 
comparison between impedances over the flow cycle. 
To couple the material strain to the flow, it is necessary to reduce the relationship through the 
mechanical energy of flow equation. This is specifically examined because the mechanical energy directly 
relates to PI, as previously specified in section 3.2.7. 
 
𝝆
𝟐
𝑫
𝑫𝒕
(𝒖𝟐) = 𝝆𝒈𝒉 + 𝛁(𝒖 ∙ 𝝈) + (𝛁 ∙ 𝒖)𝑷 − 𝝋  ( 5.2.5.6 ) 
 
Where the material derivative of the kinetic energy (u2) may be equated with the gravitational potential 
(g), volumetric potential (P), viscous loss (φ), and applied stress (σ) on the fluid. Within the experiment 
test bench neither height nor fluid viscosity changes, and we may therefore eliminate the gravitational 
potential g. The equation may then be simplified to: 
 
𝝆
𝟐
[
𝝏
𝝏𝒕
(𝒖𝟐) + (𝒖 ∙ 𝛁)𝒖𝟐] = 𝛁(𝒖 ∙ 𝝈) + (𝛁 ∙ 𝒖)𝑷 − 𝝋 ( 5.2.5.7 ) 
 112 
 
 
Here we can see that time and spatial derivatives of the kinetic energy may be directly related to the 
applied stress on the system (σ), potential energy (P) within the volume, and a summation of viscous loss 
throughout the volume (φ). Therefore, hysteresis resulting from the material strain would reduce applied 
stress and returned energy as the lumen contracts. Energy loss from hysteresis of the material would 
therefore reduce kinetic energy on the left side of equation 5.3, as well as reducing pressure on the right 
side of the equation. 
By isolating both the time-derivative and spatial-derivative in the mechanical energy of flow, we may 
directly relate this to PI and wave speed, respectively: 
 
∫
𝝏
𝝏𝒕
(𝒖(𝟎, 𝒕)𝟐)
𝒕𝒎𝒂𝒙
𝟎
= 𝒖(𝒕𝒎𝒂𝒙)
𝟐 − 𝒖(𝟎)𝟐 ∝
𝒖𝒎𝒂𝒙−𝒖𝟎
?̅?
= 𝑷𝑰  ( 5.2.5.8 ) 
 
Where the kinetic energy measured is located at fixed location (x = 0), therefore simplifying the equation. 
Where the summation of the mechanical energy from the beginning of the cycle until the maximum flow 
velocity is directly correlated with the PI. Clinically, PI is measured to determine pathological flow states 
within the arterial tree, and is a simplified measure of the mechanical energy of flow. Therefore, by 
comparing mechanical energy between elastic and viscoelastic conduits, we may relate viscoelastic 
damping to the decrease in PI. 
Additionally, we may see how energy dissipation is related to both frequency and wave speed by 
examining the spatial derivative of the Fourier transform function. 
 
𝝏
𝝏𝒙
(𝒖(𝒙, 𝒕)𝟐) =
𝝏
𝝏𝒙
(𝑪𝑵
𝟐𝑬𝒙𝒑 [𝒊𝟐𝝎(𝒕 −
𝒙
𝒄𝑸
)]) = −
𝒊𝟐𝝎
𝒄𝑸
𝒖(𝒙, 𝒕)𝟐 ( 5.2.5.9 ) 
 
 113 
 
Where u is the particle velocity, ω is the frequency, CN is the harmonic constant, t is time, x is the axial 
location along the conduit, cQ is the Q-wave speed. Here we may additionally see how increased wave 
speed due to viscoelasticity as described above would decrease mechanical energy of the system. 
These equations will not necessarily be fully solved, as mathematically coupling the relationship 
between wall properties and steady state upstream and downstream waveforms may not converge. But by 
listing these equations here, we may refer to them in the discussion of the results. 
 
 Statistical Methods 
Measured response variables were compared using multi-factor analysis of variance (ANOVA). 
Sample size for each measure was limited to three for each group, and all groups passed the Anderson-
Darling test for normality. Main effects were determined to be conduit type (E and VE), applied flow type 
(LPF and HPF), and point of measurement (Inlet and Outlet), and subsequently compared in three-way 
ANOVA. In cases where there was not separation between Inlet and Outlet, such as diameter strain and 
pressure modulus (EP), two-way ANOVA was performed. Additionally, four-way ANOVA was 
performed on wave speed analysis, separating groups conduit type, applied flow type, wave measurement 
(P and Q), and by Fourier harmonic (f). Main (single-factor) and interactive (two-factor) effects were 
examined, with special focus on conduit material type and inlet/outlet comparison, with significance of α 
< 0.05, unless otherwise noted. 
 
5.3 Results 
5.3.1 Material Properties  
Frequency sweep measurements correspond well with those from the literature,(Kalcioglu et al., 2013; 
Mrozek et al., 2011) indicating direct relationship between viscous loss and m-PDMS weight percentage. 
Specifically, values for viscoelastic materials (70% 1M CSt m-PDMS: 108 kDa v-PDMS) show shear 
modulus values of 25 kPa and tan(δ) of 0.5 at 1 Hz, while elastic material (58.8% 500 CSt m-PDMS: 108 
kDa v-PDMS) has similar stiffness with tan (δ) of 0.06.These values may then be incorporated into mock 
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blood vessel design by converting to the elastic modulus using the Poisson’s Ratio of PDMS, which is 
0.5.(Takeuchi and Cohen, 1999) Results are shown in Table 5.4.1, below: 
  
 
Table A.1.1.1- Frequency dependent material properties of poly(dimethylsiloxane) (PDMS).  
 
Strain sweep results indicate strain softening at approximately 10% for all samples, well within the 
healthy physiological strain of 5%.(Bia et al., 2006; Nagai et al., 1999) Results are further shown in 
Appendix A1. 
 
5.3.2 Comparison of Conduit Stiffness and Wave Speed 
When pressure wave velocity (cQ) and flow wave velocity (cP) were compared between the different 
conduits, results showed no significant differences between elastic and viscoelastic conduits. Also, the 
conduit stiffness, as described by the pressure modulus (EP) in equation 5.3.5.3.1, showed no significant 
differences between the groups, with pressure moduli of approximately 1200 mmHg, which matched the 
values to less compliant arteries (figure 5.4.2.1).(Bia et al., 2006; Buntin and Silver, 1990; Nagai et al., 
1999; Tan et al., 2014) 
  Elastic 
(58.8% 500 CSt : 108 kDa PDMS) 
Viscoelastic 
(70% 1M CSt : 108 kDa PDMS) 
Material Properties 
at 1 Hz 
E’ = 68.9 kPa 
E’’= 4.09 kPa 
tan(δ) = 0.06 
E’= 67.1 kPa 
E’’= 32.3 kPa 
tan(δ) = 0.482 
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Figure 5.4.2.1- Pressure Modulus. Measured pressure modulus values (EP) indicate slight increase in 
viscoelastic samples, though significant differences between tests were not found. 
 
Pulse wave speeds show no significant changes with viscoelastic wall properties (figure 5.4.2.2). 
Pressure pulse wave velocity in viscous media with viscoelastic wall properties was initially outlined 
initially by Womersley, and continued by MacDonald: 
 
𝒄𝟎 = √
|𝑬∗|𝒉
𝟐𝑹𝟎𝝆
→ 𝒄 = 𝒄𝟎/ (𝟏 − 𝒊
𝐭𝐚𝐧(𝜹)
𝟐
)   ( 5.3.2.1 ) 
 
Theoretical descriptions of wave speed show decreased viscoelasticity represented by tan(δ) in equation 
5.4.2.1, results in decreased wave velocity. This value is illustrated by a red line in figure 5.4.2.2. Results 
show viscoelastic conduit properties have no discernable effect on P or Q wave speeds. 
We additionally see significant changes between pressure wave velocities and their corresponding 
volumetric flow velocities, indicating cQ and cP response are not directly coupled. This differs from 
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theoretical pressure driven flow, which directly couples pressure and volumetric flow pulse wave 
velocities. 
  
Figure 5.4.2.2- Fractional change in harmonic wave speed values of both pressure (P) and volumetric 
flow (Q). The red line indicates theoretical values for decreased wave speed from viscoelastic wall 
properties. Results indicate no significant change in single-factor comparison between elastic and 
viscoelastic wave speeds in four-way ANOVA. 
 
5.3.3 Pressure and Diameter Waveforms are Attenuated in Viscoelastic Conduits 
The pulsatile pressure waveforms at the inlet and outlet as well as the diameter strain curves during the 
cycle of mimetic cardiac output were determined to evaluate the contributions of material property to the 
changes in pressure waveforms and to the correlation between pressure waveforms and diameter strains 
(figure 5.4.3.1). Compared to elastic conduits, the attenuation and smoothing of the diameter curve in 
viscoelastic conduits were found for both flow pressures. This result indicated viscoelastic conduits 
increased cross-sectional area throughout the pressure cycle, which in turn decreased the impedance 
within the circulation, according to equation 5.3.5.5. We additionally found a slight phase lag for 
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viscoelastic conduits when compared to elastic conduits. This is in agreement with previous studies of 
artery responses using hysteresis of pressure-strain relationship for viscoelastic characterizations. 
(Armentano et al., 2014; Bia et al., 2006; Wang et al., 2013c)  
Statistical analysis of the pressure wave results, using three-way ANOVA comparisons on three 
independent variables, i.e. conduit material type (E vs. VE), flow pressure range (LPF vs. HPF), and 
measurement location (inlet vs. outlet), showed a difference in the main effect of material property 
between elastic and viscoelastic conduits (p = 0.083). Importantly, viscoelastic conduits showed an 
average decrease of 3.9% in pressures compared to elastic ones. Also, the outlet pressures were 
significantly reduced compared to the inlet. Statistical analysis of diameter strain curves, using two-way 
ANOVA comparisons on conduit material type and flow pressure range showed ~11.3% decrease in the 
area change (ɛ2Max - ɛ
2
Min) over the cycle. No significant interactions were found between conduit material 
(E vs. VE) and either applied flow type (LPF vs. HPF), or measurement location (Inlet vs. Outlet).  
 
 
 
 
Figure 5.4.3.1- Representative pressure waveforms at inlet and outlet and corresponding diameter 
strain curves. Elastic conduit waveforms are illustrated with solid lines, while viscoelastic waveforms are 
dashed lines. Differences between elastic and viscoelastic waveforms are shown with red shading. Low 
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pressure waves (top, LPF) are shown to change between elastic and viscoelastic conduits, with both 
upstream and downstream pressure waves attenuated with viscoelastic conduit walls. Viscoelasticity of 
conduits showed less influences on pressure waves for high pressure waves (bottom, HPF). Diameter 
strain curves indicated greater smoothing in viscoelastic conduits over the cycle, with increased diameter 
strain later in the wave cycle (black, dashed line). 
 
5.3.4 Wall Shear Stress Waveforms are Attenuated with Viscoelastic Wall Properties 
Results on volumetric flow (Q) waveforms over the cycle (figure 5.4.4.1) showed attenuation of Q 
waves in viscoelastic conduits, which exhibited decreased peak-to-peak amplitude indicating decreased 
pulsatility or PI. This decreased PI value corresponded well with attenuated distension and pressure 
waveforms. Importantly, results also showed greater peak alignment between diameter strain curves and 
Q waves in viscoelastic conduits compared to elastic ones. The diameter increase during peak Q values 
for both inlet and outlet can contribute to the reduction in WSS oscillation (equation 5.4.4.1).  
Similar to changes in the quantitative index of pulsatility (PI) for Q waves (Q-PI), statistically 
significant decreases in the PI for WSS (WSS-PI) were found in viscoelastic conduits when compared to 
elastic ones (figure 5.4.4.2). In addition to the reduced WSS oscillation, the average WSS significantly 
decreased in viscoelastic conduits when compared to elastic ones.  
Main effect comparisons of volumetric flow waveforms showed a decrease of peak-to-peak amplitude 
in viscoelastic conduits compared to elastic ones, with 6% decrease in the pulsatility index (PI), and 9.1% 
decrease in PI from inlet to outlet. More importantly, resulting measures of WSS indicate significant 
decreases of 22.8% (figure 5.4.4.2). Within the ANOVA comparison, we see no interactive effect of 
conduit material (E vs. VE) with either applied flow type (LPF vs. HPF), or measurement location (Inlet 
vs. Outlet).  
In the case of LPF, viscoelastic conduits caused a decrease in Q-PI by ~15.9%, but decrease in WSS-
PI by 29.1%. These results were also found in HPF flow, though less drastic, with decreases of 2.0% in 
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Q-PI, and 20.0 % decrease in WSS-PI. This indicated is that phase alignment between diameter and Q-
waves had a significant effect on WSS. Greater phase alignment in viscoelastic conduits, as shown in 
figure 5.4.4.2, reduced WSS-PI response.  Increased WSS-PI at the outlet in elastic conduits indicates that 
resulting phase misalignment exacerbates high pulsatility in flow. Therefore, phase lag due to viscoelastic 
material properties has significant effects on improving fluid shear stress mechanical signaling. 
 
 
 
 
Figure 5.4.4.1- Representative volumetric flow (Q) waveforms at inlet and outlet and corresponding 
diameter strain curves. Elastic conduit waveforms are illustrated with solid lines, while viscoelastic 
waveforms are dashed lines. Low pressure waves (top, LPF) are shown to change between elastic and 
viscoelastic conduits, with both upstream and downstream Q waves attenuated with viscoelastic conduit 
walls. Viscoelasticity of conduits showed less influences on Q waves p for high pressure (bottom, HPF) . 
Diameter waveforms of viscoelastic conduits showed better peak phase alignment with Q (black, dashed 
line). 
 
Wall shear stress was determined through applying the formula relating volumetric flow rate as shown 
in the below equation: 
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𝑾𝑺𝑺 = −𝝁
𝝏?⃑⃑? 
𝝏𝒓
= 𝝁
𝟑 ?⃑⃑? (𝒕)
𝝅 𝑹𝟎
𝟑𝝀(𝒕)𝟑
   ( 5.3.4.1 ) 
 
Where Q is the volumetric flow, R0 is the initial radius, μ is the fluid viscosity, and λ is the stretch ratio of 
the diameter change. The use of this equation assumes fully developed, laminar flow.  
 
  
Figure 5.4.4.2- Comparison of PI as measured by flow rate (Q) and wall shear stress (WSS). 
Differences in waveform shapes and pulsatility (PI) present in comparison of elastic (E) to viscoelastic 
(VE) conduits. LPF-Q at the outlet is shown above left (Q-E: blue, solid line, Q-VE: green, dashed) 
matched with respective diameter values (E-diameter: black, solid line, VE-diameter: black, dashed line), 
with LPF-WSS shown bottom left. WSS waveforms show greater difference between elastic (E) and 
viscoelastic (VE) conduit, shown in the bar graph at right. Significant differences were seen between E 
and VE conduits for WSS measured PI using Bonferroni post-test analysis (α < 0.05, labeled with +). 
 
 
5.3.5 Mechanical Energy of Flow 
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The peak mechanical energy decreased by 4.9% (p=0.060) in viscoelastic conduits, when compared to 
elastic conduits. Mechanical energy also showed significant decreases of 5.9% occurred at the outlet 
compared to the inlet, following a similar trend as Q-wave comparisons. Additionally, interaction effects 
of conduit material type (E vs. VE) and flow type (LPF vs. HPF) indicate that there might be more 
decrease (p = 0.063) of mechanical energy in viscoelastic compared to elastic conduits for applied LPF 
than HPF (figure 5.4.5.1). Importantly, no significant changes were found in interactive effects of conduit 
material (E vs. VE) and upstream or downstream location (inlet vs. outlet). The energy results exhibited a 
similar trend as Q-PI, which can be supported by the relationship between mechanical energy and PI 
described in equation 5.3.5.8. 
The mechanical energy of flow was solved for by using equation 5.3.5.7 listed above in section 
5.3.5.4. Briefly, this is the material derivative of the kinetic energy: 
 
𝑫
𝑫𝒕
(
𝝆
𝟐
𝒖𝟐) =
𝝏
𝝏𝒕
(
𝝆
𝟐
𝒖𝟐) + (𝒖 ∙ 𝛁) (
𝝆
𝟐
𝒖𝟐)    ( 5.3.5.1 ) 
 
This data was then plotted against time to indicate differences seen during the wave cycle. This equation 
again assumes fully developed, laminar flow. Mechanical energy was quantified at each of the inlet and 
outlet sensors, using the static cross-sectional area of the connective tubing at the point of measurement. 
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Figure 5.4.5.1- Mechanical energy of flow was calculated as the material derivative of the kinetic 
energy, referred to in section 5.4.4.3. This required time derivative and divergence of the kinetic energy. 
Sample mechanical energy curves are shown to the left, specifically physiologic applied pressure (LPF). 
Peak mechanical energy aligns with peak volumetric flow, but waveforms do not match. The bar graph on 
the right shows decreased mechanical energy with viscoelastic conduits (VE) compared to elastic 
conduits. Significant differences were seen comparing LPF-E and LPF-VE in a t-test (α < 0.05). 
 
5.4 Discussion 
Our results have demonstrated several unique findings: (1) viscoelastic conduit properties attenuated 
WSS over the cycle, as well as pressure and flow waves upstream and downstream of the VE-conduit; (2) 
decreased peak-to-peak waveform amplitudes corresponded with the attenuation of diameter distension 
wave, extending strain through the end of the cycle; (3) such extension of strain through the cycle created 
greater phase alignment of diameter with Q-waveforms, thereby decreasing WSS pulsatility through 
increased cross-sectional area, as shown in figure 5.5.1. Additionally, attenuated strain waves indicated 
greater mean area over the cycle, thereby decreasing impedance, affecting upstream and downstream flow 
(figure 5.4.3.1). Finally, energy damping from viscous energy loss within the viscoelastic material would 
contribute to decreased PI over the length of the conduit. While greater Q-wave attenuation occurs with 
viscoelastic conduits, no relation is evident between PI decrease over the conduit length and conduit 
material properties. Therefore, the effects of impedance change may be the greater contributing factor to 
flow attenuation, though a longer conduit may show greater effects. 
 Shape of the strain curve was predicted in projected mechanics of the lumen (Figure 5.3.2), resulting 
from changing δ-values across the frequency spectra of the material interacting with harmonics of the 
pressure wave. Resulting WSS attenuation is supported by previous computational methods,(Raghu et al., 
2011) but has not been discussed experimentally with direct comparison between viscoelastic and elastic 
conduits. 
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Figure 5.5.1- Phase alignment of the volumetric flow with the conduit distension for both low 
pressure (left) and high pressure (right) conditions. Viscoelastic conduits exhibit a phase shift and 
increased strain later in the pressure cycle, shown by the red coloration. This results in greater cross-
sectional area during peak volumetric flow (Q), decreasing shear stress at the wall, indicated by the red 
arrows. 
 
This study has provided evidence showing that phase alignment is a major contributing factor in 
altering an important mechanical signal, WSS, whose influences on vascular endothelial and smooth 
muscle cells and on vascular inflammation have been well known . (Elliott et al., 2015; Scott et al., 2013; 
Tan et al., 2014) This is a new finding, given that existing studies have not examined the alignment of 
area and flow phase. Previously, Q-waveforms were computationally shown to attenuate due to 
viscoelastic wall properties,(Raghu et al., 2011) effects are more drastic when WSS is coupled to conduit 
distension. 
Mechanical energy of flow decreased with viscoelastic wall properties, which may be directly related 
to several clinical measures. Mechanical energy of flow is characterized with the immediate change in 
kinetic energy within the volume. While mechanical energy relates to clinical and experimental metrics 
within the literature, it has been rarely associated to cell response or disease progression. Nevertheless, 
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increased mechanical energy would directly relate to many parameters important to cardiovascular 
diseases, as illustrated by the equation below: 
 
𝒖(𝒙, 𝒕) = 𝑨𝑬𝒙𝒑 [−𝒊 𝝎 (𝒕 −
𝒙
𝒄
)] →
𝝏𝒖(𝒙, 𝒕)𝟐
𝝏𝒕
+ 𝒖(𝒙, 𝒕)
𝝏𝒖(𝒙, 𝒕)𝟐
𝝏𝒙
= 
 
−𝒊𝟐𝝎(𝟏 −
𝟏
𝒄
𝑨𝑬𝒙𝒑 [−𝒊𝝎(𝒕 −
𝒙
𝒄
)])𝑨𝟐𝑬𝒙𝒑 [−𝒊 𝟐𝝎 (𝒕 −
𝒙
𝒄
)] ( 5.3.5.1 ) 
 
Where u is the flow velocity, t is time, c is wave speed, x is distance along the artery, and ω is the angular 
frequency, which would be equivalent to the heart rate. This suggests that the mechanical energy is 
directly proportional to the heart rate (ω), flow amplitude (A), and wave speed (c), all of which are 
clinical indicators of cardiovascular disease. 
 The present study, through comparing fluid responses of viscoelasticity conduit materials with elastic 
materials of similar stiffness, highlights time-dependent wall effects on pulse wave responses. This study 
differs from previous studies in the area (Kalcioglu et al., 2013; Mrozek et al., 2011) by providing 
experimental comparisons of viscoelastic to elastic conduits, with well-defined material properties and 
flow wave parameters within physiological conditions. The majority of previous studies have focused on 
computational modeling, with minimal material characterization for experimental validation.(Bessems et 
al., 2008; Raghu et al., 2011; Taylor, 1959; Wang et al., 2016) Also, in the experimental validation of 
these studies, flow consisted of single harmonic waveform perturbations of the system, which could not 
show multifactorial effects on pulse pressure and flow waves, as demonstrated here. Effects of 
viscoelastic wall properties on wave travel and attenuation have been a subject of interest over the past 40 
years, with some debate over the contribution to pulse wave attenuation. Previous measurements of 
frequency-dependent arterial material properties showed tan(δ) of approximately 0.15-0.25 (Bergel, 1961; 
Bia et al., 2006; Gow and Taylor, 1968; Gow et al., 1974; Learoyd and Taylor, 1966). These values might 
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be irrelevant to the cardiovascular system,(Hoeks et al., 2000) and highly dependent upon smooth muscle 
contraction within the cycle. (Armentano et al., 2006; Haga et al., 2007)  
Interestingly, the study results suggest that viscoelastic wall properties could have beneficial damping 
properties on flow pulsatility. Greater viscoelasticity may reduce the detrimental pulsatility in the 
upstream as well as downstream by smoothing out high pulse waves, which could improve 
mechanotransductive signals in the arterial lumen. Because healthy vasculature is often characterized by 
higher viscoelasticity than diseased states, this finding can have significant implications to vascular 
physiology and vascular graft development. Decreased viscoelasticity may therefore be a significant 
contribution to cardiovascular disease progression, supporting previous studies examining changes in 
hysteresis with disease.(Wang et al., 2013c) Results herein additionally introduce catering frequency-
dependent, viscoelastic material properties towards improved hemodynamics, as a novel direction in 
vascular grafting.(Armentano et al., 2014; Neufurth et al., 2015) Further work should be done to fully 
develop these concepts as a metric for disease progression and vascular grafting design criteria. 
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 Future Directions 
Future directions of the work may expand upon the coupling of the material properties to the flow, as 
well as the effects of changed hemodynamics on vascular cells. These two aspects are important in 
establishing viscoelasticity as an important tissue property within the vasculature, improving in vivo 
measurements of arterial properties and flow, as well as providing guidance in vascular graft design. 
 
6.1 Coupling Material Properties and Hemodynamics 
Currently, our work indicates viscoelastic wall properties affect both upstream and downstream waves 
within a steady-state system. This complicates analysis as the radial strain of the conduit is coupled to the 
pressure wave and vice versa. Time-dependent materials are complicated by the material history, 
preventing direct comparison to immediate stresses. While previous work focused on single perturbations 
and material/fluid response after start time,(Bessems et al., 2008; Wang et al., 2016) viscoelastic systems 
have not been examined approaching steady-state response. By recording pulse waves and diameter 
change from the system at rest towards its approach to steady-state would provide some insight into 
conduit diameter and waveform interdependence. 
Experimental setup would be maintained, with the system beginning at rest with cyclic pulse waves 
applied until steady-state is reached. Data may then be analyzed through convolution of the PDMS 
material function with the measured strain and pressure: 
 
𝜎 = ∫ 𝐸(𝑡 − 𝑠)𝜀(𝑠) 𝑑𝑠
𝑡
0
 
Resulting data would aid in coupling frequency-dependent material properties to steady-state response 
of the conduit. 
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6.2 Application of Cells 
Applying cells to the inner surface of the lumen is the logical next step for understanding fluid effects 
on improving cell response. This may be done through functionalization of the PDMS lumen surface, and 
covalently attaching polypeptides capable of cell attachment, such as RGD. Due to the three-dimensional 
nature of the PDMS lumen, functionalization would require chemical treatment using hydrochloric acid 
and hydrogen peroxide,(Llobera et al., 2011) followed by APTES attachment. Poly(ethylene glycol) 
(PEG) with N-hydroxysuccinimide ester (NHS-ester) functional end groups may be used to bridge amine 
groups on both APTES and YRGDS while providing increased surface hydrophilicity, thereby providing 
an ideal surface for cell attachment. Preliminary work has been completed, indicating PEG and 
fibronectin (FN) protein binding to the PDMS surface (figure 6.2.1). 
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Figure 6.2.1- Fourier transform infra-red spectroscopy (FTIR) measurements (Left) and x-ray 
photoelectric spectroscopy (XPS) sweep (Right) of surface chemistry on treated PDMS. FTIR data shows 
characteristic NHS-Ester (triplet band at 1744 cm-1, 1788 cm-1, and 1816 cm-1) and PEG peaks (shift 
towards 2900 cm-1). Addidionally, xps survey data (Right) shows greater concentrations of Nitrogen, 
indicating binding of greater Nitrogen amounts with APTES, NHS-ester groups, and finally fibronectin 
(FN). 
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As introduced in chapter 2, and shown in chapter 3, pulsatile fluid shear applied to endothelial cells 
may induce pathological responses, inducing inflammatory response. Mechanical signaling resulting from 
wall shear stress (WSS) may act in concert, or contrast to other signals, such as wall stretch and pressure 
mechanical signaling, reducing or exacerbating inflammatory response. While previous work has 
examined mechanotransduction of single signals,(Elliott et al., 2015; Haga et al., 2007; Scott et al., 2013) 
they have not been examined in concert, except in the body. Therefore, by attaching cells to the inner 
surface of the lumen, signal combinations may be examined to establish cellular response to multiple 
additive or subtractive signals. 
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APPENDIX 1: Mechanics of the Tube 
A1.1 Thick-Walled Pressure Vessel Mechanics 
A1.1.1  Material Characterization 
 
Figure A1.1.1.1- Strain sweep on PDMS gels with 108 kDa v-PDMS chains, and 1 million CSt 
viscosity. At 10% strain, complex modulus values begin to decrease, indicating strain softening. This 
softening effect decreases for softer gels. 
 
As can be seen in results shown above, strain softening begins to occur at approximately 10% strain 
for stiffer gels (30%-50%), and occurs outside the range in softer gels (70%-80%). This range is well 
within the proposed compliance of 5-9%.  
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Figure A1.1.1.2- Shear modulus magnitude (|G*|) and ratio of viscous to elastic response (tan(δ)). 
Material stiffness and viscous response both correlate well with increased m-PDMS, as seen in the 
literature. 
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Table A.1.1.1- Frequency dependent material properties of poly(dimethylsiloxane) (PDMS).  
 
A1.1.2  Radial Wall Strain 
 Thick-walled pressure vessel mechanics were used to cater inner lumen mechanics to two 
different compliances. This was done by casting the compliant tubes within a polypropylene jacket, which 
was treated as rigid. This allowed similar material properties between the viscoelastic and the elastic 
tubes, and equivalent frequency-dependent material properties between compliant and non-compliant 
tubes. Governing equations for the compliance of the thick-walled pressure vessel began with equation 
listed in section 5.3.2.  
ur(𝑟) =
1 − 𝜈
𝐸∗
(𝑟𝑖
2𝑝𝑖 − 𝑟𝑜
2𝑝𝑜)𝑟
𝑟𝑜
2 − 𝑟𝑖
2 +
1 + 𝜈
𝐸∗
(𝑝𝑖 − 𝑝𝑜)𝑟𝑖
2𝑟𝑜
2
(𝑟𝑜
2 − 𝑟𝑖
2)𝑟
 
Where, |E*| is the magnitude of the complex shear modulus of the material, ν is 0.5 for Poisson’s ratio 
for PDMS, pi is the pressure inside the lumen, po is the pressure at the outer wall of the rigid jacket, ri is 
the starting inner lumen radius, and ro is the radius of the outer jacket.  
Here the outer pressure must be solved for by setting the motion at the outer radius to 0, and solving 
for po: 
𝑢𝑟(𝑟𝑜) = 0 → 𝑝𝑜 =
4𝑟𝑖
2
𝑟𝑜
2 + 3𝑟𝑖
2 𝑝𝑖   
This may then be inserted for po: 
  Elastic 
(58.8% 500 CSt : 108 kDa PDMS) 
Viscoelastic 
(70% 1M CSt : 108 kDa PDMS) 
Material 
Properties at 1 Hz 
E’ = 68.9 kPa 
E’’= 4.09 kPa 
tan(δ) = 0.06 
 Method: DMA 
E’= 67.1 kPa 
E’’= 32.3 kPa 
tan(δ) = 0.482 
 Method: Rheometry 
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𝑢𝑟(𝑟 = 𝑟𝑖) =
𝑝𝑖
2 𝐸∗
3𝑟𝑖(𝑟𝑖
2 − 𝑟𝑜
2)
2
(𝑟𝑜
2 − 𝑟𝑖
2)(𝑟𝑜
2 + 3𝑟𝑖
2)
 
Form this we can integrate the measured frequency-dependent values of the material, and harmonics of 
the complex pressure wave by applying a discrete Fourier transform: 
𝑢𝑟(𝑟 = 𝑟𝑖) = ℱ
−1 {
ℱ{𝑝𝑖}
𝐺∗
}
𝑟𝑖(𝑟𝑖
2 − 𝑟𝑜
2)
2
2(𝑟𝑜
2 − 𝑟𝑖
2)(𝑟𝑜
2 + 3𝑟𝑖
2)
 
From this, we can then prepare for the tube mechanics. 
A1.1.3 Longitudinal Strain 
 Longitudinal strain would result from radial distension. This may be based on isovolumetric 
properties of PDMS (ν = 0.5). Therefore, in examining a maximum radial strain of 10%, the change in 
longitudinal strain may be determined by simply accounting for the change in area resulting from radial 
strain: 
𝑉 = 𝑐𝑜𝑛𝑠𝑡.→ 𝐿 ∙ 𝐴 = 𝐿0 ∙ 𝐴0 
𝜀𝑥 =
𝐿0𝐴0
𝐴 − 𝐿0
𝐿0
=
𝐴0
𝐴
− 1 =
𝑟𝑜
2 − 𝑟𝑖
2
𝑟𝑜
2 − (𝜆𝑟𝑖)2
− 1 
Where λ is the stretch ratio of the radial deformation. Applying conservative projected values of 
lambda towards both compliant and non-compliant tubes, (λ = 0.9 and 0.98, respectively). Resulting 
longitudinal strain values were 0.66% and 1.3% for compliant and non-compliant, tubes respectively. 
 
A1.1.4 Error in Radial Strain 
To ensure radial strain occurs within a given error boundary across the tube, radial strain was given as 
a function of lateral translation of the lumen and location along the circumferential coordinate. The 
resulting equation for the radius was given as a function of pressure: 
𝑟𝑖(𝑃) = 𝑟𝑖(90 𝑚𝑚𝐻𝑔) =
90 𝑚𝑚𝐻𝑔
𝐺1
∗
𝑟𝑖(𝑟𝑖
2 − 𝑟𝑜
2)
2
2(𝑟𝑜
2 − 𝑟𝑖
2)(𝑟𝑜
2 + 3𝑟𝑖
2)
+ 𝑟𝑖 
Where, the outer radius becomes: 
 154 
 
𝑟𝑜(𝛿, 𝜃) = (𝑟𝑜(1 + 𝛿 𝐶𝑜𝑠(𝜃)))
2 
∴ 𝑟𝑖(𝑃) → 𝑟𝑖(𝑃, 𝛿, 𝜃) 
By making the outer radius a function of error (δ) and θ, we may then establish the error in cross 
sectional area by summing the area over fixed intervals of θ. 
𝐴(𝛿, 𝜃) =
1
2
∫ 𝑟𝑖(90 𝑚𝑚𝐻𝑔, 𝛿, 𝜃)
2 𝑑𝜃
2𝜋
0
=
𝑑𝜃
2
∑ 𝑟𝑖(90 𝑚𝑚𝐻𝑔, 𝛿, 𝑛 𝑑𝜃)
2𝜋/𝑑𝜃
0
 
This may then be compared to the area of a perfectly centered inner lumen, with the δ term equivalent 
to 0: 
∆=
𝐴(𝛿)
𝐴0
− 1 
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Figure A1.1.4.1- The error is positive here at low values of δ due to the summation approximation for 
integrating the cross-sectional area value. By summing the area value, some area is not included within 
the calculated error. 
 
APPENDIX 2: Normalization of the Flow System 
A2.1 Normalizing Flow from Tee-Junction 
To ensure minimal wave reflection and establish accurate volumetric flow within the flow system, 
connective tubing of the same cross-sectional area as the conduit must be used. To accomplish this, tee-
junctions are connected to the fluid system, and Q-sensors are placed in parallel branches to the conduit 
line (figure A2.1.1). 
 
 
Figure A2.1.1- Different Flow (Q) sensor setup to determine effects of tee-junctions on volumetric flow 
rates. Here we see the experimental setup used to reduce wave reflections, inline measurement to compare 
phase shifts due to the tee-junction, and staggered measurement to compare Fourier harmonic amplitudes 
between the large conduit and smaller, parallel conduit. 
 
 In comparing volumetric flow rates between the parallel and staggered measurement setups, we 
may examine resulting phase shift and amplitude changes, respectively. Measuring in parallel demands 
that the outlets of the tee-junction have the same cross-sectional area, removing the effect of impedance 
change between the two outlets. Resulting Fourier constants indicate similar flow splitting between tee-
junction outlets (figure A2.1.2), as well as phase shifts below measurement threshold (224 Hz  0.004 s) 
for phase shift of the Q-measurement. Because the distance between both the parallel and perpendicular 
outlets is near zero, this measurement is most accurate for determining the time shift caused by splitting 
the flow with a tee-junction. 
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Figure A2.1.2- Power ratio (left) of the Fourier constant moduli. This was solved by finding the quotient 
between the Fourier power series of the parallel tee-junction outlet Q-measurement and the perpendicular 
tee-junction outlet. The time shift of each harmonic was also measured by the quotient of the phase shift 
between outlets and the angular momentum (
𝜑‖−𝜑⊥
𝜔
), and compared to the sampling threshold (0.004 s). 
 
 Measuring with a staggered setup allows for the flow to split at the tee-junctions according to the 
head loss of the tee, as well as the change in impedance due to reduced cross-sectional area of the Q-
measurement. This additionally allows for the applied flow wave to be measured directly, and compared 
to the Q-measurement forced by the tee-junction. Here, we may see a drastic increase in harmonic 
moduli, with a minimal time shift of the primary harmonic. We may establish that this shift is due to the 
offset nature of the parallel measurement. Therefore, we may simply view the change in harmonic power 
to determine Q-wave amplitude in our experimental data. We multiply all Q Fourier Harmonics by the 
ratios plotted below in figure A2.1.3. 
 
 
Figure A2.1.3- Power ratio (left) and time shift (right) of the Fourier constants from flow (Q) measured 
with a staggered Q-meter setup. This was solved similar that stated above. The time shift of each 
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harmonic was also measured by the quotient of the phase shift between outlets and the angular 
momentum (
𝜑‖−𝜑⊥
𝜔
), and compared to the sampling threshold (0.004 s). 
